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INTRODUCTION
The human immune system harbors the potential to generate novel lymphoid organs within 
inflamed tissues during disease. These tertiary lymphoid organs (TLOs) resemble lymph nodes 
and can contain segregated T and B cell areas, germinal centers, high endothelial venules and 
follicular dendritic cells (FDCs)1,2. While TLO formation is likely to have evolved as a means to 
locally create an optimal environment for local eradication of infections, evidence is culminating 
that during chronic or auto-immune inflammation TLOs contribute to sustaining aberrant in-
flammation, and serve as a site for activation of auto reactive lymphocytes3,4. TLO-like structures 
can also contribute to the survival of malignancies, since disseminated follicular lymphoma in the 
bone marrow induces TLO-like structures to acquire a survival supportive microenvironment5,6.
In animal models, the development of TLOs with a higher degree of cellular organization, i.e. 
the segregation of T and B cells and the formation of B cell follicles, is guided by mechanisms 
similar to those guiding formation of murine lymph nodes during embryogenesis1,2,7,8. A crucial 
event in organized TLO formation is  lymphotoxin-β-receptor (LTbR)-dependent initiation of 
homeostatic chemokine production9. TLO formation is preceded by the accumulation of activat-
ed lymphocytes, a process guided by inflammatory chemokines. These chemokines will in most 
cases be produced by activated cells of the innate immune system10. Subsequently, two criteria 
are thought to be needed for TLO development. First, expression of the LTbR on tissue-resident 
stromal or reticulum cells and second, a persistent stimulus such as an auto antigen to ensure 
the prolonged influx of activated, lymphotoxin-expressing lymphocytes2,8. The subsequently 
achieved continuous signaling via the LTbR will lead to a switch in chemokine production, in 
which homeostatic chemokines will eventually be favored over the inflammatory chemokines 
mainly produced during the initial acute phase of the response9. Eventually, this will result in the 
influx of naïve lymphocytes and organization into T and B cell areas11,12
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Chapter 1
Lymph node development in mice
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Figure 1. LTi cell – LTo cell interactions in LN development. Mature lymphoid tissue inducer cells (LTic) ligate 
the lymphotoxin-beta receptor (LTβR) expressed by LTo cells which are triggered to express adhesion molecules and 
chemokines in order attract and retain more LTic: a positive feedback loop.
TLO formation in experimental systems was shown to display a high degree of similarity with 
murine lymph node development. In mice, lymph node development starts between days 12 
and 14 gestation, depending on the location of the lymph node13,14. This process is initiated 
via paracrine interactions between at least two cell types: sessile stromal cells and specialized 
circulating immature lymphoid tissue inducer (LTi) cells. At prospective lymph node locations 
retinoic acidprobably produced by adjacent nerve fibers, induces the expression of the homeo-
static CXC-chemokine ligand 13 (CXCL13) by local stromal cells of mesenchymal origin and 
this attracts CXCR5+ pre-mature LTi cells 15.Upon clustering, immature LTi cells start to express 
surface lymphotoxin induced by signaling through the IL-7Rα and RANK16-18. As depicted in 
Figure 1, mature LTi cells subsequently ligate the lymphotoxin-β receptor expressed by stromal 
cells, which are now designated lymphoid tissue organizer (LTo) cells, and this event leads to 
the production of the homeostatic chemokines CCL19/CCL21,elevated levels of CXCL13 and 
the expression of the adhesion molecules VCAM-1, ICAM-1 and MAdCAM-113,19,20. The up-
regulation of the homeostatic chemokines and adhesion molecules allows for the initiation of 
a positive feedback mechanism by which additional lymphotoxin-expressing cells are recruited 
and retained, reciprocally ensuring the continuous triggering of the LTβR.
In 2008, Katakai and colleagues identified the adult equivalent of LTo cells in fully developed 
SLOs and designated these cells Marginal Reticular Cells (MRCs) 21 They showed that these cells 
are developmentally programmed and depend on LT-signaling for their phenotypical integrity. 
The role of these cells has not been identified yet. Besides lymphotoxin- and the LTβR sev-
eral other genes were proven to be indispensable for murine lymph node development, mostly 
through the generation of gene targeted mice. These include knockouts for members of the 
TNF-superfamily (RANK and RANKL)22-24, chemokines and their receptors (CXCL13/CXCR5, 
CCL21,CCL19/CXCR7)25,26 and cytokine receptor signaling molecules (common-γ-chain, 
IL7Rα)27-29 (for an overview see 2,8). In subsequent developmental stages, high endothelial venules 
(HEVs) are formed, enabling the entry of cells from the circulation (reviewed in2,8). Postnatally, 
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the typical lymphoid architecture starts to become apparent from day 2, when mature T cells exit 
the thymus, flood the periphery and enter the developing lymph nodes. At day 4, T and B cells in 
the lymph node have segregated, although no B cell follicles have formed yet. This occurs at day 
7, when clearly discernable follicles containing FDCs can be readily detected30. Figure 2 depicts 
a schematic overview of an adult lymph node.  In green the B cell zone with FDCs, follicles and 
germinal centers. In blue the T cell zone where TRC produce CC21 and HEVs end. Blood vessels 
enter and leave the lymph node at the hilum. Lymphocytes in the blood enter the LN via the 
HEV. In the cortex (green area) B cells reside and are organized in follicles. When an immune 
response is underway, focal points of B cell proliferation known as germinal centers (GC) are 
localized in some follicles. T cells are located within the cortex (blue area) and paracortical area. 
Lymph enters the LN via afferent lymphatic vessels that open into the subcapsular sinus. The 
lymph drains towards the medulla and subsequently into a network of medullary chords that 
converge at the hilum and drain into the efferent lymphatic vessel.
RORC+ innate lymphoid cells
LTi cells belong to the family of RORC+ innate lymphoid cells (ILCs)31 and are derived from a 
common lymphoid progenitor-like precursor that resides in the fetal liver and the bone marrow 
in adult mice and are among the first cells to cluster at developing lymph node anlagen18,32,33. 
Crucial steps in murine Rorc+ ILC development are the expression of the inhibitor of DNA bind-
ing 2 (Id2) and nuclear retinoid-acid receptor related orphan receptor γt (Rorγt). Mice deficient 
for either of these two genes lack LTi cells and all lymph nodes and Peyer’s patches 34-37. For all 
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Figure 2. Schematic overview of an adult lymph node. Cortex is green, the paracortex and medulla blue. Adapted from 
Drayton et al., Nature Immunology, 2006.
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functional purposes, murine LTi cells strongly resemble activated lymphocytes, only without an 
antigen receptor. Based on this observation, we and others have put forward the idea that a close 
relationship exists between the formation of organized inflammatory infiltrates and the forma-
tion of lymph nodes, with LTi cells creating an inflammatory-like response in the developing 
fetus without the need for antigen38,39.
Human LTi cells are characterized as lineage- (lin-; CD3-CD20-CD14-CD34-) cells that are 
CD45int, IL7Rα+, c-Kit+  cells expressing Id2, RORc, LTA, LTB, RANK, RANKL and CCR7 in 
analogy to their murine equivalents. Similar to murine LTi cells, human LTi cells induce the ex-
pression of adhesion molecules on mesenchymal cells through lymphotoxin and TNF signaling. 
40. Human fetal RORC+ ILC produce the inflammatory cytokine interleukin-17A (IL-17) which is 
mainly known to be produced by RORC+ Th-17 cells41-43. IL-17 is associated with a inflammatory 
response against mucosal infections and was shown to play a role in several autoimmune dis-
eases where its effects are not only beneficial but also adverse44,45. In contrast to fetal RORC+ ILC 
postnatal RORC+ ILCs in tonsils and intestines produce the IL-10 family member IL-22, which 
signals through the IL-22R1/IL-10R2 heterodimer (IL-22R)46. Triggering of the IL22-R expressed 
by intestinal epithelial cells initiates the JAK-STAT 3 pathway47,48 and induces the production of 
anti-microbial proteins (AMPs) such as β-defensin-2, RegIIIβ, RegIIIγ and s-100 calcium bind-
ing proteins such as S-100A749-51. IL-22 was shown to be important in the early defence against 
intestinal bacterial infection with Citrobacter rodentium. Mice deficient for IL-22 died within the 
first week after infection with Citrobacter rodentium 52.
Cultured human fetal RORC+ ILCs express several NK cells related molecules, including CD56 
and the natural cytotoxity receptors (NCRs) NKp46, NKp44 and NKp3040. While Nkp46 and 
NKp30 are constitutively expressed by NK cells, NKp44 is only expressed by NK cells upon 
activation. In the murine genome only NKp46 is present53. NCRs are type-I transmembrane 
proteins that associate with ITAM bearing molecules for their intracellular signal transduction 
and are involved in NK cell mediated killing via granzyme and perforin excretion, and the induc-
tion of IFN-γ and TNFα production53,54. So far, several exogenous ligands for NCRs are known. 
In both mice and human the influenza virus hemaglutinin and the Sendai virus hemaglutin-
neuraminidase can bind to NKp4655,56. In mice, NKp46 plays a role in the eradication of the 
influenza virus in vivo57. Furthermore, it has been shown that NKp46 contributes to the lysis of 
monocytes infected with Mycobacterium tuberculosis 58. The involvement of NCRs in the killing 
of murine and human cancer cells has also been described 59,60. 
Human NKp44+RORC+IL-22+ cells share features with both LTi cells and immature conven-
tional natural killer (cNK) cells.  However, a recent study concluded that this lineage- c-Kit+ cell 
population is a functional and developmental distinct lineage from cNK cells61. In contrast to cNK 
precursors, NKp44+RORC+IL-7Rα+ cells maintain RORc expression when cultured in vitro. In 
addition, these cultured cells develop low cytotoxicity and IFN-γ production and killer inhibition 
receptors.  In alignment with these data on human NKp44+RORC+ cells, murine NKp46+Rorγt+ 
15
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cells in the intestines of adult mice also resemble LTi cells and cNK cell precursors. In contrast to 
cNK precursors, NKp46+Rorγt+ IL-7Rα+ cells still can develop in the absence of IL-15 signaling 
and develop no cytolytic activity and IFN-γ production62. Like LTi cells, NKp46+Rorγt+ cells are 
absent in either Rorγt-/- or Id-2-/- mice, and strongly IL-2rg-/- mice. 
Together, these data suggest that a developmental relationship between LTi cells and mucosal 
IL-22 producing NKp44+RORC+ ILCs might exist.
RORC+ ILC in the human fetal intestine
In 1986, Spencer and colleagues made an observation that has led to a great deal of speculation 
in the ensuing years96,97. Before the apparent onset of Peyer’s patch formation, at approximately 
11 weeks gestation, the lamina propria was found to contain infiltrates of CD45+CD4+CD3-HLA-
DR+ cells, which either had a macrophage-like morphology, or presented as spindle shaped cells. 
The extent of these infiltrates increased concomitantly with the age of the fetus examined. At the 
time, the authors assumed that these cells likely represented macrophages and dendritic cells96,97, 
both of which had just recently been reported as expressing the CD4 antigen99. Currently, we 
know that there is a population of Rorc+ ILC present in the fetal murine intestine that expresses 
CD4, the IL7-Rα and c-Kit100,101. As described in chapter two of this thesis, in human fetal in-
testines of 11 gw RORC+ ILCs are also already present. However, these cells lack expression of 
CD4, suggesting that Spencer and co-workers were most likely right in their assumption that 
the CD4+ cells were macrophages or dendritic cells. During fetal development, human intes-
tinal ILC gradually acquire NKp44 expression and contain low levels of IL22 transcripts. The 
NKp44+RORc+IL-7Rα+ innate lymphocytes that reside in the lamina propria of adult intestines 
produce IL22 levels comparable to tonsils40,102 and chapter 2. 
Peyer’s patch development in mouse 
Development of the murine Peyer’s patches is extensively documented63. Three clearly defined 
steps have been identified, the first of which, at E15.5, marks the beginning of Peyer’s patch 
development. At this time, VCAM-1 starts to be expressed by distinct clusters of stromal cells 
located on the anti-mesenteric side of the small intestine63. These VCAM-1 positive stromal 
cells also express Artemin, the ligand for the tyrosine kinase receptor RET64. During the 
second stage, VCAM-1 positive cells recruit RET+CD11c+cKit+lymphotoxin+ cells as well as 
IL7R+lymphotoxin+CD4+CD3- LTic63-65. The VCAM-1-positive stromal cells express the LTβR, 
and upon ligation of this receptor produce IL-7 and homeostatic chemokines such as CXCL1366. 
This will reciprocally lead to increased expression of surface lymphotoxin on LTic, forming a 
self-sustaining Peyer’s patch primordium16. From E17.5, during the third phase of Peyer’s patch 
development, circulating lymphocytes are attracted, start to enter the developing organs and fill 
up the predetermined T and B cell niches65. 
Knowledge on the mechanisms of human lymph node development is still much less detailed 
when compared to mouse. However, careful studies were performed in which the morphological 
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and cellular changes during human lymph node and Peyer’s patch development were recorded. 
In the following paragraphs we will compare these data on human organogenesis with experi-
mental data from murine studies. 
Development of the human fetal immune system
Definitive hematopoiesis in humans is initiated in the Aorta-Gonad-Mesonephros region67. 
Subsequently, at 6 weeks gestation, stem cells make their way to the fetal liver, the primary site 
for hematopoiesis during fetal development. From approximately 16 weeks onward, hematopoi-
etic cells also appear in the bone marrow which will function as the main hematopoietic organ 
postnatally68. B- and NK cells are the most abundant immune cells found in the fetal liver from 
week 8 through 12, while the end of week 12 marks the appearance of the first thymus-derived 
αβT cells in the periphery. These will rapidly increase in numbers during the following weeks68. 
This sequence of hematopoietic events is largely similar during murine hematopoietic develop-
ment. However, the timing is critically different. Murine T cells do not leave the thymus until 
day 2 post-natal69, whereas the human immune system seems to have all cellular components 
available by week 13 and is able to mount an antibody response from the 20th gestational week. 
This means that the human immune system comes of age in an environment made up almost 
solely of self-antigens. To prevent activation of T cells, and the possible generation of an autoim-
mune response, the developing human lymph nodes contain an unusually high proportion of 
regulatory T cells. These cells get activated in the fetal lymph nodes, and subsequently prevent 
activation of T cells by (self) antigens70,71.
Lymph node development in man
The exact number of lymph nodes in the human body remains unknown, but is estimated to be 
as much as 400-60072. Most of our knowledge on human lymphoid organ development stems 
from a series of pioneering studies performed in the 1970’s and 1980’s, employing light and 
electron microscopy to study morphology of the developing organ and its cellular constituents 
as well as immunostainings to identify these cells. 
Formation of lymph nodes and lymph vessels in man is initiated, as it is in mice, by the bud-
ding of endothelial cells from the jugular and cardinal veins, forming a lymph sac73,74. At ap-
proximately 8-11 weeks gestation, the first lymph node anlage, or primordium, is formed when 
mesenchymal cells that condensed at the base of the lymph sac, subsequently invaginate into 
the lymph sac, moving the endothelium inwards75,76. Besides mesenchyme, the tissue invading 
the lymph sac contains capillaries, vascular loops, fibroblastic reticulum cells (FRCs) and extra-
cellular matrix75,76. By 13 weeks gestation, the mesenchyme fills nearly the whole lymph sac, while 
the remaining space between the endothelial lining of the lymph sac and mesenchymal core 
gives rise to the marginal sinus. In addition, the number of capillaries increases and intermedi-
ate sinuses begin to develop. The outer side of the marginal sinus is surrounded by connective 
tissue which will eventually form the capsule of the lymph node75,76.Lymph node generation in 
mice is temporally controlled by the need for ligation of the LTβR during a distinct window in 
Chapter 1
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time. By blocking lymphotoxin signaling in-utero, Rennert et al. were able to show that murine 
lymph nodes develop in sequence, roughly head to tail, with brachial nodes being among the 
earliest formed, followed by axillary, inguinal, and popliteal13. In humans, similar observations 
were made by Kyriazis and Esterly, who performed a study in which 50 fetal specimens were 
analyzed77. The gestational age of each specimen in this study was estimated from the crown-
rump length and the maternal menstrual history. The first peripheral lymph node structures that 
were found were located in the cervical and retroperitoneal regions of the embryo in specimens 
of approximately 8 weeks gestation (measuring 2.5 to 4.0 cm). In the next group of specimens 
measuring 4 to 6 cm (approximately 9 to 10 weeks gestation), peribronchial, mediastinal, celiac, 
pelvic, axillary, inguinal and popliteal nodes were detectable. Omental and mesenteric lymph 
nodes were only found in the oldest samples analyzed, measuring 10-14 cm (approximately 18 
weeks gestation)77. While this study was performed using light microscopy, and small lymph 
node anlagen could obviously have been missed (mesenteric lymph nodes can be found at 13 
weeks gestation (70 and our unpublished data), the overall picture is very similar to that distilled 
from experimental data in the mouse. It is therefore very well possible that in humans a similar 
temporal control of lymph node development exists as in mice. Whether such control is also 
regulated by LTβR signaling is still undetermined.
Development of the lymphoid architecture
From the 12th week gestation onward, when T cells start to flood the periphery, the number of 
circulatory cells that enter the lymph node increases rapidly and includes, besides lymphocytes 
also cells from the erythropoietic and granulopoietic lineages (Figure 1). As a result of this influx 
the lymph node grows in size considerably 76-78. At 14 weeks, CD4+ T cells are scattered through-
out the axillary lymph node anlage, but CD8+ cells are scarce78. At the same time, B cells are found 
mainly in the outer cortex, although not yet arranged in lymphoid follicles. During subsequent 
weeks, loosely aggregated primary follicles (PF) emerge78,79. These PF also contain precursors of 
follicular dendritic cells, as indicated by their expression of CAN.42 and Ki-Mp480. However, 
CD35 and CD21, hallmarks of functional FDCs, are still absent 78. Clearly demarcated B cell 
follicles are found from 17 to 22 weeks onward. Coinciding with the appearance of these densely 
packed follicles is the expression of CD35 and CD21 on FDCs79,80.
Similar kinetics are seen when the non-hematopoietic cells in the lymph node were analyzed. 
Using light and electron microscopy, precursors of interdigitating cells (IDCs), identified based 
on morphology, are mainly located near the marginal sinus of the axillary lymph nodes ana-
lyzed76. During the 2nd trimester, precursors of IDCs become more differentiated and are located 
in the paracortical region76. From the 16th week gestation, the first fibroblastic reticulum cells 
are found in the paracortical regions of the lymph node, marking the formation of a T cell zone. 
The demarcation of cortex and medulla become more distinct with the increase in gestational 
weeks. As observed by light and electron microscopy, the marginal, intermediate and medullary 
sinuses become more developed76. Compared to the cortex, the medulla has a looser structure of 
mainly mesenchymal cells and contains more hematopoietic cells. The T cell regions are located 
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in the cortex with almost fully differentiated IDCs76,79 In the B-cell regions, primary follicles are 
clearly defined but contain no germinal centers (GCs)76,77,79. This will occur in the first postnatal 
weeks till months, when their formation is driven by antigenic stimuli81. 
12 14 17
p2 p4 p7
HUMAN
weeks gestation
MOUSE
days postnatal
T cells enter the
lymph node
birth
FDC-containing
B cell follicles
cortical and 
medullary areas 
are formed
MAdCAM-1 and
PNAd on HEVs
Figure 3. Temporal alignment of lymphoid architecture development in mouse and man. T cells leave the thymus and 
enter the periphery at day 2 postnatal in the mouse, and by week 12 gestation in humans. By day 4 postnatal, or week 14 
gestation, distinct T and B cell areas are visible, without B cell follicles. Formation of FDC-containing follicles is com-
pleted in mouse and man by day 7 postnatally or week 17 gestation respectively. The dates given for human are averages 
and will vary between individuals as well as between lymph node locations.
Adressins regulating fetal lymph node homing
To facilitate the interactions between circulating lymphocytes and the local stroma that will drive 
lymph node development, the correct cells need to be recruited from the circulation at the right 
time. To this end, expression of addressins on HEVs is crucial. In adult mice, theperipheral 
node addressin PNAd is expressed on HEVs in all peripheral lymph nodes82. PNAd is the ligand 
for the homing receptor L-selectin, which is expressed on the vast majority of circulating lym-
phocytes. On the other hand, lymph nodes draining the mucosa, as well as the Peyer’s patches 
express MAdCAM-1, the ligand for α4β7 on their HEVs resulting in the selective homing of 
α4β7 positive cells to the mucosal lymphoid organs83. In contrast, during fetal murine develop-
ment HEVs in both peripheral and mesenteric lymph nodes exclusively express MAdCAM-1. At 
this time, 40-70% of circulating cells expresses L-selectin, and only about 1-2% is α4β7 positive. 
As a result, this minor portion of fetal α4β7 positive cells, including murine LTic, is selectively 
recruited to the developing lymph nodes and Peyer’s patches84. From approximately 24 hours 
after birth onward, PNAds start to be synthesized and are expressed on HEVs in both peripheral 
and mesenteric nodes85,86. After the second postnatal week, peripheral MAdCAM-1 expression 
starts to decline and will eventually only be present in the mucosa draining lymphoid tissues. 
In the developing lymph nodes of the human fetus, the first HEVs can be identified at 15 weeks 
gestation87. In contrast to the mouse, both peripheral and mesenteric nodes co-express PNAd 
and MAdCAM-1 on their HEVs prenatally and this is maintained throughout fetal development. 
Postnatally, the number of HEVs expressing PNAd in peripheral lymph nodes keeps increasing 
for several years. Similar to mouse development, MAdCAM-1 positive HEVs gradually disap-
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pear from the peripheral lymph nodes after birth, although MAdCAM-1 positive vessels are 
occasionally found in adults87. Even though the fetal co-expression of peripheral and mucosal 
addressins in humans is different than in mice, it needs to be determined whether this leads 
to functional differences in colonization of the developing lymph nodes. Thymic-derived αβ-T 
cells leave the mouse thymus at 2 days after birth and the human thymus at week 1268,69. In both 
cases, when reaching the developing lymph node, these cells will encounter HEVs decorated with 
MAdCAM-1 and PNAd and in both cases they will be able to enter the organ using either α4β7 
or L-selectin. However, the most striking difference with mouse development is the promiscuous 
expression of MAdCAM-1 in embryonic and fetal lymphoid and non-lymphoid tissues. From 7 
weeks onward, this addressin is present on endothelial cells in the pancreas, gallbladder, kidney, 
skin and intestines, as well as in muscle tissue. In the intestines MAdCAM-1 expression outside 
of the lymphoid areas is of such prominence, that, based on addressin expression, the developing 
Peyer’s patches cannot be distinguished from the surrounding tissue87. Non-lymphoid organ-
restricted MAdCAM-1 expression peaks around week 20-23 and subsequently disappears quite 
rapidly. During the second trimester, MAdCAM-1 is also transiently expressed in the spleen and 
thymus87. It is at present unclear whether the transient broad expression of this addressin has 
functional implications in terms of hematopoietic cell migration to these non-lymphoid organs. 
However, during human fetal development, it is not uncommon to find transient lymphoid 
infiltrates containing distinct T and B cell areas in organs such as the pancreas and lung88,89.
Signaling pathways driving human lymph node development
In the mouse, signaling cascades downstream of the IL7R (consisting of the IL7Rα chain and 
the IL2Rβ or common-γ-chain) were shown to be instrumental in regulating surface expression 
of lymphotoxin on LTic and to control their proliferation16,90. As a consequence, IL7 receptor 
signaling is essential for murine lymph node-development. Mice with defects in this signaling 
route, including deficiencies for the common-γ-chain or Jak3, have a severe impairment of lymph 
node development27-29. Interestingly, one of the very few clues on signaling cascades essential for 
human lymph node development also implicate the common-γ-chain/Jak3 pathway as essential. 
Upon postmortem examination of 46 patients who died as a result of various Severe Combined 
Immunodeficiency Diseases (SCIDs), patients who had suffered from SCID due to mutations in 
the common-γ-chain (Xq13.1) or Jak3 (19p13.1) presented with an absence of lymph nodes91. 
In addition, one patient not having had either common-γ-chain or Jak3 mutations also had no 
detectable lymph nodes. The underlying mutation in this patient has however not been deter-
mined. These findings imply that signaling via the common-γ-chain and Jak3 is also in humans 
indispensable for normal lymph node development. Recent work has shown that IL7R mutations 
are the third most common cause of SCID in the United States92 and therefore the possibility 
remains that the un-typed lymph node-deficient SCID patient described by Fachetti et al. indeed 
harbored such a mutation. In addition, Vonarbourg and colleagues found that in patients with 
an IL7R deficiency IL-22 producing CD117+RORc+ were virtually absent93.
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Peyer’s patch development in man
The fetal human small intestine contains on average 60 Peyer’s patches before 30 weeks gestation, 
but their number steadily increases to reach an astonishing average of almost 240 at puberty94. To 
our best knowledge the earliest study on the formation of lymphoid organs in the human intes-
tine dates back to 1882, when Adolf Baginsky described the presence of clusters of “nice round 
cells” in the sub-mucosa of the terminal ileum of a 4 month old fetus95. Detailed analysis of fetal 
human small intestines by light microscopy led several groups to confirm and extend Baginskys 
original observation with the identification of clearly distinct clusters of T and B cells in the small 
intestine at 14-16 weeks gestation89,94,96-98. By week 19, these aggregates have matured into clearly 
recognizable Peyer’s patches containing FDCs, although no germinal centers are present. The 
latter rapidly develop after birth, when the intestines become colonized by commensal bacteria. 
It is not until 24 weeks gestation that the Peyer’s patches have sufficiently increased in size to 
become discernable macroscopically94. 
Spleen development
Development of the spleen differs in the requirement for LT signals compared to lymph node 
development. Mice deficient for Rorγt and/or Id2, lack LTi cells and no LNs and PPs develop. 
However, these mice do have spleens with segregated B and T cell compartments103,104. The 
specific role of LTi cells in the development of the lymphoid tissue of the spleen, the white pulp 
(WP), is still not fully elucidated. Data show the lack of requirement of lymphotoxin (signaling) 
for a proper development of the WP is mostly obtained in spleens from newborn mice from day 
4 and onwards in which B cells that express lymphotoxin colonize the spleen105. Lymphotoxin+ 
B cells are capable of inducing CCL21 production by resident stromal cells to induce the de-
velopment of the T zone, the PALS, prior to B cell follicle formation. RAG-/- mice lack B and T 
lymphocytes and have very low expression of CXCL13 and CCL21 which is necessary for T and 
B cell segregation106. However, grafting experiments of E 15 LTα-/- spleens in adult RAG-/- hosts 
followed by transfer of LTα-/- splenocytes revealed no requirement of lymphocyte derived LTα 
in the induction of CCL21107. These data suggest that interactions between adult LTi cells and 
embryonic stromal cells occur. More recent data show that LTi cells in the murine neo-natal 
spleen do not express membrane-bound lymphotoxin and that segregation of the RP and WP is 
primed in a LT-independent manner before E 15.5108.
The development of the human fetal spleen has been characterized by performing electron 
microscopy and immunohistochemistry on paraffin embedded fetal spleens. Together, these 
studies give an overview of the cellular hematopoietic and non-hematopoietic organization in 
fetal spleens varying from the 11th gestational week (gw.) until newborn children109-112.  However, 
no study has touched upon the presence of stromal LTo-like cells in WP development and the 
interaction of stromal cell subsets with B and T cells and LTi cells. Whether stromal LTo(-like) 
cells are present in the developing human spleen and if they play a role in the development of the 
WP is currently unknown (see chapter 5 of this thesis). 
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Models to study human lymphoid organ development
In addition to detailed observational studies on human fetal tissues of sequential stages, which 
were discussed in previous sections, few techniques have been developed that could allow func-
tional studies on human lymph nodes. The most promising technique may very well be trans-
plantation of individual human fetal lymph nodes in immuno-deficient mice. Several groups 
have shown that this is technically possible, without overt signs of rejection in the SCID hu model 
either combined with thymus and liver or as solitary lymph node transplant113,114. Depending 
on the pretreatment regiment, lymph nodes were shown to grow extensively, while maintain-
ing their original architecture114. In an independent model, co-transplantation of human fetal 
bronchial tissue and the peribronchial lymph nodes in SCID mice, led to increased survival of the 
lymph node, again with preservation of T and B cell areas115. In this study, the authors speculate 
that similar co-transplantation approaches may also work for other mucosal tissues such as the 
intestines. If proven correct, such techniques could allow for the in-vivo monitoring of lymph 
node and Peyer’s patch development. Finally, γc/RAG2-deficient mice reconstituted with hu-
man fetal liver or cord blood stem cells116,117 could be a suitable model to study organization 
of human lymphocytes within the few endogenous murine lymph nodes still present in these 
animals. Using this system, the development of a near normal splenic architecture was described, 
although no data exist on lymph nodes117.
Lymphoid malignancies recapitulating early lymphoid organogenesis
Tightly regulated bi-directional interactions between hematopoietic cells and local stromal 
cells are at the basis of lymphoid organogenesis8,118. Lymphotoxin expressed on LTic induces 
chemokines, cytokines and adhesion molecules in stromal cells, which in turn regulate retention, 
survival and proliferation of LTic. At later stages, in the postnatal lymph node, B cell derived sig-
nals maintain the B cell follicle through interactions with FDCs and the local mesenchyme119,120. 
Similar interactions are known to exist between malignant lymphocytes and their microenviron-
ment. This is especially apparent for low grade B cell malignancies like chronic lymphocytic 
leukemia (CLL) and follicular lymphoma (FL) that originate from the lymph node121. Where 
high grade B cell malignancies are characterized by intrinsic abnormalities in proliferation and 
or differentiation, the low-grade malignancies often present with survival abnormalities that are 
in part mediated by external signals. CLL cells will go in apoptosis in vitro, unless cultured in the 
presence of IL-4 or IFN- α or γ122-124. However, culturing CLL cells in the presence of stromal cells 
from lymph node or bone marrow, rescues the leukemic cells from apoptosis and supports their 
survival125,126. CLL cells, together with CD4+ T-cells, are present in a nodular fashion surround-
ing FDCs in lymph nodes and induce similar structures de-novo upon spreading to the bone 
marrow.127,128.  Furthermore, CD40 expression is up regulated in many cases of CLL compared 
to healthy donors5. A pivotal role of cross-talk between the stromal microenvironment and the 
B cell tumor was also shown for FL.  The role of the microenvironment as a prognostic factor 
for FL progression has gained appreciation129-135. FL cells have a close association with FDCs136, 
as well as with the local stroma in the B cell follicle of the lymph node. Upon spreading to the 
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bone marrow, FL cells also arrange in follicular-like structures, inducing FDCs from the bone 
marrow-mesenchyme.5. Thomazy and colleagues (2003) used transglutaminase as a marker of 
the extracellular reticulum network and found it to be up regulated in areas surrounding FL 
nodules137. In addition to this, BM biopsies of FL patients show high expression of CD40 and 
VCAM-1 by adventitial reticulum cells5. Recent work has shown that FL cells arising in the LN 
depend on interactions with FRCs for their survival138. Strikingly, upon spreading to the BM, 
FL cells can locally induce the differentiation of BM-mesenchymal cells into LN-like FRCs, a 
process that can be mimicked in-vitro139. These in-vitro experiments indicate an involvement of 
Lymphotoxin and TNFα in this process, in line with the role of these molecules in normal lymph 
node development. In essence, both FL and CLL are mimicking normal development and dif-
ferentiation of lymph node stromal cells in order to create a lymph node-like environment in the 
bone marrow that will ensure their survival. This suggests that remodeling of the non-malignant 
microenvironment in the bone marrow by malignant B cells might occur along similar lines as 
the generation of lymph node stromal cells during embryogenesis. Elucidating the molecular 
pathways involved in human lymph node development might therefore generate knowledge that 
will open up the non-malignant stromal microenvironment of the lymph nodes and the bone 
marrow as novel therapeutic targets in low-grade B cell malignancies.
Aim and outline of this thesis
During the second half of the last century, a substantial amount of knowledge has been gathered 
on the morphological changes in developing human lymph nodes during embryonic and fetal 
development (chapter 1). Overall, human and mouse lymph nodes seem to develop via similar 
schemes, both during early organogenesis as well as during the generation of the lymphoid 
architecture. The major difference is that lymphoid architecture forms prenatally in humans, yet 
postnatally in mice (Figure 1). While human LTic in fetal LNs and intestine have been described, 
knowledge on stromal organizers in humans is very poor. Observations made in SCID patients 
indicate the common-γ-chain/Jak3 as essential for human lymph node development. Determin-
ing which of the common-γ-chain cytokines is responsible for the lack of lymph nodes in these 
patients is of great interest. Finally, basic knowledge on the early events in human lymph node 
development could be a first step towards an understanding of the manipulation of the stromal 
environment by malignant lymphocytes. The fact that impaired crosstalk between stromal cells 
and lymphocytes can lead to disturbed lymph node development in mice and presumably man, 
suggests that targeting the mesenchyme with which malignant cells interact could be a potential 
mechanism to restrain survival of malignant cells. The overall aim of the studies described in this 
thesis is to identify and characterize the cellular and molecular requirements for lymph node 
development in humans.
Human LTic were identified in fetal LNs by Cupedo et al. in 2009 and belong to the family 
of RORC+ innate lymphoid cells (ILC) that play various roles in lymphoid tissue remodeling 
and innate and adaptive immune responses. In fetal LN and inflamed intestines RORC+ ILC 
contain transcripts for IL-17 while these cells in mucosal tissues like tonsils and adult intestines 
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are producers of IL-22. The analysis of a potential role for RORC+ ILC derived cytokines in 
homeostasis and disease is hampered by a poor characterization of cellular subsets and a lack of 
knowledge on the distribution of these cells in adults. We hypothesized the presence of subsets 
of RORC+ ILC with distinct phenotypes and functions in fetal and adult lymphoid and mucosal 
tissues. In chapter 2 we conduct a detailed analysis of RORC+ ILC isolated from fetal and adult 
lymph nodes, intestines and tonsils in order to characterize functional cell subsets within the 
overall RORC+ ILC population. We analyze by flow cytometry the differential expression of 
markers known from literature to be expressed by RORC+ ILC. Next, we determine the cytokine 
producing capacity of various RORC+ ILC subsets in order to designate functional subsets. 
As described in the previous section, human RORC+ ILC are present in fetal and adult tissues 
however knowledge on stromal niches of these cells is very poor. In developing murine lymph 
nodes LTic interact directly with LTo cells. The latter being a distinct stromal cell subset that 
upon activation expresses RANKL, the adhesion molecules MAdCAM-1, VCAM-1 and produces 
both CXCL13 and CCL21. In 2008,  Katakai and colleagues described in murine adult lymphoid 
tissues the Marginal Reticular Cells (MRC). This stromal cells subsets presents with a phenotype 
equivalent to LTo cells. The presence of MRC in human lymph nodes remains elusive. In chapter 
4 we analyze human fetal and adult lymph nodes for the stromal niches of RORC+ ILC. We 
hypothesized that if MRC reside in human fetal and adult LNs, RORC+ ILC might colocalize with 
this stromal subset. Therefore, we analyze frozen sections of fetal and adult lymph nodes for the 
localization of RORC+ ILC. Subsequently we analyze the niches of these cells for the presence of 
stromal cells with an LTo / MRC-like phenotype. In addition, we investigate the gene expression 
profile of the stromal cell subset of the RORC+ ILC niche in adult LNs. 
Since Katakai et al. identified MRC in all murine developmentally programmed lymphoid 
organs we set out to investigate the presence of MRC in human fetal spleens in chapter 5. Here, 
we analyze the developing white pulp of fetal spleens varying from 15 to 20 week for the presence 
stromal cells with a MRC-like phenotype. In addition, we determine whether the gene expression 
profile of the putative MRC is reminiscent of murine LTo cells. We also investigate whether 
RORC+ ILC with the putative MRC.
While murine lymph node development has been characterized extensively, the molecular and 
cellular mechanisms involved in B cell follicle formation and ectopic germinal center formation 
are poorly understood. Follicular lymphoma (FL) cells are malignant germinal center (GC) B 
cells which have the capacity to remodel bone marrow (BM) in such a way it resembles a GC. 
The GC-like structure induced by FL cells in the BM is now capable of providing the FL cells with 
signals essential for survival. In chapter 3 we set out to study the interactions between FL cells 
and BM stromal which eventually lead to the formation of a ectopic GC-like structure. Therefore, 
we set up and analyze a 3-D co-culture system conducted with cell line WSU-FSCCL en fetal BM 
derived stromal cells in order to create an in vitro model that can be applied for FL cell induced 
BM remodeling. To study at early stages the behavior of ectopic FL cells in an environment 
which can be manipulated we use an in vivo xenograft model in RAG-2-/-γc-/- mice as experimen-
tal model. Furthermore, we investigate the genetic alterations induced in the non-hematopoietic 
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compartment of lymph nodes upon entry of B cells. We inoculate RAG-1-/- mice for seven days 
with B cells and isolate and subsequently analyze by micro-array the non-hematopoietic com-
partment of isolated lymph nodes.
  Chapter 6 discusses the conclusions of the previous chapters from a broader and translational 
perspective. 
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ABSTRACT
Human RORC+ lymphoid tissue inducer cells are part of a rapidly expanding family of innate 
lymphoid cells (ILC) that participate in innate and adaptive immune responses as well as in 
lymphoid tissue (re) modeling. The assessment of a potential role for innate lymphocyte-derived 
cytokines in human homeostasis and disease is hampered by a poor characterization of RORC+ 
innate cell subsets and a lack of knowledge on the distribution of these cells in adults. Here we 
show that functionally distinct subsets of human RORC+ innate lymphoid cells are enriched for 
secretion of IL-17a or IL-22. Both subsets have an activated phenotype and can be distinguished 
based on the presence or absence of the natural cytotoxicity receptor NKp44. NKp44+ IL-22 
producing cells are present in tonsils while NKp44— IL-17a producing cells are present in fetal 
developing lymph nodes. Development of human intestinal NKp44+ ILC is a programmed event 
that is independent of bacterial colonization and these cells colonize the fetal intestine during 
the first trimester. In the adult intestine, NKp44+ ILC are the main ILC subset producing IL-22. 
NKp44— ILC remain present throughout adulthood in peripheral non-inflamed lymph nodes as 
resting, non-cytokine producing cells. However, upon stimulation lymph node ILC can swiftly 
initiate cytokine transcription suggesting that secondary human lymphoid organs may function 
as a reservoir for innate lymphoid cells capable of participating in inflammatory responses. 
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INTRODUCTION
There is an increasing awareness that early innate response involve several types of RORC+ and 
RORC— lymphoid-like cells that combine aspects of innate and adaptive immunity including the 
production of cytokines traditionally associated with adaptive immune cells. These innate cells 
are collectively referred to as innate lymphocytes (ILC) and are on the one hand important in 
early immunity to pathogenic bacteria and helminthes as well as tissue integrity after infection, 
while these cells on the other hand can be part of pathology during experimental colitis and are 
specifically expanding in Crohn’s disease patients and allergic rhinosinusitis patients 1-7
The best studied population of RORC+ ILC are lymphoid tissue inducer cells (LTi cells) that are 
present in secondary lymphoid organs and whose prime function is to control fetal development 
of lymph nodes and Peyer’s patches in mouse and man 8,9. Even though lymphoid organogenesis 
occurs in utero, cells that phenotypically resemble LTi cells have been found in adult mice 10,11. 
Similar to fetal LTi cells, adult cells express molecules involved in LN development such as lym-
potoxina1b2, (LT) and TNFa and depend on expression of Rorgt and Id2 for their development 
11-14. 
Although it remains to be determined to what extent adult LTi cells are similar to their fetal 
counterparts in terms of the ability to induce lymphoid organs, adult LTi cells were shown to 
have additional functions in the support of adaptive immune responses by facilitating memory 
T cell generation in the spleen 15,16. In humans, ILC that resemble the mouse LTi cells are pres-
ent in developing fetal lymph nodes 8. In adult mice and humans, RORC+ ILC are found in 
secondary lymphoid organs, in the skin and in the intestines. In mice, RORC+ ILC are essential 
for the first wave of defense against attaching and effacing intestinal pathogens like Citrobacter 
rodentium 4,17. IL-22 produced by ILC activates the epithelium via the IL-22 receptor to produce 
antimicrobial products 4,17,18. In humans, several mucosal ILC subsets that produce IL-22 were 
described. We have previously identified a population of CD56+RORC+ ILC in the tonsil that 
constitutively produce IL-22 8. At the same time, a population of NKp44+RORC+ ILC were 
described in tonsils, Peyer’s patches and small intestines and named NK22 17. Clonal analysis of 
tonsil-derived RORC+ ILC has since shown that CD56+RORC+ ILC and NKp44+ NK22 cells are 
the same population of ILC 19.
NKp44 belongs to a family of activating receptors found on human NK cells. These recep-
tors are collectively termed Natural Cytotoxicity Receptors (NCRs) and next to NKp44 include 
NKp30 and NKp46 20. All three are Ig-like transmembrane receptors that convey activating 
signals to NK cells. NKp46 and NKp30 are expressed constitutively, while expression of NKp44 
is induced upon NK cell activation. NKp46 is also expressed on mouse NK cells, as well as on 
mouse ILC in the intestines. NKp30 and NKp44 are not expressed in Mus. Musculus 20,21. 
Besides production of IL-22, RORC+ ILC in mice and man have been reported to produce 
IL-17a. In man, RORC+ ILC in fetal lymph nodes 8 and inflamed intestines 22 contain IL-17a 
transcripts and in mice, stimulated splenic RORC+ ILC and RORC+ ILC from the small intestines 
were shown to produce IL-17a 23,24.
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In sum, RORC+ ILC from tonsils and fetal lymph nodes differ strikingly in cytokine produc-
tion: tonsil ILC produce IL-22 while fetal lymph node ILC contain only transcripts for IL-17a 
8. Whether in vivo IL-17 and IL-22 are produced by the same population of cells or by different 
ILC populations is still subject to debate 25,26. Clarifying the cellular sources of these functionally 
distinct cytokines will increase our understanding of ILC biology and activation. In this report 
we determined the cellular source of ILC-derived IL-17a and IL-22 and show that these cyto-
kines are preferentially transcribed by distinct subsets of ILC located in peripheral or mucosal 
lymphoid organs respectively. 
RESULTS 
Differential NCR expression on tonsil- and fetal LN-derived ILC
We hypothesized that expression of Natural Cytotoxicity Receptors could be used to distinguish 
ILC subpopulations biased towards production of either IL-17a or IL-22. To test this we first 
compared the ex-vivo expression of NKp30, NKp44 and NKp46 on freshly isolated human ILC 
from fetal lymph nodes versus tonsils. The following phenotypic definition was used for ILC: 
lineage (CD3; CD19; CD14; CD34) negative cells expressing intermediate levels of CD45 and 
high levels of both CD127 (IL7Ra) and CD117 (c-Kit). Cells within this gate were uniformly 
RORC positive (Figure 1a). In fetal lymph nodes, the majority of RORC+ ILC lacked expression 
of NKp46 (Figure 1b). 
Approximately half of the cells expressed NKp30 and a very small fraction of these NKp30+ 
ILC co-expressed NKp44 (Figure 1b). In contrast, the majority of tonsil-derived RORC+ ILC 
expressed NKp44 as well as NKp30. In addition, a substantial fraction of tonsil RORC+ ILC 
expressed NKp46 (Figure 1b). The biggest differences in NCR expression between fetal lymph 
node and tonsils were observed for NKp44 and upon enumeration the percentage of NKp44-
expressing RORC+ ILC was indeed significantly increased in tonsils compared to fetal lymph 
nodes (Figure 1c). These data show that the relative distribution of NCR-positive versus NCR-
negative ILC is different between tonsils and fetal lymph nodes and follows the pattern described 
for IL-22 8.
Next, we assessed the proportion of CD56 expressing ILC in fetal lymph nodes and tonsils. The 
percentage of CD56+RORC+ ILC was low in fetal lymph nodes, but was increased in tonsils 
where on average half of the RORC+ ILC expressed CD56 (Figure 2a). This implies that CD56 
expression follows a pattern similar but not identical to NKp44, and indeed in tonsils only half 
of the NKp44+ ILC population expressed CD56 (Figure 2b). In summary, NKp44, and not 
CD56, is the most prominent cell surface marker differentiating between RORC+ ILC from fetal 
lymph nodes and adult tonsils. 
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Figure 1. NCR expression on ILC from fetal LN and tonsil 
a. Lineage-negative cells in fetal lymph nodes, fetal spleen and tonsil labeled for CD117 and CD127 are RORC posi-
tive. Shaded histogram indicates isotype control staining (representative example of 3 independent experiments). 
b. Flow cytometric analysis of NKp30 (p = 0.07), NKp44 (p = 0.00) and NKp46 (p = 0.03 ) expression on ILC and fetal 
lymph nodes and tonsil c. Percentage of NKp30, NKp44 and NKp46 expressing RORC+ ILC in fetal lymph nodes and 
tonsil (n>5; Average +/- SD.)
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Figure 2. CD56 expression on ILC from fetal LN and tonsil 
a. Percentage of CD56 expressing RORC+ ILC in fetal lymph nodes and tonsil (n > 5; Av +/- SD, p = 0.007) b. Flow cyto-
metric analysis of CD56 and NKp44 expression on RORC+ ILC in fetal lymph nodes and tonsil. (representative example 
of 5 independent experiments)
NKp44 expression allows identification of IL17 and IL22 biased ILC
On NK cells, NKp44 is only expressed upon activation. In addition, production of IL-17a in 
T cells is restricted to activated or memory cells 27. This led us to hypothesize that ILC which 
contain transcripts for either IL17A or IL22 might also be cells with an activated phenotype. To 
test this hypothesis, we analyzed the expression of surface proteins known to be regulated during 
cellular activation on RORC+ ILC cells from fetal lymph nodes and tonsils. The early activation 
marker CD69 was expressed on part of RORC+ ILC, and the combination of CD69 with NKp44 
revealed discrete ILC subpopulations (Figure 3a). In fetal lymph nodes, where the majority of 
cells lack expression of NKp44, CD69 divided the ILC population into a CD69— and a CD69+ 
population. In tonsils, NKp44+ ILC were most abundant, and all NKp44+ cells co-expressed 
CD69. In addition, a small population of CD69+NKp44— cells was present (Figure 3a). 
We next set out to determine the presence of IL22 and IL17A transcripts in these ILC sub-
populations. To this end, the NKp44— ILC were sorted from fetal lymph nodes and separated in 
CD69— and CD69+ populations. From tonsils, NKp44+ ILC were purified and divided in CD69— 
and CD69+ fractions. Transcripts for IL17A and IL22 were determined without ex-vivo stimula-
tion.Within the fetal lymph nodes, IL17A transcripts were enriched within the CD69+NKp44— 
population (Figure 3b, top right). IL22 transcripts were very low to absent in the fetal lymph 
nodes (Figure 3b, top left). In tonsil RORC+ ILC, IL22 transcripts were easily detectable within 
the CD69+NKp44+ population as expected 17 but were much lower in the NKp44— population 
(Figure 3b, bottom left). Transcripts for IL17A were undetectable in tonsil ILC (Figure 3b, 
bottom right).
In order to assess whether the divergent cytokine patterns observed directly ex-vivo are main-
tained after in-vitro stimulation we isolated tonsil NKp44+ and NKp44— ILC and stimulated 
these overnight with PMA and ionomycin. Similar to freshly isolated ILC, overnight stimula-
tion induces IL-22 secretion from NKp44+ ILC, but not NKp44— ILC (Figure 3c), confirming 
the cytokine bias seen directly ex-vivo. TheIL22 induction in NKp44+ ILC by PMA/ionomycin 
stimulation was observed in all donors analyzed, but did however show a high degree of vari-
ability.
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Figure 3. Differential cytokine production by NKp44+ and NKp44— ILC
a. Flow cytometric analysis of CD69 and NKp44 expression on RORC+ ILC from fetal LN and tonsil (representative 
example of 3 independent experiments). b. Expression of IL22 and IL17A mRNA in sorted ILC populations from tonsils 
and fetal LN (Representative of 2 individual experiments with 3 – 5 donors per experiment). c. IL-22 protein production 
by NKp44— and NKp44+ ILC from tonsils stimulated overnight with PMA + ionomycin (n=3).
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Figure 4. Human NKp44+ ILC are developmentally programmed 
a. Flow cytometric analysis of ILC from fetal intestines of indicated ages (weeks gestation) (representative examples of at 
least 3 independent experiments per time point). b. percentage of ILC expressing NKp44 in the fetal small intestine dur-
ing 1st trimester (< 12 wks) or 2nd trimester (>12wks) (n>6; Average +/- SD; p = 0.003). c. Flow cytometric analysis of ILC 
in fetal small intestines and mesentery of the same donor at 12 weeks gestation (representative example of 3 independent 
experiments). d. Expression of IL22 transcripts in NKp44+ ILC from fetal intestine compared to NK cells from fetal lymph 
node (5 independent samples per condition, Average +/- SD; p = 0.009). e. Flow cytometric analysis of NKp44 expression 
on ILC from adult intestine. Filled histogram shows isotype control staining (representative example of 5 independent 
experiments). f. Expression of IL22 transcripts in NKp44+ and NKp44– ILC from adult intestine  (n=7, Average +/- SD; 
p = 0.005)
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Figure 5. NKp44— ILC in adult non-inflamed lymph nodes 
a. Flow cytometric analysis of ILC from adult hepatic lymph nodes for expression of RORC, NKp44, NKp30, NKp46 and 
CD56 (representative example of 3 independent experiments). b. Flow cytometric analysis of CD69 and NKp44 expres-
sion on ILC from adult hepatic and inguinal lymph nodes (representative example of at least 3 independent experiments). 
c. Percentage of NKp30, NKp44 and NKp46 expressing RORC+ ILC in fetal lymph nodes, adult lymph nodes and tonsil 
(representative example of at least 3 independent experiments) d. PCR analysis for IL17a and e. IL22 transcripts of sorted 
ILC  from adult hepatic lymph nodes compared to NKp44— and NKp44+ ILC from tonsil (Adult LN vs NKp44— p=0.02; 
adult LN vs NKp44+ p=0.02; n=4).
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These findings imply that tonsil-derived NKp44 positive ILC preferentially transcribe IL-22, 
while IL-17 is preferentially transcribed by fetal lymph node-derived NKp44+CD69+ ILC, 
enriched within the ILC that lack expression of NKp44, but do express CD 
Human mucosal NKp44+ ILC are developmentally programmed
In the mouse, NKp46+ ILC develop in the absence of microbiota, and appear in the intestines 
after birth 5,25, 28. Since fetal human intestines are not yet colonized by bacteria or exposed to in-
gested antigens 29-31, this allowed us to assess the development of human fetal NKp44+ ILC in the 
absence of external stimuli. We analyzed ILC in first and second trimester fetal small intestines 
and determined their expression of CD69 and NKp44. First trimester small intestinal-derived 
ILC (7 wks gestation) did not express CD69 or NKp44 and resembled putative LTi cells (Figure 
4a). CD69+NKp44+ ILC appeared during late first trimester, between weeks 7 and 10 of gestation 
and with increasing age replaced the LTi-like cells. From week 12 onwards, the majority of ILC 
in the small intestines were expressing both CD69 and NKp44 (Figure 4b). This was specific for 
the fetal small intestines and was not found in paired mesentery samples containing developing 
lymph nodes (Figure 4c). Since our analysis of NKp44+ ILC from tonsils had shown IL22 tran-
scription in these cells, we also probed fetal intestine-derived NKp44+ ILC for IL22 transcripts. 
We consistently found low levels of IL22 transcripts in NKp44+ ILC from second trimester fetal 
small intestines (figure 4d). It was technically impossible to purify sufficient NKp44— ILC from 
fetal intestines as a comparison. 
Therefore, CD56+CD127+ NK cells sorted from fetal lymph nodes were used as a negative 
control. These data show that human NKp44+ ILC develop in-utero in the absence of microbial 
colonization and can be found in the small intestine.
To be able to compare intestinal NKp44+ and NKp44— ILC we next isolated these cells from 
non-affected adult illial mucosa acquired during resection procedures for colon cancer. In the 
adult human intestine, the majority of ILC express NKp44 (figure 4e). In line with our data from 
tonsil-derived ILC, intestinal NKp44+ ILC preferentially transcribe IL22, while NKp44— ILC only 
contain very low levels of IL22 trancripts (figure 4f).
Resting ILC are present in adult non-inflamed human lymph nodes
The presence of IL-17 transcribing ILC in fetal human lymph nodes raised the question 
whether these cells might also be found in adult lymph nodes. Therefore we determined the pres-
ence of RORC+ ILC in adult peripheral non-inflamed lymph nodes. Lymph nodes were collected 
during multi-organ donation procedures and were liver-draining hepatic lymph nodes unless 
stated otherwise. Donor age ranged from 24 — 68 years. In adult lymph nodes a population of 
Lineage—CD45intCD117+CD127+ ILC was found that uniformly expressed RORC (Figure 5a). 
Based on expression of NCRs, adult LN-derived RORC+ ILC resembled ILC from fetal lymph 
nodes rather then from tonsils in that they were mostly negative for NKp46 and NKp44 and only 
a part of the cells expressed CD56 and NKp30 (Figure 5a and 5b). There was no difference in the 
percentage of NKp30 or NKp44 expressing ILC between fetal and adult LN, while slightly more
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Figure 6. Stimulated adult CD69+NKp44— ILC produce IL-22
 a. IL17A transcripts in NKp44— ILC from adult hepatic lymph nodes and in NKp44+ ILC from tonsils stimulated 
overnight with PMA + ionomycin as well as in freshly isolated fetal LN-derived CD69+ ILC (n=3) b. IL22 transcripts 
NKp44— ILC from adult hepatic lymph nodes and in NKp44+ ILC from tonsils stimulated overnight with PMA + 
ionomycin (n=3) c. IL-22 protein production by CD69—NKp44— ILC from adult hepatic lymph nodes after 3 day culture 
with IL-23 or IL-1b (n=2) 
adult ILC expressed NKp46 (figure 5b). These data show that NKp30 is the only NCR that is 
consistently expressed on approximately half of all ILC, regardless of whether they were isolated 
from fetal LN, adult LN or tonsil.
Upon staining for CD69, the presence of CD69+ and CD69— ILC became apparent, very much 
alike the fetal LN-derived ILC. This phenotype was not restricted to hepatic lymph nodes as a 
similar distribution of NCR was seen in adult inguinal nodes (Figure 5c). To determine cytokine 
production by the ILC from adult lymph nodes, total NKp44 — ILC were purified and analyzed for 
IL22 and IL17A transcripts directly ex-vivo. Transcript levels for these cytokines were compared 
to the levels found in NKp44— and NKp44+ ILC from tonsil. Strikingly, adult lymph node ILC 
lacked detectable IL22 or IL17A transcripts (Figures 5d). These data suggest that, in contrast 
to fetal lymph node-derived ILC, adult non-inflamed lymph node–derived ILC are not actively 
transcribing detectable levels of IL17A in-vivo. 
To test whether these peripheral ILC were biased towards the production of either IL17A or 
IL22 upon activation, we stimulated adult lymph node ILC overnight with PMA and ionomycin 
(Figure 6). After overnight stimulation we could detect low levels of both IL17A and IL22 tran-
scripts in adult ILC. Induction of IL-17 was specific for adult lymph node ILC as tonsil-derived 
ILC did not contain IL17A transcripts after stimulation (Figure 6a). However, the levels of IL17A 
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transcripts were much lower then those found in freshly isolated fetal LN-derived CD69+ ILC. 
Even more so, the IL22 transcripts found in adult ILC after overnight stimulation were very low 
in comparison to the levels found in either stimulated or unstimulated tonsil ILC. These findings 
indicate that throughout adulthood human lymph nodes contain a resting ILC population that is 
characterized by the absence of NKp44 and the absence of active transcription of IL17A or IL22. 
Finally, IL-17a and IL-22 protein levels produced by adult lymph node-derived NKp44— ILC 
stimulated with physiological stimuli were determined by ELISA. Unfortunately, the scarcety of 
adult human tissue precluded the analysis of sufficient donors to draw statistical conclusions. 
This notwithstanding, in two independent donors 3 day culture in the presence of either IL-23 
or IL-1b did induce detectable levels of IL-22 protein (Figure 6 c). These culture conditions did 
not induce IL-17a secretion to levels detectable by  our ELISA (detection limit = 31 pg/ml)(data 
not shown). This suggests that even though low level transcription of IL17A ican be initiated, no 
detectable protein is secreted. The reason for this is presently unknown. These data suggest that 
resting adult lymph node-derived ILC retain the capacity to secrete IL22 upon in vitro stimula-
tion with IL-23 or IL-1b. Further work is needed to substantiate these findings.
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DISCUSSION
RORC+ ILC are increasingly recognized as important mediators of early innate immunological 
defenses against mucosal pathogens and as essential for safeguarding tissue integrity during 
infections. Both effects are mediated by ILC-derived cytokines, and especially IL-22 and IL-17a 
have been studied in this respect. In mice, IL-22 secreting ILC mediate the innate response to 
Citrobacter rodentium and IL-22 is an important mediator of epithelial homeostasis 32. Con-
versely, IL-17a producing ILC are pathogenic in a T cell-independent mouse model of intestinal 
inflammation 1. Most importantly, the balance between IL-22 and IL-17a secreting ILC was 
shown to be skewed towards IL-17a in patients with Crohn’s disease, suggesting that ILC-derived 
cytokines might be involved in human disease 22.
The systematic analysis of ILC subsets in humans and the detection of any changes in subset 
distribution as a result of disease are hampered by the poor characterization of functionally dis-
tinct human ILC. In this study we show that expression of the NCR NKp44 is a good predictor 
for ILC that are actively transcribing IL-22, and that these cells are mainly found in mucosal 
tissues. In contrast, our data suggest that throughout adulthood, non-inflammed lymph-nodes 
may function as a reservoir of resting, RORC+ non-cytokine secreting ILC that lack NKp44 
expression, yet retain the capacity to secrete IL-22 after appropriate cytokine activation in vitro. 
Production of IL-17a by T cells is normally tightly controlled to avoid unwanted or excessive 
inflammation 33 and the fact that freshly isolated CD69+NKp44— ILC in non-inflamed lymph 
nodes lack IL17A transcripts suggests that similar levels of restraint are operational for ILC. Un-
raveling the exact signals that can either induce or inhibit ILC activation is needed to understand 
regulation and control of innate IL-17 secretion.
IL-17a has been associated with several human diseases 18 and ILC-derived IL-17a has been 
reported in experimental models of colitis 1. In addition, an increase in IL-17 producing ILC has 
now also been found in the intestines of some Crohn’s disease patients 22. The IL-17 producing 
ILC in Crohn’s disease patients were mainly found within the CD56— ILC fraction, while the 
CD56+ ILC were more prominent producers of IL-22 22. Our current data would predict that a 
dissection based on NKp44 expression, rather than expression of CD56, could further enhance 
the exact enumeration of IL-22 vs. IL-17a producing ILC in humans. 
The biological function of IL17a produced by fetal LN-derived ILC remain enigmatic. De-
velopment of lymphoid organs has many similarities to a controlled inflammation and the 
inflammation-related cytokine IL-17a would fit that concept 34,35. However, IL-17a is unlikely 
to have an essential function during organogenesis as IL-17Ra deficient mice display no gross 
abnormalities in LN development (KH and TC, unpublished observations), suggesting that IL-
17a serves another yet to be determined function. 
In-vivo, distinct subsets of RORC+ ILC seem biased towards either IL17A (CD69+NKp44— ILC) 
or IL22 (CD69+NKp44+ ILC) transcription. It is not clear whether these subsets belong to differ-
ent ILC lineages, or whether they represent different activation or differentiation states of cells 
within a single lineage. In mice, conflicting data exists on the relationship between NKp46+ and 
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NKp46— ILC. Genetic approaches indicated that these two cell types belong to separate lineages 
and do not have a precursor-progeny relationship 25. Conversely, transfer of purified populations 
of ILC showed that NKp46— cells could give rise to NKp46+ ILC in-vivo 26. In humans, these 
relationships are even less clear. After in-vitro culture, freshly isolated NKp44— fetal LN-derived 
ILC acquired NKp30, NKp44 and NKp46 8. In-line with this, the adult-lymph node-derived ILC 
also up regulate NKp44 when cultured (KH and TC, unpublished). Whether the observed IL-22 
production by lymph node ILC is functionally linked to this expression of NKp44 is currently 
under investigation. Our current results indicate that in ex-vivo isolated ILC, NKp44 predicts for 
IL-22 production whereas in mice NKp46 is a marker for IL-22 producing ILC, again adding to 
the complexity of comparing data gathered in human and mouse studies.
NKp44+ ILC are preferentially found in mucosal tissues like tonsil and the intestines (this 
report and 17). Within this mucosal environment NKp44+ ILC constitutively produce IL-22 that, 
based on mouse models, acts on intestinal epithelial cells and conditions these cells to cope with 
the hostile environment to which they are exposed 4,5,32. 
Here we show that the appearance of ILC in the human intestine is developmentally pro-
grammed and NKp44+ ILC are present from early second trimester. In mice NKp46+ ILC is also a 
programmed event independent of microflora, yet these cells only appear after birth 25,28. The ob-
served differences between mouse and man in this respect might be due to the longer pregnancy 
in humans. NKp44+ ILC in the developing human intestine initiate low level IL22 transcription 
during second trimester pregnancy. However, these IL22 levels are much lower than those found 
in NKp44+ ILC from pediatric tonsils or adult intestines. Current it is unknown whether this dif-
ference reflects a role for microbial colonization of the intestines in inducing a postnatal increase 
in IL-22 levels. This would be different from the observations done in mice, where microbial 
colonization was not essential for IL-22 induction but actually induces a decrease in intestinal 
IL-22 postnatal 23,25,28. Again, an alternative and perhaps more likely explanation is that due to the 
longer gestation time in humans compared to mice, the low levels of IL22 transcription found 
during the second trimester will steadily increase throughout the third trimester, reaching levels 
comparable to postnatal ILC just before birth. Even thought the intestines are culture sterile, 
they are by no means devoid of potential immune stimuli such as TLR ligands and cytokines and 
these could still be a factor in ILC development and activation 30,31.
NKp44— ILC reside within peripheral lymph nodes throughout life but in the absence of acti-
vating signals do not transcribe detectable levels of IL17A or IL22. However, upon stimulation 
NKp44— ILC can produce at least IL-22, and also initiate low level IL17A transcription. This 
raises the hypothesis that secondary lymphoid organs are a reservoir for ILC that can participate 
in inflammatory responses in an antigen independent manner. Detailed analysis of human lymph 
node biopsies from inflammatory diseases or the study of relevant animal models is needed to 
determine the contribution of LN-derived ILC to systemic immune responses. 
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MATERIALS AND METHODS
Human tissues
The use of all human tissues was approved by the Medical Ethical Commission of the Erasmus 
University Medical Center Rotterdam, and use was contingent on informed consent. Fetal tissues 
were obtained from elective abortions and gestational age was determined by ultrasonic measure-
ment of the diameter of the skull or the femur and ranged from 7 to 22 weeks gestation. Tonsils 
were obtained from routine pediatric tonsillectomies. Adult hepatic and inguinal lymph nodes 
were collected post-mortem during multi-organ donation procedures. Adult small intestine, 
ileum, was collected as residual material after intestinal surgery for colon carcinoma. Healthy 
ileum was obtained from a clear distance from the tumour. Patients undergoing radiotherapy 
or chemotherapy were excluded. Informed consent was obtained from all patients, according to 
the Medical Ethical Commission of the Academic Medical Center, Amsterdam, the Netherlands.
Cell preparation
Fetal lymph nodes were dissected from the mesentery using dissecting microscopes, and cell 
suspensions were prepared by digestion with 0.5 mg/ml collagenase type IV (Sigma, St. Louis, 
MO) in PBS for 30 min at 37°C, while stirring continuously, and subsequently filtered through 
a 70 mm nylon mesh. Tonsils and adult lymph nodes were cut into small pieces and cell suspen-
sions were prepared by disrupting the tissue with a GentleMacs (Miltenyi Biotech) in the pres-
ence of 0.5 mg/ml collagenase type IV (Sigma, St. Louis, MO). Mononuclear cells were isolated 
from ficoll gradients. Tonsils were further enriched for ILC by labeling with CD117 microbeads 
(Miltenyi Biotech) and positive selection using MidiMacs (Miltenyi Biotech).
Adult intestinal ILC were isolated as described 36 ileum was incubated with HBSS (Gibco) 
containing DTT (154 μg/mL), 0.1% β-mercaptoethanol and 5mM EDTA at 37°C to eliminate 
mucus and epithelial cells. Thereafter mucosa was cut into small pieces and digested for 30 min-
utes at 37°C with Liberase TM (125 μg/mL) and DNaseI (200μg/mL) (Roche). Cell suspensions 
were filtered through a 70-μm nylon mesh and lamina propria mononuclear cells (LPMC) were 
isolated by Ficoll-Paque PLUS (GE, Healthcare). 
Flow cytometry
The following antibodies were used: CD117-PercP.Cy5.5, NKp44-AlexaFluor647, NKp46-
AlexaFluor647, NKp30-Pe (Biolegend, San Diego, CA); CD127-APC-eFluor780, CD45-PeCy7, 
RORgt-Pe (eBioscience, San Diego, CA);  CD56-Pacific Blue, CD69-Pe, CD19-PeDY590, 
CD3-PeDY590, CD14-PeDY590 and CD34-PeDY590 (Exbio, Praha, CZ). Flow cytometry was 
performed on a BD LSRII and cell sorting on a BD ARIA (Becton Dickinson). Analysis were 
performed using FlowJo software (Tree Star Inc., Stanford, CA)
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Cell culture 
Sorted ILC subsets were cultured overnight in the presence of IL-7 (Peprotech) and SCF R&D 
Systems) (both at 10 ng/ml) in the presence or absence of PMA (50 ng/ml; Sigma) and Iono-
mycin (100 ng/ml; Sigma) or for 3 days with IL-7, SCF and either IL-23 or IL-1b. Cells were 
cultured in 200ml DMEM supplemented with 10% FCS (Hyclone). IL-17a and IL-22 production 
was measured using the DuoSet ELISA development kit (R&D systems). ELISAs were performed 
according to the manufacturers’ instructions.
PCR
From fetal samples, adult lymph nodes and tonsil, RNA was extracted using the RNA-XS kit 
(Machery Nagel) followed by reverse-transcription with random hexamer primers. For quantita-
tive PCR, a Neviti Thermal Cycler (Applied Biosystems) and DyNAmo Flash SYBR Green qPCR 
kit (Finnzymes) were used, with the addition of MgCl2 to a final concentration of 4 mM. All 
reactions were done in duplicate and are normalized to the expression of GAPDH (glyceral-
dehyde phosphate dehydrogenase). Relative expression was calculated by the cycling threshold 
(CT) method as 2-∆t.
Primers used were:
GAPDH (Accession: NG_007073.2) FW GTC GGA GTC AAC GGA TT; Rev AAG CTT CCC 
GTT CTC AG 
IL22 (Accession: NM_020525.4) FW CCC ATC AGC TCC CAC TGC; Rev GGC ACC ACC 
TCC TGC ATA TA 
IL17A (Accession: NM_002190.2) FW GAA GGC AGG AAT CAC AAT C; Rev GCC TCC CAG 
ATC ACA GA 
For cDNA synthesis of the adult ileum samples, the high-capacity cDNA archive kit (Applied 
Biosystems) was used. PCR was performed using the SYBR Green I master mix (Roche) for 
LightCycler 480 Instrument II (Roche).
Quantification of expression levels was performed with LinRegPCR software 36. All reactions 
were performed in duplicate were normalized using 18S rRNA expression levels and expressed 
in arbitrary units.
Specific primers were as follows:
18S rRNA FW: AAT CTG GAG CTG GCC TTT CA; Rev CTG GAA GAT CTG CAG CCT TT
Statistical analysis
Samples were analyzed by Mann-Whitney U tests in SPSS PASW 17.0.2. P values < 0.05 were 
considered significant.
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ABSTRACT
Upon diagnosis with follicular lymphoma (FL), more than 70 % of patients present with ger-
minal center-like structures in the bone marrow (BM). FL cells are the malignant counterpart 
of normal germinal center cells and have the capacity to remodel the bone marrow stroma to 
resemble germinal center stromal cells in order to acquire essential signals for survival in the 
ectopic microenvironment. The mechanisms driving the development of B cell follicles and 
ectopic lymphoid follicles are poorly characterized. We set out to study the interactions between 
FL B cells and BM stromal cells required for ectopic follicle formation. Here, we present an in 
vitro 3D co-culture system and xenograft model in RAG-2-/-γc-/- mice as experimental models for 
studying ectopic FL B cell behavior. Furthermore, to understand the stromal changes induced 
during B cell follicle formation we analyzed B cell follicles formation ex-vivo in human lymph 
nodes and in-vivo in a murine model. We show that the development of B cell follicle in human 
fetal lymph nodes is completed by 18 gestational weeks. At 20 gestational weeks, stromal cells of 
the developing B cell follicle express high levels of VCAM-1, similar to an activated B cell follicle. 
Micro array analysis of the non-hematopoietic compartment of lymph nodes of RAG-1-/- mice 
7 days after B cell transplantation revealed a yet unknown stromal source for IL-22 production. 
What the role is of IL-22 in B cell follicle formation remains enigmatic since lymph nodes of 
IL-22-/- mice do not display abrogated B cell follicles. Together, our data show that B cell follicle 
development induces an activated phenotype in precursor FDCs and that in adult RAG-1-/- mice 
IL-22 is produced by an as yet unidentified stromal cell subset. 
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INTRODUCTION 
Follicular lymphoma (FL) is the second most common non-Hodgkin’s lymphoma in the 
western world. The disease is considered to have an indolent course that is characterized by 
a slow progression and a median survival of 10 years1. Treatment of patients can vary from 
the “watch-and-wait” method to aggressive therapy including high doses of chemotherapy and 
hematopoietic stem cell transplantation. Most patients experience relapse after treatment and 
25-30% progresses towards the aggressive diffuse large B-cell lymphoma (DLBL). 
Several classification schemes have been proposed for FL. The World Health Organization 
adopted the method developed by Bernard and Mann. This scheme grades FL from I to IIIa/b 
based on the number of centroblasts in 10 neoplastic follicles per high power field.  Grade I and II 
are considered indolent lymphomas whereas stage III is more advanced. The majority of indolent 
FL, i.e. grade I and II  show a follicular growth pattern. Some FL infiltrates show a partially or 
even complete diffuse growth pattern as reviewed by E. Leich et al2. Even though almost all FL 
arises in lymph nodes, at time of diagnosis most patients (>75%) present stage III with involve-
ment of the spleen, liver, peripheral blood and the bone marrow. 
FL is the neoplastic counterpart of germinal center (GC) B cells. GCs are the main anatomical 
sites where high-affinity antibody-secreting plasma cells and memory B cells are generated. Dur-
ing this process proliferating GC B cells (centroblasts) undergo somatic hypermutations (SHM) 
which results in antibody gene diversification. This enables clonal selection based on affinity 
competition by B cells for antigen presented by FDCs within the center of the follicle. At a certain 
point, centroblasts become centrocytes and stop proliferating and are selected for their capacity 
to bind antigen presented by FDCs and for the ability to elicit help from Tfh3,4. The end stage of 
this process is that GC B cells emigrate from the B cell follicle and differentiate into long-lived 
plasma cells and memory B cells. As such, FL partially recapitulates the GC in that tumor cells 
often grow in close association with follicular helper T (Tfh) cells and follicular dendritic cells 
(FDCs)5.
FL mimics the GC reaction in a “frozen state”, i.e. follicular lymphoma cells are in close as-
sociation with FDCs but do not differentiate towards long-lived plasma cells or memory cells but 
do show clonality , exhibit a complete BCR that has undergone SHM and have a follicular growth 
pattern (low grades)6. FL cells are CD19+CD20+CD10+ and in addition express BCL-6. The latter is 
essential for GC B cell formation and inhibitis differentiation towards plasma cells by binding to 
STAT 37-10. In contrast to GC B cells, the majority of the FL cases (80-90%) constitutively express 
BCL-2. This is largely due to translocation t(14;18)(q32; q21) which results in the juxtaposition 
of the BCL-2 gene in the immunoglobulin heavy chain locus on chromosome 14, leading to its 
constitutive transcription. BCL-2 does not promote cell cycle progression or cell proliferation 
but rather controls the cellular apoptotic threshold by preventing programmed cell death11. Over 
time, follicular lymphomas tend to convert from grade I to grade III and ultimately progress 
towards an aggressive diffuse large B cell lymphoma. This coincides with decreased expression 
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of CD10 and BCL-212. In DLBL, down regulation of CD10 and BCL-2 is often accompanied by 
mutations of BCL-6  and by the accumulation of p53 mutations and/or inactivation of p16. 
The role of the microenvironment as a prognostic factor for FL progression has gained appre-
ciation. Most studies, which conducted gene expression and/or immunohistochemical analysis 
demonstrated that the non-malignant microenvironment, i.e. T cells, macrophages and (fol-
licular) dendritic cells, can function as a strong predictor for life expectancy of FL patients13-19. In 
contrast to normal GC B cells in LNs where primary follicles are already present prior to a GC 
reaction, FL remodels its (ectopic) stromal microenvironment in such a way it resembles first a 
follicle-like structure and secondly mimics a GC-like environment. Invaded lymph nodes exhibit 
a modulated reticular meshwork and can present with an enormous variety in the differentiation 
status of follicular dendritic cells20,21. Upon progression towards higher grades, FL cells loose 
the dependency on the local microenvironment, and this correlates with a more diffuse growth 
pattern. As a result FDCs in infiltrated LNs loose one or more typical FDC markers or FDCs even 
disappear21. 
FL infiltrates in the BM are in most cases localized at peritrabecular sites22,23. The phenotype 
of FL in the BM is virtually identical to its nodal counterpart and a meshwork of CD21+CD23+ 
FDCs can be demonstrated in larger infiltrates. Similar to FL in lymph nodes, BM infiltrates of 
FL frequently contain high numbers of intermingled T cells22-24. In addition to this, BM biopsies 
of FL patients can show the up regulated expression of CD35, CD40 and VCAM-1 by adventitial 
reticulum cells24. An elegant in vitro study shows that cells with characteristics of fibroblastic 
reticular cells, a cell type typically present in the T zone of lymphoid organs25,  can be induced 
from bone marrow derived mesenchymal cells upon interaction with primary FL cells in vitro26.
Even though FL cells express constitutively the anti-apoptotic protein BCL-2, this is not suf-
ficient for FL survival since primary low grade FL cells spontaneously undergo apoptosis in vitro. 
However, co-culturing of FL cells with FDCs and FDC-like feeders rescues the lymphoma cells 
from apoptosis27. Together, these data suggest that FL can remodel the local BM microenviron-
ment in such a way it starts to resemble a GC-like structure that is capable of and necessary for 
providing the FL cells with essential survival signals. 
One can deduct from the previous section that low grade FL cells are dependent on stimuli 
from the microenvironment for their survival. Upon dissemination to the BM, FL cells remodel 
the BM stroma into a GC-like phenotype in order to require stimuli essential for survival in the 
ectopic microenvironment. The early interactions between FL cells and local BM stromal cells 
prior to the induction of a GC-like phenotype in the bone marrow are poorly understood. 
Murine studies demonstrated an important role for the lymphotoxin (LT) and TNFα pathways 
in normal B cell follicle development and maintenance and this has been extensively reviewed28,29. 
Rennert and colleagues, showed that mice treated in utero on gestational days 14 and 17 with 
LTβ-R–Ig or TNF-R55–Ig failed to form discrete B cell follicles in mesenteric lymph nodes 
and that antagonism of TNF-R55 in adult mice disrupts B cell follicles 30,31. Furthermore, mice 
deficient for CXCL13 or its receptor CXCR5, have segregated T and B zones but fail to develop 
B cell follicles32,33. Tumanov and colleagues generated mice in which the LTβ-gene is specific 
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targeted in B cells. Strikingly and in contrast to mice with a systemic LTβ-gene deletion, B cell 
follicle development in LNs of B-LTβ-/- was not affected. However, the B cell follicles of  spleens 
of B- LTβ-/- mice were affected and had little or no FDCs34. 
To identify and understand the early interactions between FL B cells and BM stromal cells 
required for ectopic follicle formation, the early mechanisms of B cell follicle formation under 
normal non-pathologic conditions need to be understood. 
RESULTS
FL cell line induces the expression of VCAM-1 and transglutaminase in primary bone 
marrow
We wanted to assess whether we could study the remodeling of human bone marrow induced 
by follicular lymphoma cells in vitro. Therefore, we set up a 3-D culture system in which reag-
gregates of primary fetal bone marrow derived stromal cells mixed with the follicular lymphoma 
derived cell line WSU-FSCCL, were cultured under high oxygen levels for 7 days and analyzed for 
the induction of a stromal cell-like phenotype by immunofluorescence microscopy. In patients, 
neoplastic follicular lymphoma LNs can show high levels of transglutaminase (TG)20. Upon 
culturing reaggregates with WSU-FSCCL (WSU), fetal primary BM derived stromal cells started 
to express transglutaminase (Figure 1b) compared to control (Figure 1a). In this culture system, 
also VCAM-1 was induced upon co-culturing of FL cell with fetal BM stromal cells (Figure 1d). 
No other LN stromal cell markers could not be detected by IF. Furthermore, no transcripts for 
RANKL, CXCL13, CCL21 and CXCL12 in fetal primary BM derived stromal cells after culturing 
in reaggregates with WSU cells could be detected. 
These data suggest that co-culturing the above described reaggregates without any additional 
supplements was insufficient to induce a “remodeled” BM phenotype.
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Figure 1: Fetal bone marrow derived (FBMD) stromal cells express Transglutaminase and VCAM-1 after 7 days co-
culture with WSU-FSCCL. In order to visualize the remodeling FBMD stromal cells by follicular lymphoma-derived cell 
line WSU-FSCCL in a 7 days 3-D culture system, frozen sections of reaggregates of FBMD stromal cells with or without 
CD20+ WSU-FSCCL were stained for CD20, Transglutaminase and VCAM-1. The expression of Transglutaminase and 
VCAM-1 by FBMD reaggregates (A,C) was induced after 7 days co-culture with WSU-FSCCL (B,D). 
FL derived cell line WSU-FSCCL  aggregates in clusters in the peri-trabeculae of RAG-2-/-
γc-/- KO femurs 
An in vivo model enabling the study of the early interactions between human FL cells and BM 
was established with the use of RAG-2-/-γc-/- mice. These mice lack B, T and NK cells and are 
therefore suitable for xenotransplantation studies. Human GFP-transduced WSU-FSCCL cells 
were xenotransplanted into RAG-2-/-γc-/- mice and four weeks later femurs of the mice were 
analyzed for the presence of GFP+-WSU-FSCCL cells in the bone marrow (Figure 2). Human 
derived WSU-FSCCL cells clustered preferentially in the trabeculae of murine femurs (Figures 
2a and 2b) or at bone-lining niches (Figures 2c and 2d). In human patients, disseminated lym-
phoma cells in the BM also preferentially cluster in the trabeculae or the bone-lining niches of 
femurs. The transplanted WSU-FSCCL cells were also present in other organs four weeks after 
transplantation, such as lymph nodes, spleen, liver and kidney (data not shown). Mice sacrificed 
and analyzed six weeks after transplantation, displayed a vast invasion of GFP+-WSU-FSCCL 
cells in the BM as well as in other organs (data not shown).  
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Figure 2. Human WSU-FSCCL cells cluster preferentially in the trabeculae of murine femurs or at bone-lining 
niches. Parafin-embedded sections of decalcified femurs of RAG-2-/-γc-/- mice were analyzed for the presence and local-
ization of GFP-labeled human WSU-FSCCL cells four weeks after transplantation. Human WSU-FSCCL cell clustered 
in the trabeculae (A,B) and  at bone lining niches (C,D) of murine femurs. Figure 2e is a schematic representation of the 
murine femur and gives an overview of WSU-FSCCL niches in the murine femur.
These data show that the human follicular lymphoma-derived cell line WSU-FSCCL homes to 
the BM and organizes in FL-like niches, but that its growth pattern is very progressive and there-
fore disseminates and spreads out through all organs. This observation shows that WSU-FSCCL 
does not depend on its local microenvironment for survival and therefore does not mimic the 
behavior of low grade FL. WSU-FSCCL is not applicable in studies investigating the develop-
ment of ectopic follicle-like structures..
The stromal cell subsets of the human developing B cell follicle
As discussed in the previous sections, FL is capable of remodeling stroma at ectopic sites in 
follicle-like structures. Since little is known about the first interactions in human B cell follicle 
development, we set out to study the stromal cells that co-localize with developing B cell follicles 
in human fetal lymph nodes. Therefore, fetal human lymph nodes were analyzed by immuno-
fluorescence microscopy. 
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In human fetal lymph nodes, demarcated B cell follicles were present in the cortex from 17 to 
22 gestational weeks (gw.) onward35. Figure 3 depicts a mesenteric lymph node (MLN) of 19 gw. 
The majority of the CD20+ B cells resided in the cortex at the site where a B cell follicle started 
to develop.(Figure 3a, white arrow). In addition, a few cells were positive for CD35, i.e. the 
complement receptor 1, which is a marker for follicular dendritic cells. Marginal reticular cells 
in the cortex of the fetal MLN expressed RANKL and co-localized with B cells. However, at sites 
where B cells clustered and a follicle started to develop, RANKL was absent (Figure 3c, white 
arrow). The bulk of CD3+ T cells present in the fetal MLN resided in the medulla (Figure 3b), 
attracted and retained by the homeostatic chemokine CCL21 that was abundantly expressed by 
the stromal cells of the T zone (Figure 1d). Within the developing B cell follicle both T cells and 
CCL21 were absent (Figures 3c and c, white arrow).
Figure 4 depicts a fetal MLN of 20 gw. with a more matured B cell follicle (white arrow). 
Here, the absence of RANKL expression by stromal cells in the B cell follicle area was very clear 
(Figure 4a). Marginal reticular cells that surround the B cell follicle were positive for RANKL, 
VCAM-1 and podoplanin. At this developmental stage, cells with a follicular dendritic cell-like 
phenotype had developed that resided within the center of the B cell follicle and were VCAM-1hi 
and podoplanin positive.
Together, these data show that at early stages in fetal human B cell follicle development, the 
developing B cell follicle can be identified by the lack of RANKL and CCL21 expression. At 
later stages in development, local stromal cells in the center of the B cell follicle start to express 
VCAM-1 and podoplanin, which suggests that these cells might be FDCs.
Figure 3. Demarcated B cell follicles are present in human mesenteric fetal lymph nodes of 19 gw.  Frozen sections of 
fetal MLNs of 19 gw. were stained for the indicated markers in order to reveal the presence of an early B cell follicle. (A) At 
the site where a B cell follicle starts to develop (white arrow) a few CD35+ cells reside. (B) The bulk of CD3+ T cells reside 
in the medulla of the fetal MLN and are very scarce in the outer cortex and developing B cell follicle. (C) Stromal cells in 
de cortex express RANKL. and (D) CCL21 is abundantly expressed by stromal cells of the fetal MLN. (C,D) At the site of 
the developing B cell follicle (white arrow) the expression of both RANKL en CCL21 is absent.
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Figure 4. Stromal cells with Marginal Reticular Cell-like and Follicular Dendritic Cell-like phenotypes are present 
in human fetal mesenteric lymph nodes of 20 gw. Frozen sections of fetal MLNs of 20 gw were stained for  Lyve-1, 
RANKL, VCAM-1 and podoplanin (D2-40) in order to analyze the stromal cells associated with the developing B cell 
follicle (white arrow). Stromal cells located directly underneath the Lyve-1+ subcapsular sinus are positive for RANKL 
(A), VCAM-1 (A) and podoplanin (C). In addition stromal cells in the center of the B cell follicle (white arrow) express 
both VCAM-1 (B) and Podoplanin (C).
B cells home to peripheral lymph nodes and organize in follicle-like structures in RAG-1-/- 
mice and induce IL-22 production by local stromal cells
Next, we established an in vivo model in which normal, i.e. non-malignant, B cells were trans-
planted in RAG-1-/- mice. These mice are deficient for recombination activation gene RAG-1 and 
display an early arrest of B and T cell differentiation do the inability to perform V(D)J recombi-
nation. Lymph nodes and spleen of these animals have no T and B cells and also lack follicular 
dendritic cells (FDCs). To investigate early molecular changes induced upon interactions with B 
cells in the non-hematopoietic (CD45-) stromal cell compartment of the lymph node in physi-
ological conditions, we administered spleen derived B cells (donor C57BL/6) to RAG-1-/- mice. 
To assure that the administered B cells survived after i.v. injection and are capable of homing to 
secondary lymphoid organs, we analyzed peripheral and mesenteric lymph nodes, and spleen 
for the presence of adult B cells. As depicted in figure 5, five days post-transplantation clusters 
of B cells were present in the cortex of the lymph nodes where stromal cells expressed CXCL13 
(Figure 5a). In the medulla, the T zone, stromal cells expressed CCL21 and the number of B 
cells was very low with a scattered distribution (Figure 5b). At this stage no FDCs were present. 
Seven days post transplantation FDC-M2 + FDCs could be detected at locations where B cells 
clustered (Figure 5c). To identify genes involved in the early stages of B cell follicle development, 
a microarray analysis on the CD45-  non-hematopoietic stromal cell compartment, including 
vascular and endothelial cells, 
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Figure 5. Inoculated B cells home to peripheral lymph nodes (PLNs), cluster in the paracortex and organize in folli-
cle-like structures in RAG-1-/- mice. To visualize the homing of inoculated B cells to PLNs of RAG-1-/- mice by fluores-
cence microscopy, frozen sections of PLNs of RAG-1-/- mice sacrificed five or seven days  after inoculation were stained 
for B220 , CXCL13, CCL21 and FDM-M2+ (A) B220+ B cells home 5 days after inoculation to the CXCL13+paracortex. 
(B) A low number of scattered B220+ B cells are present in the medulla where CCL21 is widely expressed. (B) At seven 
days after inoculation, B cells get organized in follicles and stromal cells start to express the FDC marker FDM-M2 (C).
of lymph nodes of RAG-1-/- mice compared to RAG-1-/- mice transplanted with 10 E6 C57/BL6 
B cells for 7 days, was performed. Therefore, all CD45- LN derived cells were isolated by flow 
cytometric cell sorting and analyzed by microarray. Table 1 represents a condensed list of the 
50 most upregulated genes by the total non-hematopoietic compartment (CD45-CD19-CD20-) 
of lymph nodes of RAG-1-/- mice seven days after inoculation with C57/BL6 B cells compared 
to control mice. The array was performed with Affymetrix Mouse Genome 430 2.0 chips. In 
table 1, column 1 (probes) depicts the probe ID, column 2 (gene title) depicts the corresponding 
gene, column 3 (hits) depicts the levels of expression of the gene (after normalization) in the 
non-hematopoietic compartment of RAG-1-/- LNs inoculated with B cells and column 4 (fold) 
depicts the fold increase in expression levels in RAG-1-/- CD45- LN derived cells with B contact 
compared to negative control. Strikingly the gene Il22 encoding for the IL-22 protein was one of 
the highest up regulated genes in the total non-hematopoietic compartment after B cell transfer. 
IL-22 has been known to be produced by RORC+ ILC, Tfh cells, Th17, Th22 and γδ-Tcells. The 
production of IL-22 by stromal cells has not been reported36-40. IL-22 plays a role in tissue immu-
nity by inducing the secretion of anti-microbial peptides and the promotion and differentiation 
of epithelial cells of mainly the gastrointestinal tract, the urinary tract, the pulmonary tract and 
the skin that express the IL-22 receptor40. A role for IL-22 in the organization of B cell follicles 
has never been reported in literature. Next to IL-22, CCR7 the receptor for CCL19 and CC21 and 
the IL-7R were highly up regulated. 
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Table 1. Fifty most uprelugated genes in RAG-1-/- mice derived CD45- lymp node cells 7 days after B cell transfer
Probe Set ID Gene Title hits fold 
1427455_x_at predicted Igkc 644,2692819 107,2125512
1452557_a_at  --- 428,8234527 84,76401382
1425763_x_at AC160982.1 380,1434176 83,90006365
1427660_x_at Predicted Igkc 542,0867748 83,30319936
1452417_x_at 2010205A11Rik 517,4443851 71,13758041
1452463_x_at  --- 380,080184 61,58597766
1427624_s_at Il22 390,462449 57,91840629
1428720_s_at 2010309G21Rik 163,7362558 37,54294709
1423466_at Ccr7 110,5518992 22,35661714
1418937_at Dio2 147,7659444 22,05081387
1454881_s_at Upk3b 130,2247629 21,38429885
1454623_at CPA2 975,9544464 20,19659247
1448186_at Pnliprp2 140,23377 18,22845017
1449452_a_at Gp2 133,2165948 17,88341062
1418666_at Ptx3 724,3684999 16,01375795
1437015_x_at Pla2g1b 140,9627339 15,35940048
1448281_a_at Cela2a 1731,011987 15,28442104
1448575_at Il7r 119,9043343 15,19737239
1423693_at Cela1 1551,771049 14,32973475
1431763_a_at Ctrl 742,2081331 14,20394722
1433431_at Pnlip 3361,524618 11,5882435
1418287_a_at Dmbt1 604,2492638 11,43385504
1424010_at Mfap4 100,0751522 11,35361641
1421868_a_at Pnlip 1363,122969 11,28613808
1415777_at Pnliprp1 913,6133996 11,27800514
1425152_s_at Serpini2 120,5485093 11,21501776
1417257_at Cel 782,4799635 10,53537674
1416523_at Rnase1 1402,320112 10,36379156
1417601_at Rgs1 305,4410167 10,2171435
1415805_at Clps 790,0334894 9,193791828
1437355_at Zchhc5 156,9422523 8,472219691
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Probe Set ID Gene Title hits fold 
1455269_a_at Coro1a 142,7067732 8,362011341
1428358_at Zg16 172,0554761 8,023323679
1428062_at Cpa1 1482,791464 7,923676607
1428359_s_at Zg16 839,9210994 7,648357715
1433573_x_at Prss2 2114,938505 7,503844856
1417682_a_at Prss2 6130,546621 7,305028998
1417898_a_at Gzma 136,4699971 7,126778074
1428102_at Cpb1 3007,606273 7,003907353
1422789_at Aldh1a2 159,6147315 6,937423704
1436905_x_at Laptm5 1869,71155 6,623528604
1426851_a_at Nov 281,2423414 6,508431938
1435507_x_at Prss2 940,3604157 6,475582618
1415905_at Reg1 1041,971426 6,454431366
1436713_s_at Meg3 140,3504617 6,440041566
1437397_at Prlr 196,0081728 6,224293109
1417447_at Tcf21 143,2836317 6,03849908
1433459_x_at Prss2 1268,3173 5,973721585
1415884_at Cela3b 1393,21288 5,785934535
1449495_at Reg3a 237,2772546 5,771554724
Adult IL-22-/- mice do not present an aberrant phenotype in lymph nodes under 
homeostatic conditions
Next we wanted to analyze adult IL-22-/- mice for abnormalities in B cell follicle architecture. 
No clear and distinct phenotype in the B cell follicles of IL-22-/- mice could be detected. The B 
cells were organized in demarcated B cell follicles that appeared normal with FDCs that express 
CXCL13 (Figures 6a and 6b) and VCAM-1 (Figure 6e). The Marginal Reticular Cells that reside 
directly underneath the Lyve-1+ subcapsular sinus expressed normal levels of RANKL (Figure 6c 
and 6d) and VCAM-1 (Figures 6e and 6f). 
These data show the absence of IL-22 does not abrogate B cell follicle development, or B cell 
follicle integrity under homeostatic conditions.
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Figure 6. Adult IL-22-/- mice display normal lymph node architecture. Frozen sections of cervical lymph nodes (a,c,e) 
and inguinal lymph nodes (b,d,f,) of adult IL-22-/- mice were analyzed by fluorescence microscopy . Sections were stained 
for B220 CXCL13 (a,b), RANKL (c,d) and VCAM-1 (e,f). The localization of B220+ B cells in follicles, and the expression 
patterns of CXCL13, RANKL and VCAM-1 all appear normal compared to wild type (data not shown).  
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DISCUSSION
In this study we set out to identify genes involved in the early stages of B cell follicle development 
in order to understand the mechanisms by which disseminated follicular lymphoma is capable of 
inducing a GC-like structure at extra-nodal sites such as the bone marrow.
Primary low grade follicular lymphoma cells undergo spontaneous apoptosis in vitro. Co-
culturing these cells with FDCs and/or FDC-like feeders rescues the follicular lymphoma cells 
from apoptosis27. In addition, low grade primary FL cells depend on extracellular stimuli for 
their survival and are capable of orchestrating a series of events leading to remodeling the ectopic 
microenvironment24 in favor of cell survival. In contrast, the FL-derived cell line WSU-FSCCL 
grows independent from external survival stimuli and and as such it can be cultured in suspension 
without the addition of supplements. The outcome of the experiments conducted with cell line 
WSU-FSCCL in both our 3-D in-vitro cultures and RAG-2-/-γc-/- mice model can be explained 
by these differences in growth characteristics and grading. It is likely that transplanting primary 
low grade FL cells in RAG-2-/-γc-/-  mice is a better model to study FL induced BM remodeling. 
Repeating both the 3-D cultures and the transplantation experiments with primary low grade FL 
cells might therefore be more representative with regard to ectopic B cell follicle formation by 
FL cells. 
We observed that lack of expression of CCL21 by stromal cells in the cortex of human fetal LN 
delineates the early developing B cell follicle. In murine peripheral LN development a role for 
CCR7 ligands has been reported41,42. Mice deficient for CCR7 lacked the characteristic distribu-
tion of B cell follicles in peripheral LNs43. The role of CCL21 in B cell follicle development is still 
unknown. Overlapping roles for CXCL13 and CCL21 have been reported with regard to the 
attraction of LTi cells41. Both CXCL13 (data not shown) and CCL21 are abundantly expressed in 
human fetal LNs, and as such one can envisage that the outer border of the developing B cell fol-
licle has a complex gradient of CXCL13 and CCL21 in which B and T cells are clearly separated 
and also RORc+ ILC reside. In addition, we have observed that in developing human fetal LNs, 
CD3-CD127+RORc+ cells reside in a ring-like pattern surrounding the developing B cell follicle 
(Hoorweg and Cupedo, unpublished data).  
Furthermore, we observed that stromal that co-localize with B cells within the developing B 
cell follicle do not express RANKL (chapter 4 of this thesis). The importance of RANKL in B cell 
follicle development has been recently established by Sugiyama et al44. In this study, neonatal 
mice that had been injected with anti-RANKL antibody at 13.5 dpc displayed an absence of B-cell 
follicle formation and all B cells and FDC-M2+ FDCs were localized at the periphery of the LN. In 
RANKL-/- mice most PLN and all MLN are absent. However, cervical LNs develop occasionally 
and present with segregated T and B cells, but fail to develop B cell follicles45. The mechanisms 
by which RANKL controls B cell follicle development are not fully understood. Based on our 
observation, RANKL+ MRC play a direct and/or indirect instructive role in the development of 
RANKL- B cell follicle stroma. 
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In order to study early events in human B cell follicle development, an in vivo B cell transfer 
model was established using RAG-1-/- mice. This model allowed the monitoring of changes in 
gene expression of lymph node stromal cells upon contact with introduced B cells during the 
earliest stages of B cell follicle formation. Surprisingly, IL-22 was found to be highly up regulated 
by the non-hematopoietic compartment of LNs upon contact with B cells. This result is very 
interesting since IL-22 is known to be produced by RORC+ ILC and subsets of T cells36-40, but 
not by stromal cells. The pool of CD45- cells that was analyzed comprises FDC, FRCs, MRCs, 
lymphatic and vascular endothelial cells and unidentified stromal cells.  The next step in this 
study is identifying an as yet unknown non-hematopoietic cellular source of IL-22. 
The role of IL-22 in B cell follicle formation is enigmatic. So far, IL-22 has been described to be 
involved in tissue immunity and integrity of mainly the gastrointestinal, urinary, and pulmonary 
tract and the skin. All these tissues also express the IL-22 receptor46-48. The observed up regula-
tion of IL-22 might be, for that reason, induced by changes in integrity of the LN structure of 
RAG-1-/- mice, a result of the entry of large numbers of B cells. To exclude the the possibility 
that up regulation of IL-22 by the non-hematopoietic compartment of LNs of RAG1-/- mice after 
transfer of B cells is an artifact, our data should be validated by PCR for IL-22. Furthermore, it 
should be addressed whether the expression of IL-22 is B cell specific and not a bystander effect. 
Our analysis of adult IL-22-/- mice for the presence of aberrant B cell follicles revealed no 
phenotype suggests that the absence of IL-22 under homeostatic conditions does not hamper B 
cell follicle formation  or  maintenance. It remains elusive if lack of IL-22 during development or 
inflammatory conditions, i.e. GC formation, results in an aberrant phenotype in B cell follicles. 
The lymphotoxin (LT) pathway is essential for lymph node development and at later stages for 
lymph node integrity30,31,49. B cells express membrane-bound LT and a possible The expression 
of IL-22 transcripts by stromal cells from RAG-1-/- mice LNs upon B cell contact might be LT 
dependent. The transfer of LT-/- B cells in RAG-1-/- mice will answer the question whether IL-22 
transcripts expressed by the stromal compartment upon B cell contact are B cell derived LT 
dependent or not. The analysis of bone marrow derived stromal cells that are co-cultured with B 
cells or WSU-FSCCL cells in three dimensional reaggregates under high oxygen conditions, for 
differentially expressed IL-22 transcripts might reveal an unknown function for this interleukin 
in the development of ectopic structures in the BM.
Together the data described in this chapter show that B cell follicle development induces an 
activated phenotype in precursor FDCs and that in adult RAG-1-/- mice IL-22 is produced by an 
as yet unidentified stromal cell subset. 
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MATERIAL AND METHODS
Human tissue
Human fetal tissues were obtained from elective abortions contingent on the receipt of informed 
consent. The use of human fetal tissues was approved by the Medical Ethical Commission of the 
Erasmus University Medical Center of Rotterdam. Gestational age was determined by ultrasonic 
measurement of the skull or femur and ranged from 18 to 20 weeks. 
Mice
RAG2/gc-/- (Balb/c) mice, RAG-1-/- (C57BL/6) mice and IL-22 -/- (C57BL/6) mice were bred 
and kept at the Erasmus MC animal facility.
Immunofluorescence 
Tissue containing GFP+ cells was prior to sectioning fixed overnight in 4% paraformaldehyde 
with 0.15M EDTA in order to preserve the GFP signal. Cryosections 6 mm in thickness (made 
on a Cryostat Jung CM3050) were fixed in acetone for 5 min and were air-dried for an ad-
ditional 10 min. For human tissue: after rehydration, sections of tissue was blocked with 1% 
(wt/vol) blocking reagent (TSAkits; Molecular Probes) and 10% (vol/vol) normal human and 
donkey serum, followed by treatment with a streptavidin-biotin blocking kit (Vector Laborato-
ries). Immunofluorescence staining was done with antibodies diluted in 1% blocking reagent. 
Sections were incubated with primary antibodies for 30 min. at 25˚C, followed by 30 min. of 
incubation with Alexa Fluor–labeled antibodies (Molecular Probes) and 5% normal human or 
mouse serum. Biotinylated primary antibodies were incubated overnight at 4˚C and visualized 
using streptavidin–horseradish peroxidase as the second antibody for 60 min. at 25˚C, followed 
by treatment with the Tyramide Signal Amplification Kits (Molecular Probes) according to the 
manufacturer’s instructions. Sections were embedded in Vectashield (Vector Labs). Fluorescent 
images were captures using a Leica DMRXA and processed Adobe Photoshop CS2.
Antibodies
Antibodies used for stainings on human tissue: rat-anti-mouse/human anti-RORg (AFKJ5-9), 
rabbit-anti-human-CD20 (EP459Y; Epitomics), rabbit-anti-, human-CD3ε (E272; Epitomics), 
mouse-anti-human-laminin (4c7; Acris), mouse-anti-human-podoplanin (D240; Covance), 
rabbit-anti-human-Lyve-1 (polyclonal; Abcam), mouse-anti-human-MAdCAM-1 (314G8; 
HBT), mouse-anti-human-VCAM-1-bio (STA, eBioscience), mouse-anti-human-TRANCE-bio 
(MIH24; eBioscience), CCL21 (AF336; R&D systems). mouse-anti-human-TG-II-bio (CUB 
7402, Thermo Lab Vision). 
Antibodies used for stainings on mouse tissue: rat-anti-mouse rat-anti-mouse-CCL21-bio 
(59106, R&D systems), goat-anti-mouse-CXCL13-bio (polyclonal, R&D systems), biotinylated 
anti-mouse FDC-M2 (clone FDC-M2; ImmunoKontact), rat-anti-mouse-RANKL-bio (R12-
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31,eBioscience), rabbit-anti-mouse-Lyve-1 (polyclonal,Acris), rat-anti-mouse-VCAM-1-bio 
(429,eBioscience), rat-anti-mouse-B220 (6B2 hybridoma supernatant)
Cell culture 
WSU-FSCCL cells (ACC 612, Leibniz-Institut DSMZ)  and stable GFP-transduced WSU-FSCCL 
cells (SFFV-GFP) were cultured in RPMI medium 1640 L-glutamine (Gibco) supplemented with 
8% FCS (Hyclone). 
Reaggregate culture
105  fetal bone marrow derived stromal cells were mixed with 4*104 WSU-SF-GFP cells and cen-
trifuged for 5 minutes at 3G in a 96-wells point bottom cell culture plate (Nunc). Subsequently 
the formed pellet was in submersion culture of 200 µl/well DMEM (Gibco) supplemented with 
10% FCS under high oxygen level conditions (1 l. pure O2 + 50 ml. CO2 + 300 ml. air) at 4˚ C.
Flow cytometry
Single cell suspensions were prepared from lymph nodes by dicing them into small pieces and 
then disaggregating with 0.5 mg/ml collagenase type IV (Sigma, St. Louis, MO) DNAse I (Bovine 
Pancreas, Calbiochem) in PBS for 15 -25 min at 37°C, while stirring continuously. After diges-
tion, the LNs were filtered though a 100µm nylon mesh. Prior to labeling, cells were blocked  with 
10% (vol/vol) normal human serum. 
A FACSAria (Becton Dickinson) was used for cell sorting. Data were analyzed with FlowJo 
software (TreeStar).
Femur decalicifation
Femurs of mice were prior to paraffin embedding decalcified by the following protocol: 80% 
EtOH 60 min., 90% EtOH 60 min., 96% EtOH 60 min., 100% EtOH 60 min. , BuOH 12 hrs., 
paraffine 120 min. and paraffine 120 min.
RAG-2/yc-/- xenograft experiment
RAG-2/yc-/- mice were sublethal irradiated (3 Gy) and subsequently i.v. inoculated with 107 
GFP+-WSU-FSCCL cells in 150 µl PBS
Rag-1-/- B cell transfer experiment
Spleens from C57/BL6 mice were isolated, cut into smaller fragments and disrupted with a Gen-
tlemacs (Milteny Biotech) in the presence of 0.5 mg/ml collagenase type IV (Sigma, St. Louis, 
MO). Subsequently, the single cell suspension was generated by mincing the cell suspension 
through a 70µm filter (BD). Mononuclear cells were isolated from ficoll gradients. The mono-
nuclear fraction was enriched for CD19+ B cells using a B cell (Milteny) isolation according 
protocol. B cell purity was (>97%) confirmed by FACS analysis. RAG-1-/- mice were inoculated 
i.v. the tail with 107 B cells (in 200µl PBS).
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Microarray
Total RNA of the non-hematopoietic compartment of RAG-1-/- lymph nodes was isolated using 
the RNA-XS kit (Machery Nagel). RNA quality and quantity was evaluated on a Agilent Bioana-
lyzer. Antisense biotinylated RNA was prepared and hybridized to Affymetrix Mouse Genome 
430 2.0 Gene Chips using the Ovation Pico WTA system (NuGEN cat# 3300) and the Encore 
Biotin Module (NuGEN, cat#4200) according the manufacturers protocols.
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ABSTRACT
As described in chapter 2 of this thesis, in human fetal and adult lymph nodes different func-
tional subsets of RORC+ ILC reside. In this study, we set out to determine the stoma niches of 
RORC+ ILC in fetal and adult lymph nodes. We show that both fetal and adult LNs contain 
populations of marginal reticular cells (MRC). MRC in fetal LNs are located in the outer cortex 
directly underneath the subcapsular sinus (SCS). In adult lymph nodes MRC are also located 
directly underneath the SCS but in association with B cell follicles. In both fetal and adult lymph 
nodes, MRC express RANKL+, MAdCAM-1+ and VCAM-1 and produce CCL21 and CXCL13. 
This phenotype is reminiscent of murine lymphoid tissue organizer LTo cells that interact with 
RORC+ ILC and are involved in lymph node development. In fetal LNs, RORC+ ILC colocalize 
with RANKL+ MRCs, whereas in adult LN RORC+ ILC pre-dominantly reside at the interface 
of the T/B zone. Collectively these data show that in fetal LNs, RANKL+ MRCs colocalize with 
RORC+ ILC and in adult LN the niche for RORC+ ILC does not consist of RANKL+ MRCs ex-
clusively. 
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INTRODUCTION 
The family of innate lymphoid cells (ILC) comprises a heterogeneous group of cells that play 
diverse roles in immunity and maintenance of mainly epithelial homeostasis1. In humans, sev-
eral subsets of ILC have been reported2-6. In chapter 2 of this thesis, we described the functional 
differences, i.e. IL-17 versus IL-22 production, and the distribution of subsets of RORC+ ILC that 
were characterized by the differential expression of the cell surface markers NKp44 and CD69. 
We found that in contrast to fetal LNs, NKp44— CD69+ RORC+ ILC in adult LN do not produce 
IL-17. 
The role of a subset of murine Rorγt+ ILC, the lymphoid tissue inducer (LTi) cells, in lymph 
node development has been well established and involves direct cell-cell contact with stromal 
cells of mesenchymal origin. Upon stimulation with retinoic acid, stromal cells express CXCL13 
which attracts CXCR5+ LTi cells7. These cells cluster and start to express surface lymphotoxin 
induced by signaling through the IL-7Rα and the receptor activator of nuclear factor kappa 
B (RANK) 7,8. Subsequently LTi cells ligate the lymphotoxin-β receptor expressed by stromal 
cells, which are now designated lymphoid tissue organizer (LTo) cells, and this leads to the the 
expression of RANK-ligand (RANKL)9 and the production of IL-7, the homeostatic chemokines 
CCL19/CCL21 and elevated levels of CXCL13 plus the expression of the adhesion molecules 
VCAM-1, ICAM-1 and MAdCAM-18.  
The TNF molecule RANKL, also known as TNF-related activation-induced cytokine 
(TRANCE) or osteoprotegerin ligand (OPGL), has diverse functions but is probably best known 
for its role in bone homeostasis and is essential for the development and activation of osteoclasts 
via binding of osteoprotegerin10. RANKL has also been described to be involved in the survival of 
dendritic cells (DCs) and communication between DCs and T cells10. Furthermore, as described 
above, RANKL is essential for lymph node organogenesis in a LT-βR dependent manner9,11,12.
In 2008, Katakai and colleagues described a novel stromal cell population in murine lymph 
nodes13. These cells are located at the interface between the B cell follicle and the subcapsular 
sinus and were designated Marginal Reticular Cells (MRCs). Interestingly, these MRCs pheno-
typically resemble stromal LTo involved in LN development and express RANKL and the adhe-
sion molecules VCAM-1, ICAM-1 and MAdCAM-1. In addition, cell lines generated from MRC 
produce CXCL13 upon LTβR stimulation. The function and origin of MRC in lymph nodes, 
remains enigmatic. In human lymph nodes, such stromal cell subset has not been described yet.
In adult lymph nodes, stromal cells provide the optimal microenvironment for activated B 
cells to undergo affinity maturation and generate high affinity antibodies and for naïve T cells 
to encounter their cognate antigen presented by antigen presenting cells. In the T cell compart-
ment of the LN, T zone fibroblastic reticular cells (TRCs) reside, that not only provide structural 
support for the migration of T cells but also deliver survival signals to the migrating T cells in the 
form of IL-7 and produce CCL21 for the attraction and retention of CCR7+ cells14-16. In addition, 
these TRCs associate with extracellular matrix (ECM) components to form conduits which func-
tion as transport channels for low molecular weight antigens through the lymph node cortex17. 
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The structural back-bone within B cell follicles is provided by follicular dendritic cells (FDCs), 
which are essential for generation of high affinity antibodies by presenting immune-complexes 
to B cells, and by supporting B cell migration and homeostasis14. Similar to TRC-conduits, B 
cell follicles contain a conduit network involved in the transport of small antigens from the 
subcapsular sinus to FDCs18 . 
In this study, we set out to determine the stomal niches of RORC+ ILC in fetal and adult lymph 
nodes as knowledge on the role of the diverse stromal cells niches of ILC is currently very poor. 
Here we show that both fetal and adult LNs contain populations of marginal reticular cells that 
can be characterized by the expression of RANKL and that specifically colocalize with ILC.
RESULTS 
Fetal RORC+ ILC localize in the outer cortex of fetal lymph nodes 
Fetal and adult lymph nodes contain RORC+ ILC that are characterized as CD45int lin—RORC+ 
cells that express CD117 (c-Kit) and CD127 (IL-7Rα). While these cells have been categorized 
in functional subsets (chapter 2) by the analysis of differences in expression of surface markers 
NKp44 and CD69 and the differential production of IL-17, little is known about the niches of 
these cells in vivo. Therefore, we analyzed the location of CD3— RORC+ ILC in cryosections of 
fetal lymph nodes varying in age from 17 to 20 gestational weeks. As shown in Figure 1a, in fetal 
lymph nodes CD3—RORC+ cells were present in the outer cortex of fetal lymph nodes. In adult 
LNs, CD3—RORC+ were localized in the interfollicular region and at the interface of the T/B zone 
(Figure 1b), as has been previously reported by S. Kim et al19.
Marginal Reticular Cells form a distinct stromal cell subset in human fetal and adult 
lymph nodes
As described in the previous section, we observed that RORC+ ILC in the fetal LN localized in the 
outer cortex. Next, we further analyzed the stromal cells that reside in the outer cortex of fetal 
LNs. In fetal lymph nodes (up to 20 gestational weeks) prior to the presence of B cell follicles 
(Figure 2a , right panel), a population of VCAM-1hiMadCAM-1+ (Figure 2b, left panel) and 
RANKL+ Podoplanin+ (Figure 2b, right panel) stromal cells was located in the outer cortex. 
These VCAM-1hi and RANKL+ stromal cells formed a layer of few cells thick directly underneath 
the sub- capsular sinus, similar to marginal reticular cells in the murine lymph nodes (Figure 
2c). Next we wanted to determine, whether a population of MRC-like cells was present in adult 
lymph nodes. Interestingly, adult lymph nodes contained also MRC-like cells but these were 
restricted in their localization to the outer border of the B cell follicle directly underneath the 
sub-capsular sinus and the interfollicular areas (Figure 2d). Here, we identified and character-
ized the RANKL+ stromal cell subset present in human fetal and adult lymph nodes as marginal 
reticular cell-like cells
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Figure 1. RORc+ILC in fetal and adult lymph nodes. Human fetal and adult lymph nodes were analyzed by fluorescence 
microscopy for the localization of RORC+ILCs and stained for RORC and CD3. (A) In fetal mesenteric LNs of 19 gw. 
CD3—RORC+ cells are located in the outer cortex.(B) In adult LNs CD3—RORC+cells  reside in the the interfollicular 
region and at the interface of the T/B zone .
Human MRC-like cells display a gene expression profile similar to LTo
The MRC-like cells present in fetal and adult lymph nodes expressed surface markers that are 
characteristic for LTo. To determine whether the MRC-like cells also have functional proper-
ties of LTo, we set out to analyze the expression of functionally relevant molecules by human 
MRC. Stromal cells in fetal human lymph nodes were sorted into MRCs and FRCs based on 
the expression of podoplanin and RANKL (Figure 3a). Based on the histology data depicted in 
Figure 2b, podoplaninhi RANKLhi cells were classified as MRCs, while podoplaninhi  RANKLlo 
cells were classified as FRCs. The sorted cells were then analyzed by real time PCR for RANKL, 
the chemokines CXCL13, CCL19 and CCL21 and IL-7. As shown in Fig 3B, MRCs showed at 
least two fold higher expression of RANKL. The IL-7 expression in MRCs was found to be lower 
than in the FRC fraction. CCL19 transcripts were higher in FRCs than in MRCs. CCL21, which 
has previously been reported to be expressed only in the T cell zone, was found to be expressed 
at higher levels on MRCs. CXCL13 levels were much higher in human MRC-like cells As shown 
by real time PCR analysis, we found expression of both CCL21 and CXCL13 by MRC-like cells. 
MRC-like cells in adult lymph nodes also expressed CXCL13 and CCL21 protein as analyzed by 
histology on frozen sections (Figure 3c).
Together, these data indicate that both fetal and adult lymph nodes contain a population of 
MRC-like cells that display phenotypic and functional similarities to LTo in the fetal LN anlagen. 
RORC+ ILC colocalize with RANKL+ MRC-like cells in the outer cortex of fetal LNs 
In the previous sections we have shown that RORC+ ILC in the fetal LN reside in the outer cortex 
and that the local stromal cell subset is made up of RANKL+ MRC-like cells. Figure 4a depicts an 
overview of a fetal LN of 19 gw. The majority of RORC+ cells colocalized with RANKL+ stromal 
cells in the outer cortex of the fetal LN, whereas the bulk of CD3+ cells resided in the medulla. The 
RORC+ cells in the outer cortex did overall not express CD3 as depicted in Figure 4b. Together, 
these show that in fetal LNs of 15-20 gw MRC-like cells with a LTo phenotype colocalized with 
RORC+ ILC. 
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Figure 2. MRCs are a distinct subset of stromal fibroblasts in human lymph nodes. In order to analyze fetal and 
adult lymph nodes for the presence of MRCs, frozen sections of human fetal mesenteric and adult lymph nodes were 
analyzed by fluorescence microscopy for the distribution of lymphocytes and for the expression of the indicated MRC 
related markers. (A) CD3+ T cells are located in the paracortex and developing medulla of the lymph node, while CD20+ 
B cells are located in the cortex. (B) A distinct population of stromal cells in the outer cortex is positive for the adhesion 
molecules VCAM-1 and MAdCAM-1 (left panel) and in addition positive for RANKL and Podoplanin (right panel). (C) 
A closer examination at higher magnification shows that the VCAM-1 (left panel) and RANKL (right panel) expressing 
stromal cells are located directly underneath the Lyve-1 expressing subcapsular sinus. To determine if stromal cells with 
a MRC-like phenotype are present in adult LNs, non-inflamed hepatic LNs were stained for VCAM-1 and MAdCAM-1 
(D) and Podoplanin and RANKL (E). Stromal cells positive for the MRC-like markers are located at the border of B cell 
follicles in association with lymphatic endothelial cells. 
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Figure 3. Human MRCs present with a LTo gene expression profile. 
(A). The CD45—CD31— fraction of fetal human lymph nodes was sorted into MRCs and FRCs based on RANKL and 
Podoplanin staining. (B) RNA was extracted from these cell populations and real time PCR was performed for il-7, cxcl13, 
rankl, ccl19 and ccl21. Gene expression was normalized to GAPDH. (C) Frozen sections of human adult non-inflamed 
LNs were stained for CD20, CCL21 and CXCL13. CCL21 is abundantly expressed by T zone fibroblasts and CXCL13 by 
follicular dendritic cells within the B cell follicle. Stromal cells located at the border of the B cell follicle express CXCL13, 
CCL21 or both (right panel).
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Figure 4. RANKL+ MRCs are associated with CD3— RORC+ ILC. Human fetal MLNs were analyzed for the localization 
of RORC+ ILC and MRCs by fluorescence microscopy. Therefore, frozen sections of fetal MLNs of 19 gw. were stained 
for CD3, RORgt and RANKL. Cells negative for CD3 but positive for RORC are closely associated with RANKL+ stromal 
cells in the outer cortex of fetal MLNs.
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DISCUSSION 
The importance of the family of RORC+ ILC in the early defense against mucosal pathogens 
and in maintaining tissue integrity during homeostasis and disease is gaining appreciation2,20-22. 
While many studies have addressed the characteristics, function and distribution of various 
subsets of ILC in health and disease, little is known about the niches that these cells occupy in the 
human system. In this study we identified the niche for RORC+ ILC in human fetal lymph nodes. 
We found that RORC+ ILC in fetal lymph nodes of 17-20 gestational weeks co-localized with 
RANKL+ stromal cells in the outer cortex. The stromal location of RORC+ ILC in adult lymph 
nodes has been described in a previous report19 and we could confirm that RORC+ ILC in adult 
LN reside at the T/B interface. 
The RANKL+ stromal cells in present fetal LNs were also observed in adult LN. Further analysis 
of this stromal population indicated these cells as the human equivalents of the murine MRC 
that Katakai and colleagues reported in 200813. These human MRC-like cells not only displayed 
a phenotype that is reminiscent of LTo cells, but also expressed transcripts for the B cell chemo-
kine CXCL13 and the T cell and dendritic cell chemokines CCL19/21. The expression of these 
homeostatic chemokines suggests that these MRC-like cells might facilitate encounters with 
RORC+ ILC, with B and T cells and DCs. As shown in figure 1A, we observed that B cells reside 
in the outer cortex of the fetal LN and co-localized with RORC+ ILCs. Furthermore, we observed 
DC-sign positive cells co-localizing with RANKL+ MRC-like cells (data not observed). This is in 
accordance with the role of RANKL for survival signals for DCs. 
The function of MRC-like cells in fetal and adult lymph nodes, remains enigmatic. These 
cells might be direct descendants of LTo cells that are found in the LN anlagen and this could 
mean that these cells are very plastic since it has been hypothesized that LTo can give rise to all 
LN stromal cell subsets8. MRC produce CXCL13, CCL19/CCL21 and might therefore facilitate 
encounters of B cells, T cells and DC. Furthermore, RANKL expressed by MRCs was shown to 
be essential for murine LN development12,23,24 and more recently, a specific role for RANKL in 
follicle development was established25. Based on these murine studies and the localization of 
RANKL+ MRC in fetal and adult human lymph nodes, MRCs might play a role in the mainte-
nance of B cell follicle integrity upon infection and damage.
Furthermore, Katakai and colleagues reported that MRCs are developmentally programmed 
since they could  not be observed in induced ectopic gastric lymphoid structures13. However, 
whether MRCs are present in human ectopic lymphoid structures is not known. The analysis of 
biopsies of patients with rheumatoid arthritis for the presence of MRCs is currently subject of 
research. 
As described in chapter two of this thesis, CD69+NKp44—RORC+ ILC in fetal LN are positive 
for IL-17a transcripts while this cell subset in adult lymph nodes is negative for IL-17a transcript. 
It has been documented that IL-17A increases the production of RANKL by osteoclasts26,27 and 
a similar function for IL-17A produced by CD69+ LTi cells in the cortex of fetal LNs can be 
envisaged. It needs to be determined, whether the CD69+NKp44- RORC+ ILC in fetal and adult 
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lymph nodes are developmentally related or that they belong to another branch of the RORC+ 
ILC family. 
Together the data described in this chapter show that fetal and adult LNs contain RANKL+ 
MRCs. In fetal LNs RANKL+ colocalize with RORc+ ILC, in adult LN the niche for RORC+ ILC 
does not consist of RANKL+ MRCs exclusively. 
MATERIAL AND METHODS
Human tissue 
Human fetal tissues were obtained from elective abortions contingent on the receipt of informed 
consent. The use of human fetal tissues was approved by the Medical Ethical Commission of the 
Erasmus University Medical Center of Rotterdam. Gestational age was determined by ultrasonic 
measurement of the skull or femur and ranged from 18 to 20 weeks. Lymph nodes were dissected 
from the mesentery with dissecting microscopes. Adult hepatic lymph nodes were collected 
post-mortem during multi-organ donation procedures. 
Flow cytometry
Single cell suspensions were prepared from lymph nodes by dicing them into small pieces 
and then disaggregating with 0.5  mg/ml collagenase type  IV (Sigma, St. Louis, MO) DNAse 
I (Bovine Pancreas, Calbiochem) in PBS for 15 -25 min at 37°C, while stirring continuously. 
After digestion, the LNs were filtered though a 100µm nylon mesh. Prior to labeling, cells were 
blocked  with 10% (vol/vol) normal human serum. The following antibodies were used:  Alexa 
Fluor-488-conjugated mouse-anti-podoplanin (D240; Biolegend), phycoerythrin-conjugated 
mouse-anti-human RANKL (MIH24; eBioscience), peridinin chlorophyll protein–cyanine 
5.5–conjugated mouse-anti-CD45 (2D1; eBioscience), phycoerythrin –cyanine 7- conjugated 
mouse-anti-human CD34 (8G12; BD Biosciences) and phycoerythrin -TexasRed-conjugated 
mouse-anti-human CD31 (MEM-05; ImmunoTools). A FACSAria (Becton Dickinson) was used 
for cell sorting. Data were analyzed with FlowJo software (TreeStar).
PCR
RNA was isolated using the RNA-XS kit (Machary-Nagel), followed by reverse-transcription 
with random hexamer primers. A Neviti Thermal Cycler (Applied Biosystems) and DyNAmo 
Flash SYBR Green qPCR kit (Finnzymes) were used for quantitative PCR, with the addition of 
MgCl2 to a final concentration of 4 mM. All reactions were done in duplicate and are normalized 
to the expression of GAPDH (glyceraldehyde phosphate dehydrogenase). Relative expression 
was calculated by the cycling threshold (CT) method as 2-∆t.
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Table 1. Primer sequences (5’ à 3’) 
Gene Forward Primer Reverse Primer
GAPDH GTC GGA GTC AAC GGA TT AAG CTT CCC GTT CTC AG
RANKL GTG CAA AAG GAA TTA CAA CA CGG TGG CAT TAA TAG TGA G
CXCL13 CCT CCA GAC AGA ATG AAG TT AGG GTC CAC ACA CAC AAT
CCL21 GTA CAG CCA AAG GAA GAT TC GGG GAT GGT GTC TTG TC
CCL19 AGC CTG CTG GTT CTC TG TGC AGC CAT CCT TGA T
IL7 CCT CCC CTG ATC CTT GTT CT CGA GCA GCA CGG AAT AAA AA
Immunofluorescence 
Cryosections 6 mm in thickness were fixed in acetone for 5 min and were air-dried for an ad-
ditional 10 min. For intracellular straining, cryosections were fixed in acetone for 20 min at 4°C 
and air-dried for an additional 10 min. After rehydration, sections of human tissue were blocked 
with 1% (wt/vol) blocking reagent (TSAkits; Molecular Probes) and 10% (vol/vol) normal hu-
man and donkey serum, followed by treatment with a streptavidin-biotin blocking kit (Vector 
Laboratories). Immunofluorescence staining was done with antibodies diluted in 1% blocking 
reagent. Sections were incubated with primary antibodies for 30 min. at 25˚C, followed by 30 
min. of incubation with Alexa Fluor–labeled antibodies (Molecular Probes) and 5% normal hu-
man serum. The Rorγt antibody was incubated for 120 min. at room temperature. Biotinylated 
primary antibodies were incubated overnight at 4˚C and visualized using streptavidin–horse-
radish peroxidase as the second antibody for 60 min. at 25˚C, followed by treatment with the 
Tyramide Signal Amplification Kits (Molecular Probes) according to the manufacturer’s instruc-
tions. Sections were embedded in Vectashield (Vector Labs). Antibodies used, were as follows: 
rat-anti-mouse/human anti-RORg(AFKJ5-9)rabbit-anti-human-CD20 (EP459Y; Epitomics), 
rabbit-anti-, human-CD3ε (E272; Epitomics), mouse-anti-human-laminin (4c7; Acris), mouse-
anti-human-podoplanin (D240; Covance), rabbit-anti-human-Lyve-1 (polyclonal; Abcam), 
mouse-anti-human-MAdCAM-1 (314G8; HBT), mouse-anti-human-VCAM-1-bio (STA, eBio-
science), mouse-anti-human-TRANCE-bio (MIH24; eBioscience), goat-anti-human-CXCL13-
bio (AF3844; R&D systems), and  goat-anti-human-CCL21 (AF336; R&D systems).
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ABSTRACT
described in previous chapters of this thesis, the development of LN involves RORC+ ILC and 
lymphoid tissue organizer (LTo) cells. Although murine spleen development has many overlaps 
with LN development, Rory+ ILC play no role in the development of the white pulp in mice. 
Murine studies indicated that lymphotoxin+ B cells are essential for the development of the white 
pulp of the murine spleen.  A stromal organizer-like cell subset involved in fetal spleen develop-
ment has not been described. In this study we analyzed human fetal spleens varying from 15-20 
gestational weeks (gw) for stromal cell subsets. We describe in fetal spleens of 18 gw onwards 
at sites where B cells cluster, a stromal cell subset that is MAdCAM-1 and VCAM-1 positive. 
+ ILC present in 
fetal spleens of 18-20 gw displayed random distribution and a phenotype similar to RORC +ILC 
organizer of the T cell zone in human fetal spleen.
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INTRODUCTION
The spleen is the largest secondary lymphoid organ (SLO) of the human body. It is the site where 
immune responses are induced against blood-borne pathogens, where effete erythrocytes are re-
moved from the blood circulation and the spleen functions as a storage compartment for plasma 
cells 1. These diverse functions are made possible by the unique structure of the spleen that can be 
divided into two compartments: the red pulp (RP) with its open sinusoidal system, and the white 
pulp (WP) that is made up of sheats of lymphoid tissue. 
The structure of the adult spleen has been described in several studies2-7. The bulk of T and B 
lymphocytes that reside in the WP are compartmentalized in the periarteriolar lymphoid sheath 
(PALS) and B cell follicles, respectively. This cellular organization resembles lymph nodes and 
enhances the chance of efficient encounters of naïve T cells with antigen presenting dendritic 
cells (DCs) as well as encounters of T cells with B cells. The distinct T/B compartments are 
supported by specialized stromal cell subsets that also interact with the residing hematopoietic 
cells, not only to enhance survival but also to optimize proper immune responses. The stromal 
compartment of the T zone (the PALS) is mainly made up of fibroblasts that correspond to fi-
broblastic reticular cells (FRCs) that form a network of conduits to which CCR7+ T cells and DCs 
adhere via the expression of the chemokines CCL19 and CCL218,9. In literature the reticular cells 
of the PALS are also designated interdigitating cells (IDCs)10,11. The reticular cells of the PALS 
wind around collagen fibers that function as anchors along which T cells travel and dendritic 
cells adhere12,13. The stromal cells of the B cell area are the follicular dendritic cells (FDCs), the 
reticular cells of the marginal zone and the marginal reticular cells (MRCs). FDCs are the best 
characterized stromal cell subset of the B cell area and express high levels of CXCL13 thereby 
attracting CXCR5+ B and Tfh cells. FDCs express Fc receptors and complement receptors which 
are involved in the presentation of unprocessed antigen in the form of immune-complexes to B 
cells. FDCs play an important role in the development of germinal center reactions and isotype 
switching and somatic hypermutations of the B cell receptor 14. The marginal zone (MZ) is a 
structure exclusively found in the spleen and acts as a boundary between the WP and the RP. The 
MZ is important in the early defense against encapsulated bacteria in the blood. The MZ harbors 
a unique set of B cells, the MZ B cells, that can respond very quickly to encapsulated bacteria by 
the production of IgM antibodies in a T cell independent manner. Compared to rodents, the 
human spleen has a larger MZ and is surrounded by a perifollicular zone that separates the WP 
from the RP. The unique MZ is made up of stromal reticular cells that are a scaffold for the MZ 
B cells as well as DCs and macrophages. In rodents, there is a population of macrophages that 
is exclusively found in the MZ. In humans no MZ specific macrophage population has been 
described. In 2008 Katakai and colleagues described a novel stromal cell subset that presents 
with characteristics of stromal lymphoid tissue organizer (LTo) cells and are common to murine 
secondary lymphoid organs, the marginal reticular cells (MRCs)15. In the murine spleen, MRCs 
are located in the inner ring of the marginal zone in close contact to the B cell follicle and express 
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CXCL13, VCAM-1 and MAdCAM-1 and RANKL. Currently, no data exist on the presence of 
MRCs in the human fetal and adult spleen.
The development of SLOs such as lymph  nodes depends on signals downstream of the LTβ-R. 
In mice deficient for LTα or the LTβ-receptor, lymph nodes and PPs are absent and T/B cell com-
partmentalization of the white pulp in the spleen is lost16,17. Mice deficient for Rorγt and/or the 
inhibitor of DNA binding protein Id2, lack LTi cells and no LNs and PPs develop. However, the 
spleens of these gene-deficient mice do have segregated B and T cell compartments18,19. Tumanov 
and colleagues generated mice with the LT-β gene specifically deleted in B cells (B-LTβ-KO)20. In 
contrast to the systemic deletion of LT-β, in B-LTβ-KO mice only the splenic microarchitecture 
was affected with only a few FDCs and not able to induce a proper immunoglobulin response. In 
these mice, LN and PPs developed normally, albeit that the latter was reduced in size. Together 
these data indicate that LT+ B cells are involved in the development of the WP of the murine 
spleen. The specific role of LTi cells in WP development is still not fully elucidated. This is partly 
due to the fact that while LTi cells are already present in the developing murine spleen from 
embryonic day (E) 13 onwards, most data about the requirement of lymphotoxin (signaling) for 
proper development of the WP is obtained from spleens from newborn mice from day 4 and on-
wards. These spleens contain LT+ B cells that colonize the spleen and T cell influx has begun21-23.
The human spleen develops in utero. The developmental stages and cells involved in early spleen 
development are therefore not well defined. Several studies have characterized the development 
of the human fetal spleen by performing electron microscopy and immunohistochemistry on 
paraffin embedded fetal spleens. Together, these studies give an overview of the cellular hema-
topoietic and non-hematopoietic organization in fetal spleens varying from the 11th gestational 
week (gw.) until neonatal children10,11,24,25. However, no study has touched upon the presence of 
stromal LTo-like cells in WP development and the interaction of this stromal cell subsets with 
B, T cells and LTi cells. The presence of stromal LTo(-like) cells in the developing human spleen 
has never been evaluated.
In this study we analyzed human fetal spleens varying from 15-20 gestational weeks for the 
presence of LTo-like cells and (precursors) of the major stromal cell subsets of the WP by im-
munofluoresence which allows the combination of multiple markers. The presence of a LTo-like 
stromal cell subset was analyzed in correlation with B and T cell organization and the presence 
of LTi cells in the developing human fetal spleen26. 
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RESULTS
Identification of distinct stromal cell subsets in the adult human white pulp 
The bulk of T and B lymphocytes that resided within the white pulp of the adult spleen were 
compartmentalized in distinct B and T zones as depicted in Figure 1a. T cells were clustered 
around central arterioles (white arrows), hence the name periarteriolar lymphoid sheeth for the 
T zone of the adult spleen and B cells were organized into B cell follicles. The red pulp of the adult 
spleen contained an open sinusoidal system that was made up of CD31+ (PECAM-1) vascular 
tissue (Figure 1b). In the white pulp, CD31 staining was absent except for the central arteriole 
(Figures 1b and 1c). Although the expression of CD31 is not restricted to vascular endothelial 
cells and is also present on the surface of macrophages, neutrophils monocytes and platelets, 
CD31 staining as a marker for vascular endothelium of the spleen has been established27. The 
stromal cell subsets that make up the WP present with a differential expression of homeostatic 
chemokines, adhesion molecules and extracellular matrix proteins. As such, these markers could 
be used to identify the different stromal cell subsets in the WP of the adult spleen. The B cell at-
tracting chemokine CXCL13 was expressed by CD31- stromal cells that were associated with the 
B cell follicle and by the CD31+ central arteriole that in the WP. The marginal reticular cells that 
surrounded the B cell follicle and the follicular dendritic cells that resided within the B cell follicle 
also both expressed CXCL13 (Figure 1c). MRCs and activated FDCs also expressed the adhesion 
molecule VCAM-1 (Figure 1c).  Reticular cells delineating the B cell follicle were positive for 
MAdCAM-1 adjacent to the follicular side and positive for smooth muscle actin (SMA) adjacent 
to red pulpa, but negative for VCAM-1. These cells were characterized as the reticular cells of the 
marginal zone (MZ) (Figures 1d and 1e). The PALS was made up of mainly fibroblastic reticular 
cells that expressed MAdCAM-1, VCAM-1 (Figure 1d, white arrow), smooth-muscle actin 
(SMA) (Figure 1e, white arrow). Furthermore, this T zone area was rich in collagen I and IV 
fibers (Figure 1f, white arrow). Based on the expression of collagen IV one can easily distinguish 
the white pulp from the red pulp (Figure 1f). In the red pulp, collagen IV was abundant while the 
presence of collagen IV in the white pulp was very limited. 
These data suggest that with the application of the above described markers,  determination 
of the major stromal cell subsets in the developing fetal spleen of 15-20 gw can be performed.
B and T cells cluster around CXCL13-expressing arterioles and are not segregated into 
distinct B and T cell compartments at 15-18 gestational weeks 
B cells present in the developing fetal spleen of 15 gw. clustered around a CXCL13 expressing 
arteriole, while the few T cells had a more scattered distribution throughout the developing 
spleen. (Figures 2a and c). At 18 gw. B cell clusters had increased in number and size and were 
interspersed with T cells (Figures 2b and d). At 15-18 gw. B and T cell compartmentalization 
was not observed. This finding is in accordance with previous reports that described that splenic 
B cell follicle development occurs from 24 gw. onwards.
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Figure 1. Stromal cell subsets of the human adult white pulp (WP). To visualize the lymphocyte distribution and the 
stromal cell subsets of the WP of the human adult spleen, frozen sections were stained for the indicated markers and 
analyzed by fluorescence microscopy.(A) In the WP of the human adult spleen the bulk of CD20+ B and CD3+ T lympho-
cytes are compartmentalized in follicles and the PALS (white arrows), respectively. (B) CD31 (PECAM-1) is expressed 
by the endothelium of the red pulp and by the central arteriole, but not by stromal cells of the WP. The different stromal 
cell subsets present in the WP can be identified by the differential expression of the applied markers. (C) CXCL13 (red) 
and CD31 (green), (D) CD20 (blue), VCAM-1 (red), MAdCAM-1 (green), (E) DAPI (blue), smooth muscle actin (SMA) 
(red), (F) Collagen-I (green), Collagen-IV (blue). 
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Figure 2. Lymphocyte clusters around arterioles in developing human fetal spleens of 15-18 gw. Human fetal spleens 
were stained for CD3, CD20 and CXCL13 and analyzed by fluorescence microscopy for the distribution of and clustering 
of B and T cells. At 15 gw., B lymphocytes were higher in numbers than the few scattered T cells and were the first lym-
phocytes to cluster around CXCL13+ arteries (A,D). At 18 gw, the number and size of lymphocyte clusters was increased 
and consisted of B lymphocytes interspersed with T cells (B,D). 
Putative stromal organizer-like cells express MAdCAM-1 and VCAM-1
The adhesion molecule MAdCAM-1 was widely expressed by endothelial cells in the developing 
fetal spleen of 15 gw. and 18 gw. (Figures 3a and b). As described in the preceding section, 
between 15 and 18 gw, the number and size of B cell clusters interspersed with T cells increased. 
From 18 gw. onwards a subset of non-hematopoietic cells co-localizing with B and T lymphocyte 
clusters started to express MAdCAM-1 (Figure 3b, white arrows). This was not observed in 
smaller B cell clusters at earlier time-points during development (Figure 3c). These MAdCAM-1+ 
cells were not of vascular or lymphatic endothelium origin since they did not express the lym-
phatic endothelium marker Lyve-1, nor the vascular endothelium marker CD31 (Figures 3e,f 
and g). The MAdCAM-1+ stromal cells were found to be aso positive for the adhesion molecule 
VCAM-1 (Figures 3f and g). 
The expression of both MAdCAM-1 and VCAM-1 by non-vascular and non-lymphatic stro-
mal cells at sites of periarteriolar B cells and T cell cluster, suggests that these cells might be 
stromal organizer-like cells involved in the development of the white pulp. The expression of 
MAdCAM-1 by CD31- stromal cells may therefore be the earliest marker for WP stroma.
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MAdCAM-1+CD31- stromal cells in fetal spleens express transcripts with a LTo signature
The MAdCAM-1+ VCAM-1+ stromal cells we observed in spleens from 18-20 gw were negative 
for vascular and lymphatic endothelial markers, and were solely observed at sites where large B 
cells clusters were found. We wanted to confirm the presence of this stroma cell subset by flow 
cytometry and analyzed fetal spleens from 14-15 gw and fetal spleens from 18-20 gw onwards for 
the presence of CD45-CD31-MAdCAM-1+ stromal cells (Figure 4a). 
In concordance with our earlier observations on cryosections, CD31-MAdCAM-1+ stromal 
cells were virtually absent in fetal spleens from 14 gw but were present in fetal spleens of 18-20 
gw. We hypothesized that theseCD31- MAdCAM-1+ stromal cells might represent a LTo-like cell 
subset and could be involved in the organization of the white pulp of the human fetal spleen. To 
test this hypothesis we analyzed purified CD31-MAdCAM-1- and CD31-MAdCAM-1+ stromal 
cells from fetal spleens from 18-20 gw for the relative expression of transcripts of LTo signature 
genes, i.e. LTβ-R, RANKL and the homeostatic chemokines CXCL13 and CCL21. Figure 4b 
depicts the results obtained from four different donors. Even though there was heterogeneity 
amongst the four samples, a clear difference in the expression of LTo related gene transcripts 
between the MAdCAM-1 positive and negative stromal cell subset could be observed. The mean 
of relative expression levels for transcripts for LTβ-R, RANKL and the homeostatic B cell che-
mokine CXCL13 was respectively 19.6, 5.37 and 1.83-fold higher in the MAdCAM-1+ stromal 
cell subset compared to the MAdCAM-1 negative population. The most striking difference in 
levels of relative gene transcripts expression between the two stromal cell subsets, was observed 
for CCL21. Transcripts for this homeostatic chemokine were exclusively and highly expressed in 
the MAdCAM-1+ stromal cells. 
Together, these data suggest that in human fetal spleens from 18-20 gw MAdCAM-1+VCAM-1+ 
LTo-like stromal cells reside that co-localize with large B cell clusters and might be involved in 
the development of the WP.
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Figure 3. Fetal MAdCAM-1 and VCAM-1 expressing stromal cells co-localize with large B cell clusters. To visualize 
the stromal cell subset that supports the large B cell clusters in human fetal spleens of 15 and 18 gw., frozen sections were 
stained for the indicated markers and analyzed by fluorescence microscopy. In human fetal spleens of 15 gw weeks CD20+ 
B cells are low in number (A,C). From 18 gw onwards CD20+ B cell numbers increase and larger B cells clusters develop 
(B, white arrow, and D).  Stromal cells that co-localize with large B cell clusters do not express Lyve-1 and CD31 (E) but 
do express both MAdCAM-1 and VCAM-1 (F and G).
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Figure 4. Non-vascular MAdCAM-1+ stromal cells in human fetal spleens of 18-20 gw, display a LTo gene expression 
profile. (A). Flow cytometric analysis of human fetal spleens of 14 gw. and 20 gw. for the presence of CD45-CD31-
MAdCAM-1+ cells . Cell suspensions were depleted from B cells (B) MAdCAM-1+ and MAdCAM-1- non vascular stro-
mal cells isolated from spleen from 18-20 gw were sorted and analyzed for the expression of gene transcripts of LTβR, 
RANKL, CXCL13 and CCL21 relative to GAPDH. 
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Precursors of marginal zone reticular cells of the white pulp are not present in the human 
fetal spleen of 19 gestational weeks
As discussed previous, the reticular cells of the marginal zone (MZ) of the human adult spleen 
were positive for both MAdCAM-1 and smooth muscle antigen (SMA) (Figures 1d and e). We 
also observed that the fetal spleen of 18-19 gw. of age had no compartmentalization of B and 
T lymphocytes. In previous reports it has been described that from 24 gw. onwards the T zone 
starts to develop24 and after the formation of the PALS from 26 gw onward, B cells get organized 
into a B follicle and the marginal zone develops. Currently, there is controversy about the initia-
tion of MZ development in the human fetal spleen. At 19 gw, SMA was expressed by vessels and 
at a very low level by reticular cells colocalizing with the large B lymphocyte clusters (Figure 5a). 
At this stage of development, the expression of MAdCAM-1 (Figure 5b) and SMA by stromal 
cells of the early white pulp appeared to be mutually exclusive .
Together these data show that MZ reticular cell-like cells are absent at 19 gw. 
Figure 5. Stromal cells with a marginal zone reticular-like phenotype are absent in developing fetal spleens of 19 
gw. The WP of fetal spleens of 19 gw. was analyzed by fluorescence microscopy for the presence of smooth muscle actin 
(SMA) and MAdCAM-1 expressing stromal cells. (B) MAdCAM-1 is expressed by stromal cells that colocalize with large 
B cell clusters in contrast to (A) SMA expressed by vessels at this stage. 
LTi cells in the human fetal spleen have a phenotype similar to LTi cells in fetal mesenteric 
lymph nodes
Human LTi cells have been described in fetal MLNs and LTi-like cells have been described in 
postnatal tonsils and adult intestines. To determine the presence of LTi cells in human fetal 
spleens, we analyzed lineage- (lin-; CD3-CD20-CD14-CD34-) cells that express intermediate levels 
of CD45 and high levels of CD117 (c-Kit) and CD127+(IL-7Rα) for the expression of intracel-
lular RORc protein. Of the lineage-CD45int cells, only 1.9% was CD117hiCD127hi LTi cell (Figure 
6a). As depicted in Figure 6b, all cells in this gate expressed the RORc protein. To determine 
whether expression of NCRs by LTi cells from fetal spleens was a fetal lymph node phenotype or 
a mucosal/ postnatal phenotype, we analyzed the expression of NKp46, NKp44 and NKp30 on 
LTi cells derived from fetal spleen. The expression of NCRs by LTi cells from fetal spleens was 
similar to LTi cells derived from fetal MLN. About 52% of the LTi cells expressed NKp30 while 
expression of NKp46, and NKp44 was lacking (Figures 6c and d). The expression of CD69 and 
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CD25, both markers of T cell activation was restricted to a minority of the fetal splenic LTi cells 
(Figures 6e and f). In the fetal MLN, CD69 expression is correlated to IL-17a production by LTi 
cells. Whether CD69+ LTi cells in the fetal spleen produce IL-17 is subject of further research 
as is the observed CD25 expression by fetal spleen derived LTi cells. Together these data show 
that LTi cells in the fetal spleen have a phenotype similar to LTi cells in fetal MLN. The cytokine 
profile of LTi cells in fetal spleen is subject of further investigation. 
RORC+ lymphoid tissue inducer cells do not co-localize specific with MAdCAM-1 
expressing stromal cells of the early white pulp
Recent murine data indicate that lymphoid tissue inducer (LTi) cells do not play a role in the 
development of the white pulp into lymphoid tissue with segregated B and T zones. So far, we 
showed the presence of LTi cells in the human fetal spleen by flow- cytometry. To determine the 
localization of LTi cells in situ we double-stained frozen sections of fetal spleen for LTi cells with 
MAdCAM-1. As expected, the number of LTi cells was very low. The spatial distribution of the 
LTi cells showed no specific localization and was not associated with MAdCAM-1+ stromal cells 
at sites of large B and T cell clusters (Figures 7a,c and e). 
The random distribution of LTi cells in the fetal spleen of 19 gw. suggests that these cells are 
not directly involved in the induction of white pulp stroma. A role for LTi cells in imprinting of 
the stroma, as has been suggested for mice, or if they play a role in later stages of development 
remains to be determined.
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Figure 6. Human fetal spleen derived RORC+ LTic display a phenotype similar to RORC+ LTi in fetal MLN. LTic 
were characterized as lineage negative CD127+CD117+ cells (A) and analyzed for the expression of the intracellular Rorc 
protein by flow cytometry (B). (C,D) Flow cytometric analysis of ILC from fetal spleens for NKp44, NKp30 and NKp46 
(representative example of 2 independent experiments). (E). Flow cytometric analysis of CD25and NKp44 and (F) CD62L 
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Figure 7 CD3-RORC+ LTic do not exclusively colocalize with MADCAM-1+ LTo-like cells. The role of LTi cells in the 
development of the human WP is uncertain. In order to visualize the localization of RORc+ LTic in the fetal spleen, frozen 
section of fetal spleens of 19 gw were stained for RORC, CD3, MAdCAM-1 and smooth muscle actin (SMA). RORc+CD3- 
ILC are present but few in numbers and do not preferentially co-localize with MAdCAM-1+ (A, C and E) or SMA+ (B, D 
and F) stromal cells.
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DISCUSSION
The spleen has a unique anatomy that supports its diverse functions and functions as a storage 
site for several populations of immune cells, iron and erythrocytes, is involved in the removal 
of effete erythrocytes and is important in the defense against blood-borne pathogens. Patients 
after splenectomy or with functional asplenia are at risk of developing overwhelming post-
splenectomy infections (OPSI)28. 
Knowledge on the development of the human fetal spleen is, for obvious reasons, restricted 
to data obtained from descriptive microscopy studies performed on tissue sections2-5,7,10,11,24,29. 
Functional data on the development of the spleen comes mostly from murine studies in which 
signaling pathways known to be involved in the development of SLOs are affected or ablated, as 
extensively reviewed by Mebius and Kraal in 20031. A good understanding of the development of 
the human spleen is currently lacking. The murine spleen develops with overlapping but slightly 
different rules and players when compared to lymph node development. In addition to this, the 
human spleen differs anatomically from its murine counterpart.
In this study we identified a stromal cell subset within the human fetal spleen of 18-20 ges-
tational weeks that is equivalent to the Marginal Reticular Cells present in the murine spleen 15 
as well as the Marginal Reticular Cell–like cells present in human fetal and adult lymph nodes 
(chapter 4 of this thesis). Furthermore, we showed that fetal spleen derived LTi cells have a 
similar phenotype as RORC+ LTi cells present in fetal lymph nodes (chapter 2) but that these cells 
do not co-localize with MRC-like stromal cells in the fetal spleen of 18-20 gw. 
Both murine MRCs and human MRC-like cells express RANKL at the protein level as can 
be visualized by immunofluorescence microscopy15 and chapter 5. In human fetal and adult spleens, 
we could not detect RANKL protein expressing cells . However, gene transcripts for RANKL 
were present in the isolated MRC-like population from fetal spleen of 18-20 gw. Whether the 
MRC-like cells do not translate RANKL transcript in protein is currently not known. Another 
possible explanation for our inability to identify RANKL at the protein level, might that RANKL 
proteolytically processed into its soluble form (sRANKL) which would be washed off during our 
protocols for protein staining on cryosections. It has been described in literature that MMP14 
is capable of cleaving RANKL into sRANKL and can be produced by many cell types such as 
endothelial cells and macrophages30. In fetal spleens from 14-20 gw DC-Sign positive cells were 
observed in large numbers (unpublished data). In addition, Steiniger and colleagues observed 
CD4+CD68+ macrophages24. In the human fetal spleen, MRC-like cells develop at sites where 
large clusters of B cells intermingled with T cells reside adjacent to open endings of arteries. 
These stromal cells are VCAM-1+MAdCAM-1+ and express transcripts for RANKL, LTβ-R, 
CXCL13 and CCL21. This gene expression profile corresponds with a MRC-like phenotype and 
is similar to that of lymphoid tissue stromal organizer (LTo) cells present in embryonic lymph 
node anlagen31and chapter 5 of this thesis. The high levels CCL21 transcript expression observed in the 
MRC-like cells are in conclusion with data of previous reports that describe that the human 
PALS is formed from the 17th gw onward prior to the development of the B cell follicle24 which 
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develops from 24 gw onward24,25,32. In addition to this, in mice CCL21 expression was found to 
be obligatory for the segregation of B and T cells and was found to be induced in a LT dependent 
manner by both B cells and to a lesser extend LTi cells33.
Similar to our observations in the human fetal lymph node, B cells in the fetal spleen co-
localized with MRC-like cells. However, in contrast to fetal LNs of 15-22 gw., RORC+ ILC in fetal 
spleens of the same gestational age did not co-localize with MRC-like cells. This finding suggests 
that at this stage in development, RORC+ ILC do not play a direct role in the development of 
the human WP. This observation is in conclusion with a study performed by Vondenhoff et al., 
which shows that LTi cell in neonatal mice do not express membrane bound lymphotoxin and 
are therefore suggested to play no further role in the development of the WP23. In addition to 
this, it has been described that mice with a specific deletion of the LTβ gene in B cells show aber-
rant development of the white pulp indicating that B cells are required for the proper LT signal 
to the LT-βR expressed by the local stromal cells20. Together these data suggest that B cells in the 
fetal spleen of 18-19 gw, might signal via the LT-LTβ-R pathway to induce further development 
of the white pulp. 
In conclusion to previous reports, we could not observe an developing MZ at this stage in 
fetal spleen development 24,25. Our data complement the findings of Steiniger that B cells in fetal 
spleens of approximately 15-18 gw reside around SMA+ reticular cells located adjacent to large 
arteries24. We observed that SMA+ reticular cells also resided within the MAdCAM-1+ MRC-like 
area and could not detect any overlap of these two subsets of reticular cells in the developing 
fetal WP.
In this study we identified MRC-like cells with a LTo-like phenotype that are putatively in-
volved in the development of the human WP in the fetal spleen of 18-20 gw. The observation 
that these MRCs do not co-localize with LTi cells but do appear at sites where large B cell clusters 
intermingled with T cells reside, indicates that B cells rather than LTi cells interact with MRCs 
thereby inducing the development of the WP. 
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MATERIAL AND METHODS
Human tissue
The use of all human tissues was approved by the Medical Ethical Commission of the Erasmus 
University Medical Center of Rotterdam and contingent on informed consent. Fetal tissue was 
obtained from elective abortions. Gestational age was determined by ultrasonic measurement of 
the skull or femur and ranged from 15to 20 weeks. Adult spleens were obtained post-mortem 
during multi organ donation procedures. 
Immunofluorescence
Cryosections 5-6 mm in thickness were fixed in acetone for 5 min and were air-dried for an 
additional 10 min. When stained for RORγt, sections were fixed in acetone for 20 minutes by a 
temperature of -20 °C and air-dried.  After rehydration, sections of human tissue were blocked 
with 1% (wt/vol) blocking reagent (TSAkits; Molecular Probes) and 10% (vol/vol) normal hu-
man and donkey serum, followed by treatment with a streptavidin-biotin blocking kit (Vector 
Laboratories). Immunofluorescence staining was done with antibodies diluted in 1% blocking 
reagent. Sections were incubated with primary antibodies for 30 min. at 25˚C, followed by 30 
min. of incubation with Alexa Fluor–labeled antibodies (Molecular Probes) and 5% normal 
human serum. Biotinylated primary antibodies were incubated overnight at 4˚C and visualized 
using streptavidin–horseradish peroxidase as the second antibody for 60 min. at 25˚C, followed 
by treatment with the Tyramide Signal Amplification Kits (Molecular Probes) according to the 
manufacturer’s instructions. Sections were embedded in Vectashield (Vector Labs). Antibodies 
used, were as follows: rabbit-anti-human-CD20 (EP459Y; Epitomics), rabbit-anti-human-CD3ε 
(E272; Epitomics), mouse-anti-human-laminin (4c7; Acris), mouse-anti-human-MAdCAM-1 
(314G8; HBT), mouse-anti-human-VCAM-1-bio (STA; eBioscience), goat-anti-human-
CXCL13-bio (BAF801; R&D systems), and  goat-anti-human-CCL21 (AF336; R&D systems), 
mouse-anti-human collagen I (COL-1; Abcam), rabbit-anti-human collagen IV (polyclonal; 
Abcam), mouse-anti-human SMA (1A4; Sigma), rat-anti-mouse/human ROR(g)t (AFKJS-9; 
eBioscience).
Cell preparation
Fetal spleens were dissected from the mesentery with dissecting microscopes. Single cell suspen-
sions were prepared by dicing spleens into small pieces and then disaggregating with collagenase 
type IV (0.5 mg/ml; Sigma, St. Louis, MO) and DNAse I (Bovine Pancreas, Calbiochem) in PBS 
for 15 -20 min at 37°C.  After digestion spleens were filtered (70 µm for lymphocytes and 100µm 
for stromal cells) in DMEM (Invitrogen) supplemented with 8% (vol/vol) FCS (Hyclone) and 
DNAse I. Erythrocytes were lysed using Lysing Solution (Stem-Kit Reagents, Beckman Coulter). 
Prior to labeling for stromal cell sort, cells were further enriched for obtaining a CD45- popula-
tion using the DynaMag-50 in combination with Dynabeads Biotin Binder ( both Invitrogen, 
Dynal AS, Oslo, Norway) .
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Flow cytometry and cell sorting 
The following antibodies were used: Alexa Fluor 647–conjugated  anti-NKp46 (9E2) and 
anti-NKp44 (P44-8), peridinin chlorophyll protein-anti-CD117(A3C6E2), phycoerythrin-
anti-NKp30(P30-15), biotinylated-anti-CD117(104D2), allophycocyanin-anti-VCAM-1 (STA), 
pacific blue-conjugated-anti-CD31 (WM59) (all from Biolegend),  allophycocyanin –eFluor 
780–anti-CD127 (eBioRDR5), phycoerythrin Cy7-anti-CD45(HI30)(all from eBioscience), 
phycoerythrin -anti-CD69(FN50), phycoerythrin-DY-590–conjugated anti-CD3(MEM-57), 
phycoerythrin-DY-590–conjugated  anti-CD19(LT19), phycoerythrin-DY-590–conjugated 
anti-CD14(MEM-15), phycoerythrin-DY-590–conjugated -CD34(4H11) (all from ExBio), 
phycoerythrin -anti-ROR(g)t (AFKJ5-9; Ebioscience), biotin-conjugated anti-CD45 (eBiosci-
ence), phycoerythrin-anti-CD62L (SK11; BD), MAdCAM-1 (314G8; HBT), FITC-conjugated 
anti-CD25 (Immunotools).  For cell sorting and FACS analysis, a FACS Aria (Becton Dickinson) 
was used. Data were analyzed with FlowJo software (TreeStar).
Quantitative RT-PCR Analysis
RNA from human tissues was extracted using the RNA-XS kit (Machery Nagel) followed by 
reverse-transcription with random hexamer primers. A Neviti Thermal Cycler (Applied Biosys-
tems) and DyNAmo Flash SYBR Green qPCR kit (Finnzymes) were used for quantitative PCR, 
with the addition of MgCl2 to a final concentration of 4 mM. All reactions were done in duplicate 
and are normalized to the expression of GAPDH (glyceraldehyde phosphate dehydrogenase). 
Relative expression was calculated by the cycling threshold (CT) method as 2-∆t.
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INTRODUCTION 
The human body contains approximately 600-700 lymph nodes (LNs)1. These secondary lym-
phoid organs (SLO) function as central players in our immune system by facilitating encounters 
of antigen presenting cells with lymphocytes and enhancing the chance of activation of antigen 
specific lymphocytes. The development of human lymph nodes occurs during fetal life and 
starts approximately at 8-11 gestational weeks2,3. The number and type of studies on human LN 
development are limited and functional studies on LN development are obtained predominantly 
from mouse studies. Murine lymph node development starts between 12-14 days of gestation 
and involves direct cell-cell contact of lymphoid tissue inducer (LTi) cells with lymphoid tissue 
organizer (LTo) cells. Upon retinoid acid induced CXCL13 expression by stromal cells, CXCR5+ 
LTi cells cluster and start to express surface lymphotoxin induced by signaling through the 
IL-7Rα and the receptor activator of nuclear factor kappa B (RANK) 4,5. The mature LTi cells 
ligate the lymphotoxin-β receptor expressed by LTo cells and this event leads to the expression 
of RANK-ligand (RANKL)6 and the production of IL-7, the homeostatic chemokines CCL19/
CCL21, elevated levels of CXCL13 plus the expression of the adhesion molecules VCAM-1, 
ICAM-1 and MAdCAM-1 all involved in the attraction and retention of LTi cells and circulat-
ing lymphocytes5. Mice deficient for Rorγt and/or the inhibitor of DNA binding protein Id2 
lack LTi cells and hence no LNs and Peyer’s patches (PPs) develop. However, spleens develop 
normal in these gene-deficient mice and contain segregated B and T cell compartments7,8. In 
addition, in mice deficient for LTα or the LTβ-receptor, LNs and PPs are absent and T/B cell 
compartmentalization of the white pulp in the spleen is lost9,10. Together these data indicate that 
related yet different mechanisms can give rise to lymphoid structures with segregated B and T 
cell compartments.
Human RORC+ILC
In 2009, IL-17a producing cells resembling murine LTi cells were described in fetal lymph 
nodes11. At the same time studies reported a IL-22 producing NK/LTi-like cell population pres-
ent in human tonsils and adult intestines11,12. The discovery of these cytokine producing cells 
led to a gain of interest in innate immunity11-21. Crellin et al. showed in an elegant study, that 
human IL-22 producing NK/LTi-like cells are a stable RORC+ expressing line and therefore are 
not related to NK cells22. In a proposal for uniform nomenclature,  IL-17a and IL-22 producing 
RORC+ LTi-like cells were categorized in the expanding family of innate lymphoid cells (ILC)23. 
ILC make up a family of lymphocytes that lack a specific antigen receptor and are capable of 
initiating rapid responses to pathogens24. From mouse studies we know that all ILC derive from 
a common Id2+ progenitor cell in the fetal liver and bone marrow. The subsequent differentiation 
into a mature ILC is mediated by specific transcription factors25. Based on the cytokine produc-
tion profiles and the expression of lineage specific transcription factors, ILC have been classified 
into three distinct groups resembling the various T helper cell subgroups23. 
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Group 1 comprises the ILC1. This group of ILC expresses the transcription factor T-bet and 
produces “type 1” cytokines such as interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α) 
in order to induce immune responses to intracellular pathogens24. The expression of the lineage 
transcription factor T-bet is not required for the development of ILC1 since NK cells, the best 
studied member of this group, develop in the absence of the T-box transcription factor26-29.  
Group 2, the ILC2, depend for lineage specification on transcription factor GATA-3 30. 
ILC2 are widely expressed and secrete IL-5 and IL-13 in order to mediate immune responses 
during helminth infections and allergies24,31-34. Human ILC2 are defined by the expression of 
CRTH235. 
Lineage specification into the ILC3 lineage requires the stable expression of Roryt36. LTi cells 
involved in the development of LNs and PPs and postnatal IL-17 and IL-22 producing RORC+ 
ILC belong to the ILC3 family. Cytokine producing RORC+ ILC are recognized as important 
mediators of early innate immunological defenses against mucosal pathogens and as essential 
players in tissue integrity during infections. Human ILC3 can produce a variety of effector mol-
ecules involved as reviewed by Cornelissen et al37.
Functional distinct subsets of human RORC+ILC
Human RORC+ ILC can produce IL-17 and IL-22. In mice, Rorc+ ILC derived IL-22 was shown to 
play an important role in the early defense against intestinal bacterial infection with Citrobacter 
rodentium15 while Rorc+ ILC-derived IL-17a was shown to be pathogenic in T-cell independent 
intestinal inflammation38.
A detailed analysis of the distribution and role of human RORC+ ILC in homeostasis and 
pathological conditions was up to now hampered due to the absence of markers that distinguish 
IL-17a+ RORC+ ILC from IL-22+ RORC+ ILC. In chapter 4 we show that expression of NKp44 
is a good predictor for RORC+ ILC that are actively transcribing IL-22 and are mainly found in 
mucosal tissues. In addition, our data suggest that non-inflamed lymph nodes may function as a 
reservoir of resting, RORC+ non-cytokine secreting ILC that lack NKp44 expression, yet retain 
the capacity to secrete IL-22 after appropriate cytokine activation. Furthermore, RORC+  ILC 
already present in the intestine at early second trimester start to express NKp44 but display low 
levels of IL-22 transcription which gradually increases in levels comparable to postnatal. The role 
of bacterial colonization in inducing higher levels of IL-22 is still under debate39-41.
IL-17a has been associated with several diseases and is associated with an inflammatory re-
sponse against mucosal infections as well as several autoimmune diseases42-44. Freshly isolated 
CD69+NKp44— RORC+ ILC from fetal LNs are positive for transcripts of IL-17a. The biological 
function of IL17a produced by RORC+ ILC in fetal LNs is still not unraveled. Even though LN 
development resembles a controlled inflammation in many aspects, IL-17a is unlikely to have an 
essential function during organogenesis as IL-17Rα deficient mice display no gross abnormali-
ties in LN development (KH and TC, unpublished observations)45,46. However, the development 
of inducible bronchus associated tissue (iBALT) in mice was shown to depend on CD4+ T cell 
derived IL-1747. The production of IL-17a by T cells is stringent controlled in order to avoid 
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unwanted or excessive inflammation 48. Freshly isolated CD69+NKp44— ILC in non-inflamed 
lymph nodes lack IL17A transcripts suggesting that similar levels of restraint are operational for 
ILC. Unraveling the exact signals that can either induce or inhibit ILC activation is needed to 
understand regulation and control of innate IL-17 secretion.
RORC+ ILC colocalize with RANKL+ in fetal LNs
In murine LN anlagen LTi cells interact with LTo cells. In 2008, Katakai et al. described Marginal 
Reticular Cells in adult lymphoid organs. In fetal LNs of 15-20 gw, prior to B cell follicle forma-
tion, RORC+ ILC are located at the outer cortex (chapter 4) while in adult LNs, RORC+ ILC reside 
at the interface of the T/B zone which was in concordance with an earlier finding by Kim et al.49, 
and at the apical site of B cell follicles. Stromal cells that reside directly underneath the subcap-
sular sinus in the cortex of fetal LNs of 17-20 gw and thus co-localize with RORC+ ILC display 
a phenotype reminiscent of LTo cells, and MRC cells, i.e. RANKL+VCAM-1+MAdCAM-1+ and 
positive for transcripts of the homeostatic chemokines CXCL13 and CCL21. In adult LN MRC-
like cells co-localize with RORC+ ILC. The function of MRC-like cells in fetal and adult lymph 
nodes remains enigmatic. The expression of the homeostatic chemokines suggests that MRC-like 
cells might facilitate encounters with RORC+ ILC, with B and T cells and DCs. We observed in 
fetal LNs, the co-localization of RORC+ ILC and RANKL+ MRCs suggesting a direct or indirect 
interaction between these two cell types. Furthermore, unpublished data (TC and KH) suggests 
that RORC+ ILC co-localize with DC-Sign+ cells in the RANKL+ outer cortex of fetal LNs. 
RORC+ ILCs and MRCs in the human fetal and adult spleen 
Spleen development in the mouse has overlapping but slightly different mechanisms compared 
to lymph node development. In addition, the human spleen differs anatomically from its murine 
counterpart50. In chapter five of this thesis we identified a MAdCAM-1+ stromal cell subset in 
the developing white pulp of the human fetal spleen from 18-20 gestational weeks onwards 
that has LTo characteristics. MAdCAM-1+ MRC-like cells in the human fetal spleen expressed 
VCAM-1 and transcripts for RANKL, LTβ-R, CXCL13 and CCL21. This gene expression profile 
corresponds with a MRC-like phenotype and with LTo cells present in embryonic lymph node 
anlagen5 and chapter 5 of this thesis. While murine and human MRC in fetal and adult LNs 
express the RANKL protein51 and chapter 5, no RANKL protein was observed in human fetal 
and adult spleens. Whether the MAdCAM-1+MRC-like cells of the fetal spleen do not translate 
RANKL transcript in protein is currently not known. In contrast to RORC+ ILC in fetal LN, we 
did not observe a specific co-localization of RORC+ ILC with MAdCAM-1+ MRC-like stromal 
cells in the fetal spleen of 18-20 gw. This finding suggests that at this stage in development, 
RORC+ ILC do not play a direct role in the development of the human WP. This observation 
is in line with a study performed by Vondenhoff et al., which shows that splenic LTi cell in 
neonatal mice do not express membrane bound lymphotoxin and are therefore suggested to 
play no further role in the development of the WP52. In addition, it has been described that mice 
with a specific deletion of the LTβ gene in B cells show aberrant development of the white pulp 
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indicating that B cells are required for the proper LT signal to the LT-βR expressed by the local 
stromal cells53. Together these data suggest that B cells in the fetal spleen of 18-19 gw might signal 
via the LT-LTβ-R pathway to induce further development of the white pulp. 
In line with previous reports, we could not observe MZ-like structure this stage of spleen 
development54,55. Our data complement the findings of Steiniger that B cells in fetal spleens of 
approximately 15-18 gw reside in proximity of SMA+ reticular cells located adjacent to large 
arteries55. We observed that SMA+ reticular cells also reside within the MAdCAM-1+ MRC-like 
area and could not detect any overlap of these two subsets of reticular cells in the developing 
fetal WP. 
B cell follicle development and GC-like structures
In human adults, tertiary lymphoid organs (TLO) can develop at ectopic sites under persistent 
inflammatory conditions or by low grade malignancies such as follicular lymphoma in the bone 
marrow (BM)56-58. The mechanisms and cellular components required for secondary lymphoid 
organ (SLO) development, might remain functional throughout adulthood and contribute to the 
formation of TLO59. In order to understand the mechanisms by which disseminated follicular 
lymphoma is capable of inducing a GC-like structure at extra-nodal sites such as the bone mar-
row we set out to study B cell follicle formation in vitro and in vivo.
Low grade FL cells depend on the local microenvironment for survival. Due to the lack of a cell 
line reflecting an indolent B cell lymphoma, we performed 3-D in-vitro cultures and xenograft 
experiments in RAG-2-/-γc-/- mice using cell line WSU-FSCCL. This cell line grows independent 
of external stimuli and might therefore not be representative for primary low grade FL. However, 
in our 3D co-culture with WSU-FSCCL we observed the induction of transglutaminase (TG) and 
VCAM-1 on fetal BM derived stromal cells. Interestingly, Vega et al. describe the upregulation of 
TG by the FRC network in FL infiltrated LN60. In addition the upregulation of VCAM-1 during 
FL B cell induced lymphoid stroma differentiation has also been described61. Together these data 
suggest that remodeling of fetal BM derived stromal cells in our 3-D in vitro model could be used 
with primary low grade FL cells. The results from the RAG-2-/-γc-/- xenograft model shows that 
human malignant B cells disseminate in the bone marrow preferentially to bone lining niches 
and the trabeculae suggesting RAG-2-/-γc-/- are a good model to study in vivo behavior of FL B 
cells at ectopic sites.
Stromal cells of early developing B cell follicles lack expression of CCL21 and RANKL (chapter 
4 of this thesis). Mice deficient for CCR7 lack the characteristic distribution of B cell follicles62. In 
murine peripheral LN development, a role for CCR7 ligands has been reported63,64. We observed 
that absence CCL21, the ligand for CCR7, in cortical stromal cells in human fetal LN delineates 
the early developing B cell follicle from the residing MRC. A putative role for CCL21 in B cell 
follicle development has not been put forward yet. However, overlapping roles for CXCL13 and 
CCL21 have been reported in regard to the attraction of LTi cells63. In addition we have observed 
in developing human fetal LNs, CD3-CD127+ cells forming a rim around the developing B cell 
follicle (Hoorweg and Cupedo, unpublished data). The importance of RANKL in follicle devel-
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opment has been recently established by Sugiyama et al65. In this study, neonates injected with 
anti-RANKL antibody at 13.5 dpc displayed an absence of B-cell follicle formation. Furthermore, 
all B cells and FDC-M2+ FDCs were localized at the periphery of the LN. RANKL-/- mice lack 
most PLN and all MLN. Cervical LNs do develop occasionally and present with segregated T and 
B cells, but fail to develop B cell follicles66. The mechanisms through which RANKL is involved in 
B cell follicle development are not fully understood. The study of Sugiyama and our observation, 
suggest that RANKL+ MRC have an instructive role in the development B cell follicle stroma. 
However, the answer to this question remains enigmatic. 
Current knowledge on the genetic changes of stromal cells during B cell follicle formation is 
poor. FL cells can remodel ectopic BM stroma in such a way that a follicle-like structure is formed. 
To gain insight in the changes in gene expression of lymph node stromal cells during the earliest 
stages of B cell follicle formation we used an in vivo B cell transfer model in RAG-1-/- mice. Seven 
days post inoculation we harvested lymph nodes and analyzed the CD45- cells including FDC, 
FRCs, MRCs, lymphatic and vascular endothelial cells and un-identified stromal cells. We found 
the induced expression of IL-22 by the non-hematopoietic compartment of LNs upon contact 
with B cells. Literature does not report the production of IL-22 by CD45- cells. It is known to 
be produced by RORC+ ILC and subsets of T cells67-71. IL-22 has been described to play a role in 
tissue immunity and integrity of mainly the gastrointestinal, urinary, and pulmonary tract and 
the skin that express the IL-22 receptor12,72,73. The observed up regulation of IL-22 might be, for 
that reason, induced upon loss of integrity of the LN structure of RAG-1-/- mice upon the entry 
of large numbers of B cells. To exclude that up regulation of IL-22 by the non-hematopoietic 
compartment of LNs of RAG1-/- mice after transfer of B cells is an artefact, our data should be 
validated by PCR for IL-22 on the same samples used for the microarray analysis. Furthermore, 
it should be addressed whether the expression of IL-22 is B cell specific and not a by-stander 
effect. The analysis of adult IL-22-/- mice for the presence of aberrant B cell follicles revealed 
no phenotype suggesting that absence of IL-22 does not hamper B cell follicle formation or B 
cell follicle maintenance in homeostatic conditions. A role for IL-22 in the maintenance of B 
cell follicle integrity during development and under inflammatory condition can be studied in 
IL-22-/- by analyzing LN isolated during different developmental stages and under inflammatory 
conditions.
 The lymphotoxin pathway is essential for lymph node development and at later stages for B 
cell follicle development and integrity74-76. B cells express membrane-bound LT and IL-22 could 
be involved in B cell follicle formation. The upregulation of IL-22 by CD45- lymph node derived 
cells upon contact with B cells might be LT mediated.  The transfer of LT-/- B cells in RAG-1-/- mice 
can give a conclusive result on this question. In addition, the analysis of gene transcripts of BM 
stromal co-cultured in 3-D reaggregates with B cells or WSU-FSCCL cells for IL-22 transcripts 
might reveal a role for this interleukin in the development of ectopic structures in the BM. 
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Future directions for research on MRC & IL17+ and IL-22+ RORC+ ILC
Tertiary lymphoid organs (TLO) develop at sites of pathogenic infection in order to facilitate 
the production of antibodies specific for the pathogen. However, TLO develop also at numerous 
types of chronic inflammatory lesions leading to excessive inflammation and as a consequence 
tissue destruction.  Several chronic autoimmune disorders such as rheumatoid arthritis (RA), 
Sjögren’s syndrome (SS) and Hasimoto’s thyroiditis (HT),low grade follicular lymphoma (FL) 
and chronic graft rejection can present with TLO which are associated with a poor outcome77,78. 
Therefore, it has been suggested that blocking the formation of TLO could be a strategy in the 
treatment of the excessive inflammations. In RA and Sjögren’s syndrome patients and during the 
experimental formation of inducible bronchus-associated lymphoid tissue (iBALT), the degree 
of cellular organization of TLO has been associated with the expression of the homeostatic 
chemokines CCL21 and CXCL13 and molecules involved in SLO development by local stromal 
cells47,79-83. From mouse studies we know that TLO development shares many similarities with 
SLO development77. While prenatal SLO development requires the LTi-LTo cell interaction, a 
similar cell-cell interaction for TLO formation has not been identified yet. The role of Rorc+ ILC 
in the formation of TLO remains to be addressed since in mouse models in the absence of these 
cells iBALT and TLO in inflammatory bowel disease develop84,85. The identification of human 
MRC in adults (chapters 4 and 5) shows that cells reminiscent of LTo cells reside throughout 
adulthood in man. Currently it is unknown whether human MRC are restricted to developmen-
tally programmed lymphoid tissues as Katakai suggested for murine MRCs or that these cells 
also reside and / or can be induced in other non-lymphoid organs51. The presence of MRC cells 
in ectopic lymphoid structures has never been reported to be extensively evaluated.
Targeting the microenvironment of ectopic lymphoid structures
Follicular lymphoma is an indolent B cell lymphoma that depends for survival on its special-
ized microenvironment. Microarray analyses showed that the clinical outcome of FL patients 
is primarily predicted by molecular features of non-malignant cells86.+ In addition, a large panel 
of predictive markers reflecting the number, activation, and spatial distribution of infiltrating 
immune non-B cell subsets in FL infiltrates has been identified87. FL B cells interact with stromal 
cells in order to create the optimal FL niche that upon activation by FL B cells provide pro-survival 
signals and are involved in the organization of a tumor promoting GC-like niche88. However, the 
number and spatial distribution of the stromal cell subsets of infiltrated follicular lymphoma LN 
has been poorly characterized. The presence of MRC in FL niches has never been investigated. 
An accurate functional characterization of the major stromal cell subsets, including MRCs, of FL 
infiltrated LN in various stages of grading might lead to the determination of stromal cell mark-
ers that contribute to the prediction of the clinical outcome of patients. In addition the course of 
stromal cell differentiation in the follicular lymphoma microenvironment can be characterized.
Upon diagnosis, up to 70% of the FL patients display bone marrow involvement. FL cells are 
capable of remodeling the BM stroma in a lymphoid like structure in order to create an optimal 
local niche60,89-91. It has been shown that stromal cells of infiltrated LN and in the BM provide 
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essential pro-survival factors such as hedgehog (Hh) ligands that in addition indirectly could 
be involved in stroma-mediated chemotolerance92-94. Stromal cells of the ectopic FL microenvi-
ronment are because of the aforementioned reasons emerging as therapeutic targets. However, 
mesenchymal stromal cells in the BM difficult to target and are also radio resistant95. 
Ibrutinib is a Bruton tyrosin kinase (Btk) inhibitor which in B cell chronic lymphocytic leuke-
mia (CLL) reduces the migration towards CXCL12 and CXCL13 and delibitates the adhesion of 
primary CLL B cells in the lymph node and bone marrow microenvironment96. In addition to this 
study, an in vitro study determining the effects of Ibrutinib on multiple myeloma and octeoclasts 
and BM stromal cells, shows that Ibrutinib acts on the bone resorption activity of osteoclasts 
(OC), to inhibit tumor growth factors from OC and BM stromal cells and to reduce the secretion 
of MIP1-α, MIP1-β, SDF-1, TGF-β, activin A, APRIL, BAFF, and IL-8. 97. Together these studies 
show that inhibiting B cell receptor signaling via inhibiting of Bruton tyrosine kinase results in 
interfering with the migration and adhesion of the malignant B cells towards the ectopic micro-
environment results and in loss of contact with the beneficial microenvironment. This strategy 
could sort a similar effect in follicular lymphoma B cells in their local microenvironment. More-
over, a recent study suggests that another tyrosine kinase pathway, the Syk-mTor pathway, is 
involved in FL cell invasion through the regulation of metalloproteinase-9 and angiogenesis as 
an upstream regulator of vascular endothelial growth factor98. Currently clinical trials evaluating 
the Syk inhibitor in various relapsed or refractory hematologic malignancies including FL might 
yield promising therapeutic targets. 
RORC+ ILC derived cytokines in health and disease
Postnatal, human RORC+ innate lymphoid cells reside predominantly in the skin and mucosal 
tissues. RORC+ ILC produce besides IL-17 and IL-22 the cytokines IL-2, IL-5, IL-13 and BAFF 
and this is reviewed by Cornelissen et al37. Here, I will focus on IL-17 and IL-22 producing ILC.
From mouse studies we know that Rorc+ ILC play important roles in innate immune responses 
at mucosal surface to pathogens. ILC derived IL-17 acts within hours upon epithelial injury or 
activation by pattern recognition receptors (PPRs) and induces inflammatory cytokines such as 
IL-6, G-CSF and SCF and the recruitment of neutrophils(reviewed in 99). In mouse models IL-17 pro-
ducing Rorc+ ILC were shown to drive intestinal inflammation upon H. hepaticus infections38,100 
and to be protective against mucosal Candida infections101. In addition, a colitis model in mice 
demonstrated that ILC derived IL-17 can be pathogenic38. IL-22 can serve both as a protective 
and inflammatory mediator depending on several factors. Mouse models demonstrated a pro-
tective role for IL-22 in de the early defense against Citrobacter rodentium-induced colitis15,102, 
systemic infection with  Salmonella enterica103   and gastrointestinal  Candidasis  in the absence 
of IL-17R104. In contrast, IL-22 is required for the development of Toxoplasma gondii-induced 
immunopathology in the small intestine105. 
However, emerging data indicate a prominent role for RORC+ ILC in chronic inflammatory 
diseases. In humans, IL-17 has been associated with several disease processes including IBD, 
rheumatoid arthritis, and psoriasis106. In Crohn’s disease (CD) patients, IL-17 producing ILC 
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were present and suggested to contribute to the disease38,107. In addition, patients suffering from 
CD display high levels of IL-22, which could be (in part) NKp44+ RORC+ ILC mediated108. 
Also in synovial fluids and sera of RA patients, increased levels of IL-17 and IL-22 have been 
described109,110. 
Currently, the role of RORC+ ILC derived cytokines in autoimmune diseases has been poorly 
evaluated. The distribution and conceivably shift in balance of RORC+ ILC subsets in tissues 
from patients compared to healthy donors should be analyzed in detail. When a significant shift 
in the composition of IL-17+ vs IL-22+ RORC+ ILC subsets is observed, it needs to be addressed 
how this phenomenon and the cytokine production of these cells is regulated in vivo.
The high levels of IL-17A in rheumatoid synovial tissue, causes cartilage and bone degradation. 
In vitro experiments suggested that IL-1β, an endogenous damage associated molecular pattern 
(DAMP), is involved in the regulation of IL-17 secretion by ILC20,111. In CD and joints of RA 
patients, levels of IL-1β are relatively high. However, since Th17 cells require two signals in order 
to secrete IL-17 it is likely that a second activation signal is required. Currently, Canakinumab, 
an antibody directly against IL-1β is studied in Phase III trials. Whether the production of IL-17 
by RORC+ ILC (if present in synovial tissue and fluid) is abrogated has not been evaluated yet112. 
Furthermore, in literature it has been proposed that IL-17 controls the pro-inflammatory versus 
tissue-protective properties of IL-22113. In this model, blocking IL-17 will affect the function of 
IL-22. Presently, IL-17 is recognized as an attractive therapeutic target in RA. The anti-IL-17A 
antibody secukinumab is very promising with phase III trials ongoing in patients on background 
methotrexate who had inadequate responses to previous tumor necrosis factor blocker therapy114.
Furthermore, a recent report decribes that chondrocytes express NKp44 ligand.115 . Nkp44 
signaling in RORC+ ILC activates a pro-inflammatory program resulting in the production of 
TNF which is involved in chondrocyte destruction116. Blocking NKp44 in RA may therefore be a 
promising therapeutic target.
In sum, the work described in this thesis is of basic biomedical nature and can facilitate transla-
tional research for identifying new therapeutic targets for the management of diseases suffering 
from ectopic TLOs and RORC+ ILC derived cytokines.
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Human secondary lymphoid organs (SLOs) develop during embryogenesis. As described in 
chapter 1 of this thesis, knowledge on human SLO development is very limited and most data 
on SLO development are obtained from murine studies. In relation to various chronic inflam-
matory diseases, there is a gaining interest in tertiary lymphoid structures (TLS). These TLS 
can at various degrees recapitulate the complex and highly organized structure of lymph nodes 
with segregated T and B cell zones, germinal centers (GCs), high endothelial venules (HEVs), 
and follicular dendritic cells (FDCs). While TLS are formed during inflammatory responses in 
order to create an optimal environment for the eradication of infections, evidence is culminating 
that during chronic or autoimmune inflammation TLS contribute to sustaining the aberrant 
inflammation and serve as a site for activation of auto reactive lymphocytes1. The mechanisms 
that drive the development of human ectopic lymphoid structures are not well characterized. 
From murine models, we know that many pathways and players in the development of TLS are 
similar to those involved in the development of SLOs. Since relatively little is known about SLO 
development in human, we set out to identify and characterize the cellular components involved 
in the development of human SLOs.
Lymph node development in mice starts between days 11 and 14 gestation. Upon CXCL13 
dependent clustering of specialized circulating lymphoid tissue inducer cells (LTic) at prospec-
tive lymph node locations, stromal lymphoid tissue organizer (LTo) cells start to express the 
lymphotoxin-β-receptor (LTβR) which is ligated by surface-bound lymphotoxin (LTα1β2). 
Ligation of this receptors triggers the expression of the adhesion molecules ICAM-1, VCAM-1 
and MAdCAM-1 and homeostatic chemokines such as CXCL13, CCL19 and CCL21 that attract 
and retain more LTic. The clustering of more LTic induces a local self-sustaining primordium in 
which, over time, high endothelial venules will be induced and postnatally T and B cell areas will 
be shaped and germinal centers can form. 
In 2009, Cupedo at al. identified the human LTi cells in fetal LNs. These lineage negative RORC+ 
innate lymphoid cells were shown to interact with mesenchymal cells through lymphotoxin and 
tumour necrosis factor and to produce IL-17. In adult man and mice, RORC+ ILC were shown to 
be present in SLO, skin and in the intestine. In mice, RORC+ ILC are essential in the early defense 
against attaching and effacing pathogens like Citrobacter rodentium via the production of IL-
22. In human, IL-22 producing ILC were described in mucosal tissue such as tonsils, Peyer’s 
patches and the intestine. In chapter 2 of this thesis we show that functionally distinct subsets of 
human RORC+ innate lymphoid cells are enriched for secretion of IL-17a or IL-22. While both 
subsets have an activated phenotype they can be distinguished based on the presence or absence 
of the natural cytotoxicity receptor NKp44. We found that NKp44+ IL-22 producing cells are 
present in tonsils and adult intestines while NKp44— IL-17a producing cells are present in fetal 
developing lymph nodes. We also show that the development of human intestinal NKp44+ ILC is 
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a programmed event independent of bacterial colonization. Furthermore, NKp44— ILC remain 
-
scription suggesting that secondary human lymphoid organs may function as a reservoir for 
As mentioned in the previous section, the development and cellular organization of lymph nodes 
is guided by subsets of stromal reticular cells. Fibroblastic Reticular Cells (FRCs) and FDCs are 
the major stromal constituents of the adult T cell zone and B cell follicles respectively. In 2008 
Katakai et al. described a novel stromal cell subsets in adult murine lymphoid organs that are 
+ Marginal Reticular 
Cells are located in the outer follicular region immediately underlying the subcapsular sinus in 
LNs and in the follicular dome area of Peyer’s patches. As described in chapter 2 of this thesis, 
+ILC reside. In 
chapter 4, we set out to determine the stromal niches of RORC+ ILC in fetal and adult lymph 
nodes. We showed that both fetal and adult LNs contain populations of MRCs which resemble 
murine lymphoid tissue organizer cells. Human MRCs can be characterized by the expression of    
RANKL and are positive for CXCL13 and CCL21. In fetal LNs, RORC           +       ILC co-localize  
with RANKL+ MRCs whereas in adult LNs RORC  +  ILC reside at the interface of  the T/B zone. 
Collectively these data show that in fetal and adult lymph node cells RANKL+ stromal cells reside 
which are remiscent of murine LTo cells found in LN anlagen. 
Studies with genetically altered mice indicated an essential role for signals downstream of the 
lymphotoxin-beta receptor in lymph node and Peyer’s patches development. While mice de-
white pulp (WP) of the spleen was lost. Murine studies indicated that LT+ B cells are involved 
be addressed. In addition, the presence of stromal LTo-like cells in the fetal spleen involved in 
WP development have not been described. In chapter 5 of this thesis we analyzed human fetal 
spleens varying from 15-20 gestational weeks (gw) for a stromal organizer cell. We show in fetal 
spleens of 18 gw. a MAdCAM-1   +     VCAM-1    +   stromal cell subset  that is positive for MRC-related gene  
transcripts: RANKL, CCL21 and CXCL13. RORC                          +               ILC      in fetal spleens of 18-20 gw displayed a 
random distribution and a phenotype similar to RORC+ 
in fetal spleens MRC-like cells are involved in WP development.
In chapter 3 we set out to study the interactions between follicular lymphoma (FL) B cells and 
BM stromal cells required for ectopic follicle formation. Our results derived from in vitro 3D 
-/-γc-/- mice were obtained with the 
progressive FL derived cell line WSU-FSCCL. In contrast to primary FL cells, WSU-FSCCL cells 
grows independent of external signals for its survival and therefore does not need to induce 
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changes to its microenvironment. Nevertheless, results show that WSU-FSCCL induces the 
expression of VCAM-1 by human primary bone marrow stromal cells in vitro. Furthermore, the 
RAG-2-/-γc-/- xenograft model showed that WSU-FSCCL disseminated to peritrabeculaer sides. 
Together, these data hold the promise that with primary follicular lymphoma B cells interest-
ing result can be obtained. Furthermore, we show that human fetal B cell follicle development 
starts at 18 gw and induces an activated phenotype in pre-cursor FDCs by the high expression 
of VCAM-1. To identify differentially expressed genes by LN stromal cells upon B cell, we con-
ducted a B cell transfer experiment in adult RAG-1-/- mice. This revealed the production of IL-22 
by a yet unidentified stromal cell subset in murine LNs.
In this thesis we describe the identification and characterization of RORC+ ILC and MRC in 
lymphoid tissues. We found these cells, which are phenotypically and functionally reminiscent of 
LTi and LTo cells, to be present in adult tissues. Currently, knowledge on the presence and role 
of RORC+ ILC in homeostatic and pathological conditions is poor and for human MRC lacking. 
The cytokines and chemokines produced by these cell types suggest roles in immune responses. 
In addition one could envision a role for RORC+ ILC and MRC in the development of ectopic 
tertiary lymphoid structures.
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Cellen betrokken bij de immuunrespons zijn georganiseerd in gespecialiseerde lymfoïde organen 
om zo optimaal mogelijk te kunnen functioneren. De belangrijkste lymfoïde organen kunnen 
worden onderverdeeld in primair en secundair. De primaire lymfoïde organen, het beenmerg 
en de thymus, zijn de locaties voor respectievelijk B en T lymfocyt ontwikkeling. De secundaire 
lymfoïde organen bieden een omgeving waarin afweer reacties worden gestart en waar de kans 
op interacties tussen lymfocyten en antigen presenterende cellen verhoogd is en omvatten o.a. de 
lymfeklieren, de milt en de platen van Peyer.
Secundaire lymfoïde organen (SLO) ontwikkelen zich tijdens de embryogenese. Het bestu-
deren van SLO ontwikkeling in de mens kent hierdoor grote beperkingen en derhalve is de 
wetenschappelijke kennis over dit onderwerp voornamelijk verkregen middels muis studies. 
Lymfeklierontwikkeling in de muis begint tussen dag 11 en 14 van de embryogenese wanneer 
-
male cellen induceren tot de expressie van de lymphotoxine bèta (LTβ) receptor. Activatie van de 
LTβ-receptor door LTic-membraan gebonden lymfotoxine, induceert de expressie van homeo-
statische chemokines (CXCL13, CCL19 en CCL21) en adhesiemoleculen (ICAM-1, VCAM-1 
resulteert in het aantrekken en behouden van meer en meer LTic waardoor er een positieve 
feedback loop ontstaat. Verder in de ontwikkeling worden de typische hoog endotheliale venules 
geïnduceerd en postnataal de T en B cel gebieden gevormd. 
Vanuit de medische wetenschap is er een grote interesse in tertiaire lymfoïde organen (TLS). 
Deze ectopische lymfoïde structuren worden gevormd tijdens ontstekingreacties om zo een 
optimaal lokaal milieu te genereren van waaruit de infectie bestreden kan worden. TLS zijn 
er qua structuur en complexiteit in verschillende gradaties en lijken in meer of mindere mate 
op lymfeklieren met T en B cel gebieden, hoog endotheliale venules, folliculair dendritische 
-
neer ze ontwikkelen tijdens chronische ontstekingen of auto immuunziekten en dienen als een 
plaats voor auto-reactieve lymfocyt activatie. De mechanismen die ten grondslag liggen aan 
de ontwikkeling van humane ectopische lymfoïde structuren zijn niet goed gekarakteriseerd. 
met SLO ontwikkeling. Zoals hierboven besproken is de wetenschappelijke kennis over humane 
SLO ontwikkeling zeer beperkt. Daarom hebben wij in deze studie de cellulaire componenten 
LTi cellen die behoren tot de familie van de RORC+ -
ing: RORC+ ILC), bleken te communiceren met mesenchymale cellen via lymfotoxine en tumor 
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necrosis factor en produceerden IL-17a. In volwassen mensen evenals in volwassen muizen zijn 
RORC+ ILC aanwezig en wel in tonsillen, lymfeklieren, de huid en in de darm. In volwassen 
muizen is aangetoond dat RORC+ ILC in de darm essentieel zijn in de eerste verdediging tegen 
Citrobacter rodentium via de productie van IL-22. In de mens zijn IL-22 producerende ILC 
aangetoond in volwassen mucosaal weefsel zoals de tonsillen, de platen van Peyer en de darm. 
Samengevat: in foetale lymfeklieren resideren IL-17a producerende ROR+ILC en in tonsillen en 
de adulte darm resideren IL-22 producerende RORC+ ILC. De vraag die wij ons stelde was of de 
IL-17a en IL-22 producerende RORC+ ILC konden worden onderscheiden van elkaar op basis 
van fenotypische kenmerken.
In hoofdstuk 2
humane RORC+ ILC  verrijkt zijn voor de secretie voor IL-17a of IL-22. Beide subsets hebben 
een geactiveerd fenotype maar kunnen onderscheiden worden op basis van de aanwezigheid of 
afwezigheid van de natuurlijke cytotoxiciteits receptor NKp44. We vonden dat NKp44+ IL-22 
producerende cellen aanwezig zijn in tonsillen en adulte darm en dat NKp44- IL-17a producer-
ende cellen aanwezig zijn in de foetale lymfeklieren. Verder tonen we aan dat de ontwikkeling 
van NKp44+ ILC in de humane darm is aangeboren, wat betekent dat ontwikkeling van deze 
resideren NKp44- ILC maar deze produceren geen IL-17a noch IL-22. Echter, stimulatie van 
adulte lymfeklier RORC+ ILC induceert de transcriptie van cytokine genen. Dit suggereert dat 
secundaire humane lymfoïde organen kunnen fungeren als een reservoir voor RORC+ ILC die 
indien nodig in staat zijn te participeren in ontstekingsreacties.
(FDCs) de belangrijkste stromale cellen van respectievelijk de volwassen T en B cel gebieden. In 
2008 beschreef Katakai et al. een tot dan toe nog onbekende stromale cel subset in de lymfoïde 
organen van adulte muizen. Deze RANKL+ Marginal Reticular cellen (MRC) doen fenotypisch 
denken aan de  stromale lymfoïde organizer cellen en zijn gelegen in het buitenste folliculaire 
gebied direct onder de subcapsulaire sinus van de lymfeklier en in de folliculaire dome van platen 
van Peyer. In hoofdstuk 4 tonen we aan dat zowel foetale als volwassen humane lymfeklieren 
populaties van MRCs bevatten die MAdCAM-1 en VCAM-1 positief zijn en worden gekenmerkt 
door de expressie van RANKL.Verdere analyse toonde aan dat humane MRCs positief zijn voor 
de homeostatische B cell en T cell chemokines, CXCL13 en CC L 2 1 . RORC                                +.          ILC in foetale LK
 
+ MRCs. In adulte lymfeklieren bevinden de RORC+ ILC 
zich in het gebied tussen de T en B cel gebieden en de follikels waar zich ook RANKL+ MRCs 
RANKL+ MRCs bevatten die fenotypisch en functioneel lijken op de stromal lymfoïde weefsel 
organiserende cellen zoals in LN anlagen van de muis.
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Nu we in foetale en adulte humane lymfeklieren de aanwezigheid van RANKL+ MRC hadden 
aangetoond, wilden we foetale en volwassen milten ook analyseren voor de aanwezigheid 
van deze stromale cel subset. In hoofdstuk 5 tonen we aan dat de foetale milt van 18 gw een 
MAdCAM-1+VCAM-1+ stromale cel bevat die positief is voor RANKL, CCL21 en CXCL13. 
RORC+ ILC aanwezig in de foetale milt van 18-20 gw. hebben een fenotype overeenkomstig met 
RORC+ ILC in foetale lymfeklieren maar clusteren niet specifiek met de MAdCAM-1+VCAM-1+ 
stromale cellen. Deze data suggereren dat in de foetale milt MRC-achtige cellen aanwezig zijn die 
mogelijk betrokken zijn bij de ontwikkeling van de witte pulpa. 
In hoofdstuk 3 bestudeerden we de interacties tussen folliculair lymfoom (FL) B-cellen en 
stromale beenmerg cellen (BM) nodig voor ectopische B cel follikel vorming. De in vitro 3D 
co-cultuur experimenten en het xenograftmodel in RAG-2-/-γc-/- muizen werden uitgevoerd met 
de progressieve FL afgeleide cellijn WSU-FSCCL in plaats van met primaire folliculair lymfoom 
cellen. In tegenstelling tot primaire FL cellen is WSU-FSCCL niet afhankelijk van externe sig-
nalen voor survival en is de nood voor het veranderen van het  lokale micromilieu om zo de 
overlevingskans te verhogen gering dan wel afwezig. Ondanks dit gegeven laten onze resultaten 
zien dat WSU-FSCCL de expressie van VCAM-1 door humane primaire beenmerg stromale cel-
len induceerde in vitro. Het RAG-2-/-γc-/- xenotransplantatie model leerde ons dat WSU-FSCCL 
evenals primaire FL cellen, preferentieel clusterde in de peritrabeculae van het BM. Om de eerste 
differentieel tot expressie gebrachte genen in de niet hematopoeietische cellen van de lymfeklier 
na het eerste B cel contact te analyseren, hebben we adulte RAG-1-/- muizen geïnoculeerd met B 
cellen en na 7 dagen geanalyseerd met microarray analyse. Met dit experiment vonden we heel 
verrassend een nog niet eerder beschreven stromale bron van IL-22 productie. Welke cellen dit 
zijn en wat de functie is van IL-22 in deze, is onderwerp van verder onderzoek.
Gezamenlijk, dragen de data in dit proefschrift bij aan een beter begrip van de ontwikkeling 
van humane secundaire lymfoïde organen.. De identificatie en karakterisering van “inducers” 
(RORC+ ILC) en de “organizers” (RANKL+ MRCs) in foetaal en adult lymfeweefsel kan gebruikt 
in studies naar de ontwikkeling van ectopische tertiaire lymfoïde structuren en de rol van deze 
structuren tijdens ontstekingsziekten.   
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ABBREVIATIONS
AMP adenosine monophosphate
Bcl B cell lymphoma
BCR B cell receptor
BM bone marrow
CCL19 c-c chemokine  motif ligand 19
CCL21 c-c chemokine  motif ligand 21
CXCL13 c-x-c chemokine motif ligand 13
CXCR5 c-x-c chemokine motif receptor type 5
CXCR7 c-x-c chemokine motif receptor type 7
CD cluster of differentiation
cKIT proto-oncogene KIT, CD117
DAPI 4’,6-diamidino-2-phenylindole
DC dendritic cells
DLBL diffuse large B cell lymhoma
DNA desoxyribonucleic acid
ELISA enzyme-linked immuno sorbent assay
FDC follicular dendritic cells 
FRC fibroblastic reticular cells
FL follicular lymphoma
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
GFP green fluorescent protein
gw gestational weeks
GC germinal center
HEV high endothelial venule
IDC interdigitating cells
ICAM-1 intercellular adhesion molecule 1
Id2 inhibitor of DNA binding protein 2
IFN-y interferon gamma
IL-17 interleukin 17 
IL-22 interleukin 22
IL-7 interleukin 7
IL-7Rα     interleuking 7 receptor alpha
ILC innate lymphocyte cell
JAK Janus kinase
LTic lymphoid tissue inducer cell
LT lymphotoxin
LTβ-R  lymphotoxin-beta receptor
LToc lympoid tissue organizer cell
MAdCAM-1 mucosal addressin cell adhesion molecule 1
MRC marginal reticular cell
MZ marginal zone
NCR natural cytotoxicity receptor
NK natural killer
NKp natural killer cell related protein
PALS periarteriolar lymphoid sheath
PECAM-1 platelet endothelial cell adhesion molecule 
PNAd peripheral node addressin 1
PPs Peyer’s patches
RAG recombination activating gene
RALDH2 
RANK receptor activator of nuclear factor kappa-B 
RANKL receptor activator of nuclear factor kappa-B ligand
RET rearranged during transfection proto-oncogene
Roryt RAR-related orphan receptor yt
RORc RAR-related orphan receptor C
SCID severe combined immune disease
SHM somatic hypermutation
SLO secondary lymphoid organ
SMA smooth muscle actin
TLO tertiary lymphoid organs 
TLS tertiary lymphoid structure
TNF tumor necrosis factor
VCAM-1 vascular cell adhesion molecule 1
WP white pulp
WSU-FSCCL 
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DANKWOORD
In oktober 2007 begon ik met mijn promotieonderzoek op de afdeling Hematologie van het 
werkvloer als daarbuiten, die ik koester en waarvan ik op 31 december 2011 afscheid nam. Een 
periode van radiostilte volgde maar van uitstellen kwam gelukkig geen afstellen. Het langver-
want dit werk zou niet tot stand zijn gekomen zonder de inbreng van anderen. Het schrijven van 
dit dankwoord doe ik dan ook met veel plezier. 
Zeer veel dank ben ik verschuldigd aan mijn copromotor Tom. Via Prof. dr. Mebius, aan wie 
ik had verteld wat voor type promotieplek ik ambieerde, vernam ik dat jij op zoek was naar een 
promovendus. Het onderzoeksplan dat je had geschreven, beantwoordde mijn ambitie volledig. 
Na een prettig sollicitatiegesprek met jou en Jan mocht ik in Rotterdam beginnen. Ondanks de 
vele inspanningen kwam het folliculair lymfoom project niet van de grond, iets dat je op tijd 
signaleerde. Je bood me aan om mee te werken aan het lopende onderzoek naar RORC+ innate 
Natalie vormde zo klein was, waren de samenwerking en begeleiding intens. Het scherpe denken, 
je enthousiasme en doorzettingsvermogen waren stimulerend en een goed voorbeeld van hoe 
je wetenschappelijk onderzoek moet benaderen. Dat ervoer ik heel sterk tijdens onze trip naar 
werden daar geboren. Wanneer nodig kon ik altijd even bij je binnenlopen, de spreekwoordelijke 
drempel was er niet. Nadat ik niet meer in Rotterdam werkte, heb je veel tijd en energie gestoken 
in het mij aanzetten tot het afronden van het manuscript. Dat heb ik niet altijd met gelijke munt 
uitstekend geweest, dat is een verdienste, en dat maakte dat ik met veel plezier gewerkt heb op 
als ik denk aan dingen als:  je systeem der chaos op je bureau, waar je wonderwel toch altijd 
binnen korte tijd dat wist te vinden wat je nodig had. De spannende avonturen met de inmiddels 
legendarische en afgeschreven Volvo. En natuurlijk het beeld dat jij lachend en in je handen 
wrijvend onze werkkamer binnen kwam lopen, nieuwsgierig naar nieuwe data en…. op jacht 
naar snoep. Tom, ik heb je leren kennen als een betrokken mens en wil je bij deze bedanken voor 
alles wat je voor me hebt gedaan.
Jan, bedankt dat je mijn promotor wilde zijn. Ondanks dat je een druk man in de kliniek was 
(bent), bleef je zeer betrokken en goed op de hoogte van het lopende onderzoek. Je kritische
opmerkingen tijdens werkbesprekingen, brachten zwakheden in mijn kennis of onderzoek  
feilloos voor het voetlicht. “ Ai-auw-stom!”  Hierdoor zat ik een volgende keer beter voorbereid 
in mijn stoel, althans dat dacht ik. Tot je weer een vraag stelde. Ik zou je tekort doen door hier 
142
alleen maar een beeld van de kritische professor te schetsen, want naast je strenge doch recht
-vaardige kant heb ik je leren kennen als een hele prettige, sociale en benaderbare man. 
En dan is het nu tijd voor Natalie. Lieve Natalie, heel erg bedankt voor al het werk dat je hebt 
verricht. Zonder de door jou uitgevoerde experimenten zou dit boekje een stuk dunner zijn 
geworden. Ik weet nog goed dat je in het begin wel even moest wennen aan zo’n halve zool naast 
je in het lab. En dan deed hij ook nog altijd de radio aan. Maar al redelijk snel konden we het 
zeer goed met elkaar vinden en spraken we over de meest uiteenlopende onderwerpen. Wel zo 
prettig als je samen de hele dag experimenten aan het uitvoeren was. Dat je geen 9.00-17.00 uur 
mentaliteit had, was wel een zegen. De beruchte dinsdagen konden weleens laat worden…Zeker 
in de tijd van vÓÓr de positieve CD117 selectie. Zo aan het einde van die lange dagen, kwamen 
20.00 uur ging ik poppetjes tekenen bij de ARIA en jij moest raden wie het was: van zo’n beetje 
de hele afdeling zijn er karikaturen getekend. Het avondje stappen in Birmingham is vereeuwigd 
schitterend! Ik hoop bij deze dat jij de foto’s niet meer hebt. Ik heb ze overigens nog wel. Je was 
werken. Heel erg bedankt voor al je inspanningen ten bate van mijn promotie!
Beste Eric, als collega promovendi zaten we in het zelfde schuitje en deelden we gelijke ervarin-
Verkopen ze daar ook Snelle Jelle? En zo niet, met wat vervang je dan dit essentiële stukje koek? 
Ik hoop vurig dat jouw bijzondere dromen stuk voor stuk uitgebracht gaan worden als stripboek. 
Deel 1 zal dan moeten gaan over je ontsnapping, samen met De Burgemeester, aan een reuze 
octopus die de stad komt terroriseren. Mocht je geen geschikte tekenaar vinden, bij deze bied ik 
mij aan als vertolker van het werk. Ik ben ervan overtuigd dat als je net zulke bijzondere vragen 
een voertuig kon zijn, wat zou je dan kiezen?”), je een mooie carrière voor je hebt. Heel veel suc-
ces! Uiteraard moet ik me ook even richten tot Elwin. Ontelbaar vaak heb ik iets aan je gevraagd, 
heb je geholpen met de meest uiteenlopende zaken en was het soms behelpen als je er eens een 
keer niet was. Dank voor al die momenten. Rogier, we hebben in feite maar kort samengewerkt 
-
nen praten en lachen. Ambitie en talent zijn goed vertegenwoordigd in je persoonlijkheid en ik 
wens je het beste toe in je verdere carrière als onderzoeker. Ferry, ik hoop dat na alles wat je hebt 
diepe indruk op me gemaakt. Patricia, ik hoop dat je onderhand meer Nederlands spreekt dan ik 
Spaans en dat je een prettige loopbaan zult hebben in de wetenschap. Eric Braakman, jij bedankt 
voor alle suggesties tijdens werkbesprekingen 
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Ik wil bij deze de leescommissie bestaande uit Prof. dr. Reina Mebius, Prof. dr. Rudi Hendriks 
en Prof. dr. Steven Pals bedanken voor het beoordelen van mijn manuscript. Natuurlijk bedankt 
ik ook de overige leden van de promotiecommissie, Prof. dr. Ivo Touw, dr. Eric Lubberts en dr. 
Marc Raaijmakers voor het zitting nemen.
Beste King Lam en Jeanette Doorduijn, jullie wil ik bedanken voor alle  inspanningen ten bate van 
het folliculair lymfoom project. Aan alle medewerking die ik van jullie heb mogen ervaren  
-
enhuis bedanken dat we op zijn afdeling toestemming voor het gebruik van tonsillen mochten 
vragen. In het verlengde hiervan bedank ik alle chirurgen, OK personeel, verpleegkundigen en
dames van de OK planning voor hun medewerking. Jaap Kwekkeboom en Geert Kazemier wil
ik bedanken voor het adult lymfeklier en milt weesfel dat zeer belangrijk voor mijn ondezoek en
en geduld. Charlotte Peters, Jenny Mjösberg en prof. dr.  Hergen Spits wil ik graag bedanken  
voor de vruchtbare samenwerking. En natuurlijk wil ik de medewerkers van het EDC bedanken 
voor de prettige samenwerking.
I want to thank Marc Coles and Priyanka Narang for the ongoing collaboration. I believe that  
combining your mouse data with our human data will result in a beautiful publication. 
De mensen van de afdeling Hematologie wil ik bedanken voor alle collegialiteit en gezelligheid. 
Samen vormen jullie een hele leuke groep mensen die hard werken, afwisselen met zo nu en dan 
zeer geslaagde borrels, lab-days, en voor wie wil zelfs ski vakanties. Justine en Paulette, ik vond 
het leuk om met jullie een jaartje in de LDC te zitten. Persoonlijk hoogtepunt was toch wel om 
als Sinterklaas een Gerard Joling imitatie te moeten geven. Suming, het was zwaar maar de or-
ganisatie van de AIO-lunches hebben we overleefd. Leuke tijd was het in de kopkamer. Een soort 
van speciale AIO biotoop binnen de afdeling. Later ben ik verhuisd naar een andere, zeer leuke 
werkplek en kwam op een kamer te zitten met o.a. de heren Jasper en Francois en mw. Jeanine. 
Hier was het soms moeilijk te focussen op werk en is de strip “Broodje Gilworst” geboren. Ook 
de secretaresses bedank ik bij deze. Egied, bedankt voor het vormgeven van mijn proefschi.
  Ook wil ik Bob Löwenberg, Ivo Touw, Ruud Delwel, Peter Valk, Marieke von Lindern, Marc 
Raaijmakers en Stefan Erkeland bedanken voor de discussies op de Vroege Vrijdagochtenden en 
het toetsen van mijn onderzoek. 
Lotte en Marleen, laatst dacht ik “mijn” aantekeningen van de bachelor BMW en de master 
in Oncology op te ruimen die ik in al die studiejaren had verzameld. Gek genoeg was er maar 
op de VU die ik met jullie en Lot in het bijzonder had, is de opmaat geweest voor het willen 
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promoveren. Een retrospectieve beschouwing leert mij dat ik naar een manier zocht om die leuke 
tijd te verlengen.
of de mannen van iSoulation een afwezige blik in hun ogen krijgen wanneer ik zo simpel als 
mogelijk tracht te vertellen wat ik al die jaren heb gedaan. Nu is het allemaal gebundeld in dit 
boekje mannen! Ik weet ‘t...... dat verandert niks.
Timothy, Swalter, Scherrie, Schalie en in principe ook Sjako: het oorspronkelijke idee voor het 
geboren op een camping in Biscarosse in het jaar dat Cassius met het album 1999 de hitlijsten 
-
den: 1. Het voorlezen aan kinderen voor het naar bed gaan: hoe snel vallen ze in slaap? 2. Vijf 
mannelijke proefpersonen (genoeg power! muscles….) moeten na het drinken van teveel lauwe 
rode wijn uit een jerrycan een passage uit beide boekjes navertellen: hoe ver komt het proefper-
soon? De winnaar zal nipt winnen, immers beide boekjes hebben genoeg potentie om boven de 
ander te eindigen. Jongens, het is een rijk gevoel om zulke goede vrienden als jullie te hebben.
Tot slot wil ik mijn familieleden bedanken voor hun onvoorwaardelijke steun. Nelly, en in het 
bijzonder, Johan wil ik extra bedanken voor hun betrokkenheid bij het afronden van dit proef-
hebben we binnenkort gezinsuitbreiding. Jullie zijn het allermooiste in mijn leven, daar kan geen 
titel of diploma tegenop!
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CURRICULUM VITAE 
Kerim Hoorweg werd geboren in Willemstad (Curaçao)  op 30 juni 1978. Exact één jaar later 
zat hij in het vliegtuig naar Nederland alwaar hij opgroeide in de gemeente Renkum. In 1997 
behaalde Kerim het VWO diploma aan het Dorenweerd College en aansluitend studeerde hij 
tot 1998 Biologie aan de Katholieke Universiteit Nijmegen. In de zomer van 1998 werd het 
testimonium Natuurkunde aan het James Boswell Institute behaald. Na een periode van werken 
en twee jaar Technische Bedrijfskunde aan de Universiteit Twente ging hij in 2002 Biomedische 
Wetenschappen (BMW) studeren aan de Vrije Universiteit te Amsterdam. Na de bachelor BMW 
volgde Kerim tot 2007 met succes de Master in Oncology aan het VU medisch centrum (VUmc). 
Als student aan de VU heeft Kerim verscheidene onderzoeken gedaan. Tijdens de bachelor BMW 
onderzocht hij “TRANCE expression in lymph nodes at E16.5 in wild type and lymphotoxin 
deficiënt mice” op de afdeling Moleculaire Cel Biologie and Immunologie van het VU medisch 
centrum (VUmc) onder de  supervisie Prof. Dr. R. Mebius. Tijdens de Master in Oncology deed 
Kerim onderzoek naar  “Mechanisms of glucocorticoid resistance in childhood acute leukemia” 
op de afdeling Hematologie  van het VUmc onder de supervisie van dr. Jacqueline Cloos en 
onderzoek naar “Inducing enteroendocrine differentiation in colorectal cancer cell line LS174 
by ways of evading NOTCH signaling en over expressing atonal bHLH transcription factors” 
in het Clevers-lab van het Hubrecht Instituut onder de supervisie van dr. Wim de Lau. In 2007 
begon Kerim als promovendus in de groep van dr. Tom Cupedo met als promotor Prof. dr. Jan 
Cornelissen op de afdeling Hematologie van het Erasmus Medisch Centrum. Dat onderzoek 
staat beschreven in dit proefschrift. Op dit moment is Kerim werkzoekende en in afwachting van 
een mooie baan is hij met veel plezier fulltime huisvader.
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Name PhD student: Kerim  Hoorweg PhD period: 01-10-2007  -  31-12-2011
Erasmus MC department: Hematology Promotor: Prof. Dr. J.J. Cornelissen
Research School: Molecular Medicin Co-promotor: Dr. T. Cupedo
PHD TRAINING         Year                         ECTS
Courses
• Animal experimentation Article 9 WOD 2007 4.2
• Animal imaging by AIME 2008 1.4
• The Course Molecular Medicin (MM) 2008 1.8
• Advanced Immunology (ALIFI) 2009 4.2
Workshops & Seminars
• 3rd symposium & masterclasses on Mucosal Immunology 2008 0.5
• Browsing genes and genomes w Ensemble IV (MM) 2009 0.6
• Basic data analysis on gene expression arrays (MM) 2009 0.5
• Erasmus Hematology Lectures 2007-2011 2.0
Presentations
Oral
• Hematology presentations 2007-2011 3.5
• AIO/Postdoc presentations 2007-2011 1.5
• Literature discussions 2009-2011 1.5
• Workdiscussions 2007-2011 6.0
(Inter)national conferences
• Molecular Medicin day, poster  2008-2009 1.0
• The Dutch Hematology Congress, oral 2008-2009 2.0
• Annual meeting of the dutch society of immunolog poster 2008 1.0 
•  Microanatomy of Immune responses in health and Disease,  2009 2.0
  Birmingham, poster 
• Annual meeting of the dutch society of immunology, oral 2009 1.0
Teaching activities 
• Supervising Master Student 2009-2010 7
   Organizing invited speaker lunch 2009-2010 1.0
• Organizing GOL-day 2008-2009 2
Total ECTS  44.7
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STELLINGEN
 1.   De lokalisatie in perifere lymfeklieren van aangeboren lymfoïde cellen die de celkern-
hormoon receptor RORC tot expressie brengen, suggereert dat deze geactiveerd kunnen 
worden door via lymfe aangevoerde antigenen (dit proefschrift).
 2.  De karakterisatie van interleukine (IL)-17A en IL-22 producerende aangeboren lymfoïde 
cellen biedt de mogelijkheid om een verschuiving in cel populaties en daarmee cytokine 
balans in ziektes waaraan deze cellen mogelijk bijdragen, waaronder inflammatoire darm-
ziekten, te monitoren (dit proefschrift).
 3.  De Marginale Reticulaire Cel (MRC) is een tussen muis en mens evolutionair gecon-
serveerde stromale cel die op basis van fenotype en functionaliteit direct verwant lijkt te zijn 
aan de stromale voorlopercel betrokken bij lymfeklier ontwikkeling (dit proefschrift).
 4.  De productie van interleukine 22 tijdens de ontwikkeling van B cel follikels in de lymfeklier 
suggereert dat de vorming van het stromale netwerk van de lymfeklier overeenkomsten 
vertoont met wondheling (dit proefschrift).  
 5.  Het chemokine profiel van stromale cellen die de adhesie factor MAdCAM-1+ tot expressie 
brengen in de foetale milt suggereert dat dit de stromale voorlopercellen zijn van het T cel 
gebied van de witte pulpa (dit proefschrift).  
 6.  De Marginale Reticulaire Cellen in de platen van Peyer lijken essentieel te zijn voor de differen- 
tiatie van M (micro-plooi) cellen uit epitheliale stamcellen die de G-proteïne-gekoppelde 
receptor Lgr5 tot expressie brengen (The Journal of Immunology, 2008, 181: 6189–6200. 
J Immunol 2009; 183:5738-5747, Mol Cell Biol. 2012 September; 32(18): 3639–3647).
 7.  De factor die wordt aangemaakt bij een te lage zuurstofspanning “Hypoxia-Inducable-
Factor-1” (HIF-1) alpha speelt mogelijk een rol in de ontwikkeling en functie van het 
aangeboren lymfoïde systeem en verdient om die reden nader wetenschappelijk onderzoek 
(Nature Reviews Immunology 5, 712-721; Cell 2011 Sep 2;146(5):772-84; Eur. J. Immunol. 
2012. 42: 1226–1236).
 8.  Men zou zich meer dik moeten maken over de overwichtsproblematiek in onze samenleving 
(Draft action plan for the prevention and control of noncommunicable diseases 2013–2020, 
WHO, 17 jan 2013).
 9.  Muziekles zou tot de verplichte lesstof moeten behoren op alle basisscholen omdat het de cog-
nitieve vermogens van kinderen significant verbeterd (Psychol Sci. 2004 Aug;15(8):511-4). 
 10.  De kans dat een wetenschappelijk onderzoek naar koffieverslaving door een niet koffiever-
slaafde vakgenoot wordt beoordeeld is zeer klein.
 11.  De weg naar een academische promotie kent een duidelijk vertrek- en eindpunt. De route 
naar het eindpunt is voor elke promovendus anders in tegenstelling tot de drijvende kracht die 
nodig is om van vertrek- tot eindpunt te geraken: ambitie.
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